<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003195.pub2" GROUP_ID="INCONT" ID="942699091410312479" MERGED_FROM="" MODIFIED="2013-10-28 14:41:40 +0000" MODIFIED_BY="Muhammad Imran Omar" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Short title (no longer in use): Urodynamics for urinary incontinence:&lt;/p&gt;&lt;p&gt;Editors' comments received and incorporated 12.3.01.&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 14:38:32 +0000" NOTES_MODIFIED_BY="Muhammad Imran Omar" REVIEW_NO="0020" REVMAN_SUB_VERSION="5.2.6 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2013-10-28 14:41:40 +0000" MODIFIED_BY="Muhammad Imran Omar">
<TITLE MODIFIED="2011-12-06 15:11:53 +0000" MODIFIED_BY="[Empty name]">Urodynamic studies for management of urinary incontinence in children and adults</TITLE>
<CONTACT MODIFIED="2013-10-28 14:41:40 +0000" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="7513" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Cathryn</FIRST_NAME><MIDDLE_INITIALS>MA</MIDDLE_INITIALS><LAST_NAME>Glazener</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>c.glazener@abdn.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Health Services Research Unit</DEPARTMENT><ORGANISATION>University of Aberdeen</ORGANISATION><ADDRESS_1>3rd Floor, Health Sciences Building</ADDRESS_1><ADDRESS_2>Foresterhill</ADDRESS_2><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><REGION>Scotland</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1224 438168</PHONE_1><FAX_1>+44 1224 438165</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-10-28 14:41:40 +0000" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="24979160635922216753120525101156" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Keiran David</FIRST_NAME><LAST_NAME>Clement</LAST_NAME><EMAIL_1>keiran.clement.09@aberdeen.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Cochrane Incontinence Group</DEPARTMENT><ORGANISATION>University of Aberdeen</ORGANISATION><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="14235" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Marie Carmela M</FIRST_NAME><LAST_NAME>Lapitan</LAST_NAME><POSITION>Professor of Urology</POSITION><EMAIL_1>melalapitan@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Division of Urology</DEPARTMENT><ORGANISATION>Philippine General Hospital</ORGANISATION><ADDRESS_1>Taft Ave</ADDRESS_1><CITY>Manila</CITY><ZIP>1000</ZIP><COUNTRY CODE="PH">Philippines</COUNTRY><PHONE_1>+632 5255453</PHONE_1><PHONE_2>+632 5226237</PHONE_2><FAX_1>+632 5264356</FAX_1></ADDRESS></PERSON><PERSON ID="74740356430336605589110415170237" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Muhammad Imran</FIRST_NAME><LAST_NAME>Omar</LAST_NAME><POSITION>Managing Editor Cochrane Incontinence Review Group</POSITION><EMAIL_1>m.i.omar@abdn.ac.uk</EMAIL_1><EMAIL_2>drimran@yahoo.com</EMAIL_2><ADDRESS><DEPARTMENT>Academic Urology Unit</DEPARTMENT><ORGANISATION>University of Aberdeen</ORGANISATION><ADDRESS_1>Health Sciences Building (second floor)</ADDRESS_1><ADDRESS_2>Foresterhill</ADDRESS_2><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><REGION>Scotland</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 (0) 122 4438126</PHONE_1></ADDRESS></PERSON><PERSON ID="7513" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Cathryn</FIRST_NAME><MIDDLE_INITIALS>MA</MIDDLE_INITIALS><LAST_NAME>Glazener</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>c.glazener@abdn.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Health Services Research Unit</DEPARTMENT><ORGANISATION>University of Aberdeen</ORGANISATION><ADDRESS_1>3rd Floor, Health Sciences Building</ADDRESS_1><ADDRESS_2>Foresterhill</ADDRESS_2><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><REGION>Scotland</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1224 438168</PHONE_1><FAX_1>+44 1224 438165</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-10-21 13:13:30 +0100" MODIFIED_BY="Cathryn Glazener" NOTES="&lt;p&gt;Minor update: 11/10/06&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 5/29/06&lt;/p&gt;" NOTES_MODIFIED="2013-10-21 13:13:30 +0100" NOTES_MODIFIED_BY="Cathryn Glazener">
<UP_TO_DATE>
<DATE DAY="19" MONTH="2" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="2" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="9" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2002"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2012"/>
</DATES>
<WHATS_NEW MODIFIED="2013-10-28 13:06:08 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-10-21 13:20:03 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="10" YEAR="2013"/>
<DESCRIPTION>
<P>Added two new trials (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) and excluded one trial which was included in the previous update (<LINK REF="STD-Kristjansson-1999" TYPE="STUDY">Kristjansson 1999</LINK>) as participants included men with LUTS</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-10-28 13:06:08 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="10" YEAR="2013"/>
<DESCRIPTION>
<P>Added two new trials (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) and excluded one trial which was included in the previous update (<LINK REF="STD-Kristjansson-1999" TYPE="STUDY">Kristjansson 1999</LINK>) as participants included men with lower urinary tract symptoms (LUTS)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-10-21 13:13:40 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-10-21 13:13:38 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="12" YEAR="2011"/>
<DESCRIPTION>
<P>Four new trials added, but data only available from 5 of the 7 included trials. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-10-21 13:13:40 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="3" YEAR="2011"/>
<DESCRIPTION>
<P>Four new trials added, but data only available from 5 of the 7 included trials.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-12-01 10:23:53 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-10 16:47:06 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="9" YEAR="2006"/>
<DESCRIPTION>
<P>Minor Update Issue 1 2007. 12 new trials were excluded, and one new trial was added (O'Connell 2004). However, the trialists provided no data, so the conclusions of the review are unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-10 16:47:04 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="3" YEAR="2004"/>
<DESCRIPTION>
<P>Minor Update Issue 3 2004. 18 new studies were excluded. Two of these may have been relevant RCTs but we were unable to confirm this with the trialists or obtain extra data.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-10-10 16:47:43 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="5" YEAR="2002"/>
<DESCRIPTION>
<P>Review first published</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-03-29 14:02:57 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2013-03-29 14:02:57 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2013-03-29 14:02:57 +0000" MODIFIED_BY="[Empty name]">
<NAME>The National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Incontinence Group. </P>
<P>Disclaimer:<BR/>The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-10-28 13:07:31 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-11-04 11:33:29 +0000" MODIFIED_BY="[Empty name]">Urodynamic studies (tests) for the management of urinary incontinence in children and adults</TITLE>
<SUMMARY_BODY MODIFIED="2013-10-28 13:07:31 +0000" MODIFIED_BY="[Empty name]">
<P>Urinary incontinence is defined as the involuntary loss of urine and is the inability to retain urine in the bladder between voluntary acts of urination. It has a number of different causes. Urodynamic tests are used to measure nerve and muscle function, pressure around and in the bladder, flow rates, and other factors which might help to explain why someone leaks urine or what type of leakage they have. Some people find these tests embarrassing and uncomfortable. However, they might show what the cause of the incontinence is, or what sort of incontinence the person has, so that the correct treatment can be chosen. This might improve the success of the treatment.</P>
<P>Eight trials were found, which included around 1100 people, although information was only available for 1036 women. There was not enough evidence to determine whether the urodynamic tests led to better outcomes. There was some evidence that urodynamic testing increased the number of people given drugs but not the number of people undergoing surgery. This did not result in any difference in the number of people who leaked urine, and it was not known whether they had a better quality of life.</P>
<P>More research is needed in which people are randomised to having treatment decisions based on either their symptoms and examination alone or after taking into account the extra information provided by urodynamic tests.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-10-28 13:07:24 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-10-28 13:06:10 +0000" MODIFIED_BY="[Empty name]">
<P>Urodynamic tests are used to investigate people who have urinary incontinence or other urinary symptoms in order to make a definitive, objective diagnosis. The aim is to help select the treatment most likely to be successful. The investigations are invasive and time consuming.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-10-28 13:06:37 +0000" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to determine if treatment according to a urodynamic-based diagnosis, compared to treatment based on history and examination, led to more effective clinical care of people with urinary incontinence and better clinical outcomes.</P>
<P>The intention was to test the following hypotheses in predefined subgroups of people with incontinence:<BR/>(i) urodynamic investigations improve the clinical outcomes;</P>
<P>(ii) urodynamic investigations alter clinical decision making;</P>
<P>(iii) one type of urodynamic test is better than another in improving the outcomes of management of incontinence or influencing clinical decisions, or both.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-10-28 13:06:49 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Incontinence Group Specialised Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and MEDLINE In-Process, handsearching of journals and conference proceedings (searched 19 February 2013), and the reference lists of relevant articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-10-28 13:06:53 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised and quasi-randomised trials comparing clinical outcomes in groups of people who were and were not investigated using urodynamics, or comparing one type of urodynamic test against another were included. Trials were excluded if they did not report clinical outcomes.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-10-28 13:06:57 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed trial quality and extracted data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-10-28 13:07:18 +0000" MODIFIED_BY="[Empty name]">
<P>Eight trials involving around 1100 people were included but data were only available for 1036 women in seven trials, of whom 526 received urodynamics. There was some evidence of risk of bias. The four deaths and 12 dropouts in the control arm of one trial were unexplained.</P>
<P>There was significant evidence that the tests did change clinical decision making. Women in the urodynamic arms of three trials were more likely to have their management changed (proportion with change in management compared with the control arm 17% versus 3%, risk ratio (RR) 5.07, 95% CI 1.87 to 13.74), although there was statistical heterogeneity. There was evidence from two trials that women treated after urodynamic investigations were more likely to receive drugs (RR 2.09, 95% CI 1.32 to 3.31). On the other hand, in five trials women undergoing treatment following urodynamic investigation were not more likely to undergo surgery (RR 0.99, 95% CI 0.88 to 1.12).</P>
<P>There was no statistically significant difference however in the number of women with urinary incontinence if they received treatment guided by urodynamics (37%) compared with those whose treatment was based on history and clinical findings alone (36%) (for example, RR for the number with incontinence after the first year 1.02, 95% CI 0.86 to 1.21). It was calculated that the number of women needed to treat was 100 women (95% CI 86 to 114 women) undergoing urodynamics to prevent one extra individual being incontinent at one year.</P>
<P>One trial reported adverse effects and no significant difference was found (RR 1.10, 95% CI 0.81 to 1.50).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-10-28 13:07:24 +0000" MODIFIED_BY="[Empty name]">
<P>While urodynamic tests did change clinical decision making, there was some evidence that this did not result in better outcomes in terms of a difference in urinary incontinence rates after treatment. There was no evidence about their use in men, children, or people with neurological diseases. Larger definitive trials are needed in which people are randomly allocated to management according to urodynamic findings or to management based on history and clinical examination to determine if performance of urodynamics results in higher continence rates after treatment.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<P>Urodynamic tests are used in the diagnostic investigation of people complaining of urinary incontinence or bothersome lower urinary tract symptoms (LUTS) during bladder filling or voiding, or both. Urodynamic investigations measure bladder pressure and urine flow rate during bladder filling and voiding in order to assess the neuromuscular function and dysfunction of the urinary tract, and identify the cause(s) of urine storage and voiding dysfunction.</P>
<P>In the evaluation of urinary incontinence, the aim of urodynamic tests is to demonstrate incontinence objectively and differentiate between types of incontinence so that the most effective method of treatment can be selected. However, there is as yet no evidence that this approach improves clinical outcomes or that urodynamic tests can predict who will be cured of or develop overactive bladder (OAB) or voiding dysfunction after surgery for stress incontinence (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>).</P>
<P>In the evaluation of urinary incontinence in men, urodynamics are commonly used in the diagnosis of stress urinary incontinence (SUI), OAB and LUTS such as voiding dysfunction (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>). In the evaluation of voiding dysfunction in men, it is thought to be important to distinguish between LUTS due to bladder outlet obstruction (BOO) or due to detrusor underactivity as management decisions can be altered depending on the findings; there is some low level evidence that making this distinction is important as clinical outcomes are affected (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>). However, this review is confined to the use of urodynamics to help in the diagnosis of stress and urgency incontinence only. Urodynamic studies amongst people with LUTS and voiding dysfunction will be addressed in a separate Cochrane review. Finally, there is strong expert opinion amongst clinicians that the management of certain types of neurogenic bladder requires urodynamic evaluation (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>).</P>
<CONDITION MODIFIED="2013-10-28 13:08:04 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Definitions and terminology</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Urinary incontinence</HEADING>
<P>Urinary incontinence is defined as 'a symptom or sign of any involuntary loss of urine' (<LINK REF="REF-Abrams-2002" TYPE="REFERENCE">Abrams 2002</LINK>) and 'the involuntary loss of urine' (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). Continence (storage of urine) is maintained when the pressure in the outlet from the bladder (urethral pressure) is greater than the pressure inside the bladder itself (intravesical pressure). The principal lower urinary tract storage symptoms are due either to urethral sphincter weakness causing stress urinary incontinence or detrusor overactivity resulting in overactive bladder symptoms (OAB) with or without urgency urinary incontinence.</P>
<P>Urinary incontinence is a common problem. Estimates from a variety of sources present a picture of increasing prevalence during young adult life (prevalence 20% to 30%), a broad peak around middle age (prevalence 30% to 40%) and then a steady increase in the elderly (prevalence 30% to 50%) (<LINK REF="REF-Hunskaar-2002" TYPE="REFERENCE">Hunskaar 2002</LINK>). The presence of severe or 'significant' incontinence (defined by a high frequency or amount of leakage, soakage of clothes, usage of pads, etc) is fairly consistent and ranges between 3% and 17%, with most studies reporting between 6% and 10%. These figures may not reflect the true scope of the problem because embarrassment and other factors may lead to under-reporting, or alternatively because some people may have incontinence without finding it bothersome. Incontinence is more frequent amongst women, increases with age and is particularly common amongst those in residential care.</P>
<P>Urinary incontinence is commonly divided into two types based on the symptoms of stress and urgency.<BR/>
</P>
<UL>
<LI>Stress urinary incontinence (SUI) is the complaint of involuntary loss of urine on effort or physical exertion (e.g., sporting activities) or on sneezing or coughing (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). This is usually due to anatomical defects in the structures that support the bladder and urethra, or dysfunction of the neuromuscular components that help control urethral pressure, or both. It is less common in men than women. The diagnosis 'stress incontinence' is based on the assumption that the bladder (intravesical) pressure exceeds the urethral pressure (such as when the abdominal pressure rises during coughing or laughing), in the absence of detrusor muscle (bladder smooth muscle) contraction.</LI>
<LI>Urgency urinary incontinence (UUI) is the involuntary leakage of urine accompanied by or immediately preceded by urgency (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). It usually results from involuntary increases in the bladder pressure due to detrusor overactivity (bladder smooth muscle contractions).</LI>
<LI>When symptoms of stress and urgency incontinence are present together, this is called mixed urinary incontinence (MUI) (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>).</LI>
</UL>
<P>When symptoms of stress or urgency incontinence are confirmed objectively using urodynamic investigations, the two main types of incontinence are called urodynamic stress incontinence (USI), implying the sign of stress incontinence in the absence of detrusor muscle contraction, and detrusor overactivity (DO) incontinence (DOI), incontinence triggered by a detrusor muscle contraction, respectively (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>).</P>
<P>Overactive bladder syndrome (OAB) is diagnosed when urinary urgency occurs in the absence of urinary tract infection; other urinary symptoms such as urgency urinary incontinence, detrusor overactivity, frequency and nocturia may also be present.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Voiding dysfunction</HEADING>
<P>Voiding symptoms are experienced during the voiding phase (emptying the bladder). Voiding dysfunction can include slow stream, intermittent stream, splitting or spraying, hesitancy, straining or terminal dribble (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). Bladder outlet obstruction (BOO) and detrusor underactivity are the two most common causes of voiding dysfunction but they cannot be distinguished by patient report of symptoms such as slow stream. Voiding difficulties and other LUTS due to BOO are more common in men but the use of urodynamics in their diagnosis and management is not covered in the scope of the current review.</P>
</SUBSECTION>
</SUBSECTION>
</CONDITION>
<INTERVENTION MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<P>The term &#8216;urodynamics&#8217; encompasses a number of varied physiological tests of bladder and urethral function that aim to demonstrate an underlying abnormality of storage or voiding (<LINK REF="REF-NCCWCH-2006" TYPE="REFERENCE">NCCWCH 2006</LINK>). The term is often used loosely to mean multichannel cystometry.</P>
<P>Urodynamic studies are invasive, usually involving at least the insertion of a catheter into the urethra. A range of parameters may be measured, including pressure in the urethra, bladder and abdomen, electrical nerve function and urinary flow rates. A significant number of people who are tested find the procedures embarrassing, painful or distressing (<LINK REF="REF-Gorton-1999" TYPE="REFERENCE">Gorton 1999</LINK>). However, urodynamics has been invaluable in increasing our understanding of the different processes involved in both continence and incontinence (<LINK REF="REF-Homma-1999" TYPE="REFERENCE">Homma 1999</LINK>).</P>
<P>During urodynamic studies in women, the most important aim is to reproduce the symptoms of incontinence. This is usually achieved by using a urinary catheter to fill the bladder with water, physiological saline or contrast medium (or the normal urine output during time of testing) in order to provoke the conditions resulting in incontinence (mediated by coughing, standing up or with other manoeuvres). The bladder sensations are reported by the patients as desire to void, discomfort or pain.</P>
<P>Another aspect of urodynamic investigation is the measure of pressures during the phases of the micturition cycle, that is, during filling or voiding, or both. The principal pressures are:</P>
<UL>
<LI>the intravesical pressure (within the bladder); and</LI>
<LI>the abdominal pressure (within the abdominal cavity, usually measured in the vagina or rectum).</LI>
</UL>
<P>Intravesical pressure (Pves) is a summation of pressures generated by bladder contraction (Pdet) and the abdominal pressure transmitted to the bladder wall (Pabd). The difference between the intravesical and abdominal pressure is called the detrusor pressure (Pdet). Pressure is usually measured by a strain gauge outside the body: the pressures generated inside the body must be transmitted to it by fluid-filled catheters. Alternatively, transducers to measure pressure can be mounted on a 'microtip' catheter that can be inserted into a body cavity. The variation in pressure pattern changes (rather than absolute values) are usually used to diagnose various conditions.</P>
<SUBSECTION>
<HEADING LEVEL="3">Urine flow rate measurement and residual volume measurement</HEADING>
<P>Aside from pressure measurements, urodynamic investigation may also involve the measurement of urine flow rates. Uroflowmetry is a measure of the rate of flow of urine, and may be followed by the measurement of the residual volume either by ultrasonographic scanning of the bladder or by catheterisation. Pressure-flow studies relate flow rates to changes in pressure during bladder emptying.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other types of urodynamics</HEADING>
<P>Surface electromyography is an indirect measure of pelvic floor and sphincter muscle contractility. Videourodynamics involves synchronous X-ray or ultrasound imaging of the bladder with multichannel cystometry and is so called because originally the information was recorded on a videotape. Ambulatory urodynamics involves multichannel cystometry carried out with physiological bladder filling rates and using portable recording devices that enable the patients to perform their usual activities during the test.</P>
<P>Gas cystometry uses carbon dioxide as the medium to fill the bladder during the study. It has been found to be unreliable and is now not recommended (<LINK REF="REF-Homma-1999" TYPE="REFERENCE">Homma 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Risks of urodynamics</HEADING>
<P>The main risks of urodynamic tests are those associated with urethral catheterisation, such as dysuria (painful urination) and urinary tract infection (UTI). A separate Cochrane review addresses interventions to reduce the risk of infection (<LINK REF="REF-Latthe-2012" TYPE="REFERENCE">Latthe 2012</LINK>). Urodynamic tests also require the use of sophisticated machines and technical expertise, which may result in considerable expense to the patient or the healthcare system. Many women also find them an uncomfortable or embarrassing experience.</P>
<P>Furthermore, the reliability of urodynamics in diagnosing some forms of incontinence may lead to false-positive or false-negative results. For example, a false-positive result for DO due to artefactual detrusor contractions (for example, due to the insertion of a catheter) may lead to the inappropriate prescription of drugs for this condition and hence the postponement of surgery. Conversely, a false-negative result for DO may lead to conservative or surgical therapy instead, and therefore failure to treat the symptoms correctly.</P>
</SUBSECTION>
</INTERVENTION>
<THEORY MODIFIED="2013-10-28 13:09:29 +0000" MODIFIED_BY="[Empty name]">
<P>Although urodynamic tests are widely used, their place in the investigation and management of incontinence is controversial. It has been questioned whether urodynamic findings are reproducible (<LINK REF="REF-Lose-1996" TYPE="REFERENCE">Lose 1996</LINK>; <LINK REF="REF-Sorensen-1988" TYPE="REFERENCE">Sorensen 1988</LINK>) and whether urodynamics are sufficiently sensitive and specific to identify the underlying pathology reliably (<LINK REF="REF-Lose-1998a" TYPE="REFERENCE">Lose 1998a</LINK>). It has long been recognised that there is considerable discrepancy between patients' symptoms and the urodynamic diagnosis (<LINK REF="REF-Cardozo-1980" TYPE="REFERENCE">Cardozo 1980</LINK>; <LINK REF="REF-Gorton-2000" TYPE="REFERENCE">Gorton 2000</LINK>; <LINK REF="REF-Jarvis-1980" TYPE="REFERENCE">Jarvis 1980</LINK>). Despite this, the Royal College of Obstetricians and Gynaecologists in the UK recommends that women undergoing surgery for stress incontinence should have urodynamic investigations prior to treatment (<LINK REF="REF-RCOG-2003" TYPE="REFERENCE">RCOG 2003</LINK>). This is not necessarily common practice in the UK (<LINK REF="REF-Black-1997" TYPE="REFERENCE">Black 1997</LINK>) or internationally (<LINK REF="REF-Duggan-2003" TYPE="REFERENCE">Duggan 2003</LINK>), however.</P>
<P>There is currently no consensus about whether or not urodynamic investigations need to be performed to guide management. Indeed, no published research supports a need for cystometric testing in routine or basic evaluation of urinary incontinence (<LINK REF="REF-AHCPR-1996" TYPE="REFERENCE">AHCPR 1996</LINK>). For example, in a survey of 442 women treated surgically for stress incontinence, Black and colleagues found that the likelihood of improvement was similar regardless of whether or not urodynamic pressure studies had been conducted before surgery (<LINK REF="REF-Black-1997" TYPE="REFERENCE">Black 1997</LINK>). Although this study did not conclusively show that urodynamics had little or no prognostic value, it suggested that the role of urodynamic testing needed reappraisal.</P>
<P>The need for preoperative urodynamics is often justified by the consideration that pre-existing DO may be either a contra-indication for surgery or at least carry a worse prognosis. However, in one study women who suffered from urgency before operation actually reported a reduction in urgency after surgery (<LINK REF="REF-Ward-2002" TYPE="REFERENCE">Ward 2002</LINK>). Similarly in a report of the success of tension-free vaginal tape surgery in elderly women (all of whom had preoperative urodynamics), 46% had preoperative urgency cured after surgery and 21% developed it de novo (<LINK REF="REF-Sevestre-2003" TYPE="REFERENCE">Sevestre 2003</LINK>). This symptom is commonly believed to worsen after surgery for stress incontinence, is often considered to be a contra-indication and is thought to result in worse outcomes, but the reverse may be the case in practice as preoperative urgency symptoms resolve in a substantial proportion (50% to 65%) of women after surgery (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>). It seems likely that this finding would also apply to DO, and therefore its preoperative diagnosis would seem to be unnecessary as it would not influence management. Similarly, the value of distinguishing between intrinsic sphincter deficiency and bladder neck or urethral mobility has also not been established, and the official position of the International Continence Society (ICS) is that these are simplistic and arbitrary terms and not to be used until further research has been done (<LINK REF="REF-Abrams-2002" TYPE="REFERENCE">Abrams 2002</LINK>).</P>
<P>A Committee of the International Consultation on Incontinence (ICI) has published a recent overview of the best scientific evidence with regard to the role of urodynamics in the management of people with urinary incontinence or voiding difficulties (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>). In contrast to the conclusions of the previous consultation (<LINK REF="REF-Griffiths-2005" TYPE="REFERENCE">Griffiths 2005</LINK>), the new Committee concluded that "urodynamic studies should be carried out in all women prior to surgery for stress urinary incontinence" (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>). Nevertheless, they also found that the chance of developing overactive bladder syndrome or urinary urgency after surgery was largely unpredictable (by urodynamics or any other method) (). Nor was urodynamics clearly useful as a predictor of surgical failure (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>) or of postoperative voiding dysfunction (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>). Nor was it useful to predict which women would develop SUI after prolapse surgery (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>).</P>
<P>They did suggest that "a well-designed multicentre study should address the question as to whether women with symptoms of pure stress urinary incontinence are more at risk of failure from surgical treatment of their incontinence without pre-operative urodynamics or have more adverse events following surgery without pre-operative urodynamics" than women who do have these investigations.</P>
<P>The committee also felt that the cost effectiveness of urodynamic testing should be taken into account when discussing the necessity of urodynamic investigation. For example, it was not considered to be cost effective to carry out urodynamic studies in a primary healthcare setting for women with predominant stress symptoms.</P>
<P>It is possible that one type of urodynamic investigation may provide more useful information than another. This is the issue addressed by studies comparing the utility of ambulatory urodynamics and conventional urodynamics, particularly in diagnosing DO and UUI. In one study conventional urodynamic tests were normal but an alternative method (ambulatory urodynamics) provided a pathological diagnosis. However, in this study subsequent management did not appear to be influenced by the new test results as only two thirds of those diagnosed with DO were treated with anticholinergic drugs, of whom less than half improved, and a quarter of those who did not have DO were treated with drugs anyway (<LINK REF="REF-Gorton-2000" TYPE="REFERENCE">Gorton 2000</LINK>).</P>
<P>The place for drug treatment of urinary incontinence is the subject of other Cochrane Reviews (<LINK REF="REF-Alhasso-2006" TYPE="REFERENCE">Alhasso 2006</LINK>; <LINK REF="REF-Campbell-2007" TYPE="REFERENCE">Campbell 2007</LINK>; <LINK REF="REF-Madhuvrata-2012" TYPE="REFERENCE">Madhuvrata 2012</LINK>; <LINK REF="REF-Mariappan-2005" TYPE="REFERENCE">Mariappan 2005</LINK>) and one on anticholinergic drugs (<LINK REF="REF-Nabi-2006" TYPE="REFERENCE">Nabi 2006</LINK>) and another on adrenergic agonists (<LINK REF="REF-Alhasso-2005" TYPE="REFERENCE">Alhasso 2005</LINK>) have been published.</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<P>Urinary incontinence is an increasingly common problem. In 2008, the ICI (International Consultation on Incontinence) estimated that, globally, there were 250 million adult females and 98 million adult men with some form of incontinence, with these figures expected to rise to 275 and 109 million respectively by 2013 (<LINK REF="REF-Abrams-2009" TYPE="REFERENCE">Abrams 2009</LINK>).</P>
<P>The diagnostic accuracy of a test is normally determined by verifying the test results against a reference (gold) standard which defines true disease status. The diagnostic performance of urodynamics cannot be assessed in this way, however, because there is no accepted gold standard. In the absence of a gold standard, there may be no alternative to evaluating whether the treatment response after urodynamics leads to more health gain than where the treatment response is based on tests which do not include urodynamics.</P>
<P>Furthermore, the tests are not without cost. They are invasive, expensive and may have adverse effects. For the financial year 2011 to 2012, in the National Health Service (NHS) in England urodynamically testing one patient on an outpatient basis was calculated to cost GBP 147. This increased to GBP 340 on a day-case basis. With regards to adverse effects, it is estimated that a single urodynamics episode results in a 3% to 20% incidence of symptomatic UTI (<LINK REF="REF-Latthe-2012" TYPE="REFERENCE">Latthe 2012</LINK>). The use of prophylactic antibiotics to reduce this rate is addressed in another Cochrane review (<LINK REF="REF-Latthe-2012" TYPE="REFERENCE">Latthe 2012</LINK>).<BR/>
</P>
<P>The value of accurate diagnosis depends on the availability and effectiveness of appropriate treatments. It is of no clinical value unless it is known, for example, that urodynamics distinguishes between a group for whom surgery is effective and another group for whom it is not effective or is contra-indicated, or where management needs to be altered in a specific way.</P>
<P>The value of urodynamic investigation in the diagnosis and management of people complaining of incontinence is therefore open to question (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>). Urodynamic studies amongst people with voiding dysfunction will be addressed in a future update of this review.</P>
<P>This review addresses whether the extra information generated by urodynamics influences clinical decision making for people with incontinence, and particularly whether it leads to an improvement in clinical and economic outcomes.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-10-28 13:10:18 +0000" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to determine if treatment according to a urodynamic-based diagnosis, compared to treatment based on history and examination, led to more effective clinical care of people with urinary incontinence and better clinical outcomes.</P>
<P>The intention was to test the following hypotheses in predefined subgroups of people with incontinence:<BR/>(i) urodynamic investigations improve the clinical outcomes;</P>
<P>(ii) urodynamic investigations alter clinical decision making;</P>
<P>(iii) one type of urodynamic test is better than another in improving the outcomes of management of incontinence or influencing clinical decisions, or both.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-10-28 13:12:56 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-10-28 13:11:35 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-10-28 13:10:21 +0000" MODIFIED_BY="[Empty name]">
<P>All randomised or quasi-randomised controlled trials on the management of urinary incontinence in which people with symptoms were randomised to having urodynamics in at least one arm of the study.</P>
<P>Studies which did not report the clinical outcomes of incontinence management or effects on clinical decision making were excluded.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-10-28 13:10:23 +0000" MODIFIED_BY="[Empty name]">
<P>All people presenting for the investigation and management of their urinary incontinence, as defined by the trialists.</P>
<P>It was intended to examine urodynamic tests in the following subgroups of people: women, men, people with neurological diseases, and children. Studies with participants who had primary incontinence or recurrent incontinence after failed treatment were included.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-10-28 13:10:33 +0000" MODIFIED_BY="[Empty name]">
<P>1. Urodynamic investigations as part of the diagnostic work-up prior to management decisions compared with work-up without recourse to urodynamics (including clinical history, examination, symptoms reported on enquiry or by questionnaire, urinary diaries, pad tests, etc).</P>
<P>2. Comparison of different types of urodynamics programmes prior to management decisions.</P>
<P>All types of urodynamics were eligible for consideration in this review (<LINK REF="REF-AHCPR-1996" TYPE="REFERENCE">AHCPR 1996</LINK>; <LINK REF="REF-Homma-1999" TYPE="REFERENCE">Homma 1999</LINK>). These include:</P>
<UL>
<LI>cystometry (simple, multichannel or subtracted: study of the pressure-volume relationship of the bladder during urine storage (filling cystometry) and urine expulsion (voiding cystometry));</LI>
<LI>urethral pressure measurements (profilometry: measurement of the pressure within the urethra; the urethral closure pressure is the difference between the intraluminal pressure in the urethra and the intravesical pressure in the bladder at rest or during stress such as coughing or straining);</LI>
<LI>leak point pressure measurements (the pressure within the bladder at which leakage of urine from the urethra occurs: a direct measure of the closure function of the entire urethra);</LI>
<LI>uroflowmetry, and residual urine measurement (recording of the volume of fluid expelled via the urethra per unit time during voiding, and the volume of urine left in the bladder after voiding);</LI>
<LI>pressure-flow studies of voiding (study of the bladder pressure-urine flow rate relationship during voiding);</LI>
<LI>electromyography (direct measurement of the contractility of the muscles concerned with continence, i.e., urethral sphincter, anal sphincter, or pelvic floor muscles);</LI>
<LI>video urodynamics (radiologic (X-ray) imaging and urodynamic measurements of the lower urinary tract performed simultaneously during filling and voiding); and</LI>
<LI>ambulatory urodynamic monitoring (urodynamic test performed under physiologic bladder filling and circumstances where the patient is free to move around).</LI>
</UL>
<P>The following comparisons were made:</P>
<P>1. urodynamics versus clinical management without urodynamics;</P>
<P>2. one type of urodynamics versus another.</P>
<P>Cystoscopy and imaging tests (radiography, ultrasonography) are not usually considered to be routine urodynamic tests and were not included in this review. This review is not intended to consider whether urodynamic tests are reliable for making clinical diagnoses, nor whether one type of urodynamic test is better than another for this purpose.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-10-28 13:11:35 +0000" MODIFIED_BY="[Empty name]">
<P>Outcome measures used in this review were selected on the basis of their relevance to the clinical cure or improvement of incontinence. We regarded the principal measures of effectiveness as the proportion of people still incontinent (wet) following a therapeutic intervention, and the proportion of people whose condition was not improved. In addition, the effect of urodynamics in influencing clinical decisions was quantified. Studies which did not report clinical outcomes or effects on clinical decision making were excluded.</P>
<P>We adopted the recommendations made by the Standardisation Committee of the International Continence Society (ICS) for outcomes of research investigating the effect of therapeutic interventions for people with urinary incontinence or voiding dysfunction. These outcome categories include: observations (symptoms) of people being investigated for incontinence; quantification of symptoms; the clinician's observations (anatomical and functional); quality of life; and socioeconomic measures (<LINK REF="REF-Lose-1998a" TYPE="REFERENCE">Lose 1998a</LINK>).</P>
<P>Data could be obtained from both history and questionnaire assessment, or from urinary diaries (including time and type of incontinence, frequency of micturition, and voided volumes) and pad tests (a quantitative estimate of weight of urine lost under standard conditions).</P>
<P>The review also included adverse events as outcome measures.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-10-28 13:10:45 +0000" MODIFIED_BY="[Empty name]">
<P>The proportion of people with persistent urinary incontinence after treatment following assessment with and without urodynamic studies.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-10-28 13:11:35 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">A. Clinical decision making</HEADING>
<UL>
<LI>Number of people receiving conservative, drug or surgical treatments</LI>
<LI>Number of people whose treatment was changed after urodynamics</LI>
<LI>Need for repeat or alternative treatment</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">B. Observations of people being investigated for incontinence</HEADING>
<UL>
<LI>Persistent incontinence or lack of improvement in the short term (&lt; 12 months) and longer term (&gt; 12 months)</LI>
<LI>Voiding dysfunction (subjective)</LI>
<LI>Urgency symptoms or urgency incontinence (post-intervention, clinical diagnosis without urodynamics)</LI>
<LI>Satisfaction with treatment</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">C. Quantification of people's symptoms</HEADING>
<UL>
<LI>Pad changes over 24 hours (from self-reported number of pads used)</LI>
<LI>Pad tests of quantified leakage (mean volume or weight of urine loss on pad)</LI>
<LI>Incontinent episodes over 24 hours (from self-completed bladder chart or diary)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">D. Clinician's observations</HEADING>
<UL>
<LI>Objective assessment of incontinence cure or improvement at post-intervention urodynamics testing</LI>
<LI>Detrusor overactivity (post-intervention urodynamic diagnosis)</LI>
<LI>New or recurrent urogenital prolapse (in women)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">E. Adverse effects</HEADING>
<UL>
<LI>Adverse events (side effects of the urodynamic investigation, or of treatment selected as a result of the investigation)</LI>
<LI>Deaths</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">F. Quality of life</HEADING>
<UL>
<LI>Time to return to normal activity</LI>
<LI>General health status measures (physical, psychological, other)</LI>
<LI>Condition-specific health measures (specific instruments designed to assess incontinence or voiding dysfunction)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">G. Economic outcomes</HEADING>
<UL>
<LI>Health economic measures</LI>
<LI>Costs of investigations</LI>
<LI>Costs of treatments</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">H. Other outcomes</HEADING>
<UL>
<LI>Non-prespecified outcomes judged important when performing the review</LI>
</UL>
<P>Primary and secondary outcomes, as defined above, were classified by the review authors as 'critical', 'important', or 'not important' for decision making from the patient's perspective. The GRADE working group strongly recommends including up to seven critical outcomes in a systematic review.</P>
<P>In this systematic review, GRADE methodology was adopted for assessing the quality of the evidence for the following outcomes.</P>
<UL>
<LI>Number of people whose treatment plan was altered following urodynamics.</LI>
</UL>
<UL>
<LI>Incidence of urinary tract infection associated with urodynamics.</LI>
<LI>Number of women having surgery for incontinence following urodynamics.</LI>
<LI>Number of people with incontinence after 12 months (subjective).</LI>
<LI>Subjective patient satisfaction with treatment.</LI>
<LI>Quality of life measures following treatment after urodynamics.</LI>
<LI>Health outcome measures such as quality-adjusted life years (QALYs).</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-10-28 13:12:07 +0000" MODIFIED_BY="[Empty name]">
<P>We did not impose any language, status of publication or other limits on the searches.<BR/>
</P>
<ELECTRONIC_SEARCHES MODIFIED="2013-10-28 13:12:07 +0000" MODIFIED_BY="[Empty name]">
<P>This review has drawn on the search strategy developed for the Incontinence Review Group. Relevant trials were identified from the Group's Specialised Register of controlled trials which is described, along with the Group's search strategy, under the Incontinence Group's <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/INCONT/frame.html">module</A> in <I>The Cochrane Library</I>. The register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, CINAHL, and handsearching of journals and conference proceedings. The Incontinence Group Specialised Register was searched using the Group's own keyword system, and the search terms used were:<BR/>({design.cct*} OR {design.rct*})<BR/>AND<BR/>({topic.urine*})<BR/>AND<BR/>{intvent.invest*}<BR/>(All searches were of the keyword field of Reference Manager 12, Thomson Reuters).<BR/>The date of the most recent search of the register for this review was 19 February 2013. The trials in the Incontinence Group Specialised Register are also contained in CENTRAL.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2011-11-02 13:52:49 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of relevant articles.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-10-28 13:12:56 +0000" MODIFIED_BY="[Empty name]">
<P>Studies were excluded if they were not randomised or quasi-randomised trials involving people or children with urinary incontinence. In addition, studies which did not report clinical outcomes or an effect on clinical decision making were excluded. Excluded studies were listed, with details of the interventions compared and the reasons for their exclusion.</P>
<P>Included data were processed as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<STUDY_SELECTION MODIFIED="2013-10-28 13:12:19 +0000" MODIFIED_BY="[Empty name]">
<P>The reports of all possibly eligible studies were evaluated by two review authors for methodological quality and appropriateness for inclusion without prior consideration of the results. Any disagreements were resolved by discussion. Where these were not resolved, arbitration would rest with a third person.</P>
<P>For this review, no disagreements arose regarding the assessment of the review authors on the methodological quality nor appropriateness for inclusion of the studies selected.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-10-28 13:12:22 +0000" MODIFIED_BY="[Empty name]">
<P>Data extraction was undertaken independently by the review authors and cross checked using a customised data collection form. Where data may have been collected but not reported, clarification was sought from the trialists. Included trial data were processed using RevMan software as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Authors of original reports were contacted for extra information and data if required.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-10-28 13:12:33 +0000" MODIFIED_BY="[Empty name]">
<P>Critical appraisal and assessment of risk of bias were undertaken by each review author independently as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The following were assessed and reported in the Cochrane risk of bias tables.</P>
<UL>
<LI>Was the allocation sequence adequately generated?</LI>
<LI>Was allocation adequately concealed?</LI>
<LI>Were incomplete outcome data adequately addressed?</LI>
<LI>Are reports of the study free of suggestion of selective outcome reporting (or, were all relevant outcomes adequately reported)?</LI>
<LI>Were full details of financial support and funding provided for the trial?</LI>
<LI>Was a sample size calculated prior to recruitment and did it take in to consideration the required numbers needed to meet a particular statistical power?</LI>
<LI>Was ethical approval sought and gained prior to the beginning of the trial?</LI>
</UL>
<UL>
<LI>Was the study apparently free of other problems that could put it at a high risk of bias?</LI>
</UL>
<P>Studies were considered to be at low risk of bias if the method of blinding was adequate, or if we judged that the lack of blinding could not have affected the results or could not be avoided. Each element was assessed as low risk, high risk, or unclear risk of bias (the latter usually where no information was supplied).</P>
<P>In this review update, we decided to exclude performance bias as a domain of risk of bias assessment from the risk of bias assessment table. Blinding of participants undergoing urodynamic testing or the staff carrying out the test is not possible and would have been judged as 'high risk' across all the trials.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-10-28 13:12:36 +0000" MODIFIED_BY="[Empty name]">
<P>For categorical outcomes we related the numbers reporting an outcome to the numbers at risk in each group to derive a summary risk ratio (RR). For continuous variables we used means and standard deviations to derive a mean difference (MD) if the outcomes were measured in the same way between trials. Any continuous data that were the product of a number of different scales (for example, scales used to assess symptoms such as pain or quality of life) were summarised as the standardised mean difference (SMD) using a fixed-effect model. A fixed-effect model was used for calculation of all summary estimates and 95% confidence intervals (CIs) except if there was significant heterogeneity. When appropriate, meta-analysis was undertaken.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-10-28 13:12:41 +0000" MODIFIED_BY="[Empty name]">
<P>Analysis of studies with non-standard designs, such as crossover trials and cluster-randomised trials, would have been undertaken as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Studies with multiple treatment groups would be analysed by treating each pair of arms as a separate comparison, as appropriate. All studies in this review were of standard design and were two-armed trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-10-28 13:12:43 +0000" MODIFIED_BY="[Empty name]">
<P>We defined an intention-to-treat analysis to mean that all participants were analysed in their randomised groups whether or not they received the allocated intervention. We included data as they were reported for each outcome and did not impute missing values but used the data as presented by the trialists. However, we would carry out sensitivity analyses if there was a differential dropout from the randomised groups or another reason to suspect systematic bias from missing data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-10-28 13:12:50 +0000" MODIFIED_BY="[Empty name]">
<P>Trial data were only combined if there was no clinical heterogeneity. Differences between trials were investigated if significant heterogeneity was found from the Chi<SUP>2 </SUP>test or the I<SUP>2 </SUP>statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>), or was obvious from visual inspection of the results and data plots. Visual heterogeneity was deemed positive when the confidence intervals of studies did not overlap. This was then confirmed by formal statistical testing. Statistical heterogeneity was regarded as substantial if either the I<SUP>2 </SUP>was greater than 50%, as reported by the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>, or there was a low P value (P &lt; 0.10) in the Chi<SUP>2 </SUP>test for heterogeneity. In those outcomes, a random-effects model was used.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-10-28 13:12:52 +0000" MODIFIED_BY="[Empty name]">
<P>Publication bias would have been examined by a funnel plot if there were 10 or more studies in a meta-analysis, but this did not occur.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-10-28 13:12:54 +0000" MODIFIED_BY="[Empty name]">
<P>Fixed-effect model analysis was used to carry out the meta-analyses, except if significant heterogeneity was suspected when a random-effects model was used.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-10-28 13:12:56 +0000" MODIFIED_BY="[Empty name]">
<P>We planned to carry out subgroup analysis amongst: different groups of people (women, men, people with neurological diseases, and children); and amongst groups having a primary versus a secondary investigation after failed treatment, if the data allowed. When significant heterogeneity was found, we used a random-effects rather than a fixed-effect model.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2011-11-17 17:09:36 +0000" MODIFIED_BY="[Empty name]">
<P>We could carry out sensitivity analysis based on eligibility criteria such as including and excluding results from abstract-only publications if there were enough trials (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-10-28 13:13:54 +0000" MODIFIED_BY="[Empty name]">
<P>Ninety-one studies were considered. However, 83 were excluded (see below) because they did not randomise patients to at least one type of urodynamic investigation or one method of performing a urodynamic investigation. One study (<LINK REF="STD-Kristjansson-1999" TYPE="STUDY">Kristjansson 1999</LINK>), which was included in the second update of the review, was excluded as the study was about the comparison of treatment based on urodynamic findings versus a direct treatment decision in men with presumed bladder outflow obstruction (voiding dysfunction). The updated objective of this review therefore now classed this study as excluded.</P>
<P>One other trial is ongoing (<LINK REF="STD-Hilton-2011" TYPE="STUDY">Hilton 2011</LINK>) (<LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
<P>The flow of literature through the assessment process is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-10-28 13:13:49 +0000" MODIFIED_BY="[Empty name]">
<P>We found eight trials which met the inclusion criteria, of which two are new in this update (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>). The authors of the trials have been approached for further information. One trial was only reported as a conference abstract (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>).</P>
<P>Information about another was provided in a report to a grant awarding body (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>) but no useable data relating to the randomised groups were available, although the method of randomisation was classed as secure (A).</P>
<P>No trials were identified which compared one method of urodynamics with another and also provided clinical outcome data.</P>
<P>Further details are provided in the table 'Characteristics of <LINK TAG="INCLUDED_STUDIES_DESCR" TYPE="SECTION">Included studies</LINK>'.</P>
<SUBSECTION>
<HEADING LEVEL="4">Methods</HEADING>
<P>All included studies were two-armed randomised controlled trials with a standard parallel group design. The duration of the studies included:</P>
<UL>
<LI>final outcome evaluation at 12 months (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>);</LI>
<LI>questionnaire follow up three years after initial presentation and investigation (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>);</LI>
<LI>questionnaire follow at six months (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>);</LI>
<LI>three months following assessment and treatment (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>);</LI>
<LI>primary outcome assessed at 12 months but follow up in questionnaire format continued to 24 months (<LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>).</LI>
</UL>
<P>No randomised data were available for one trial (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>Participant types included:</P>
<UL>
<LI>community dwelling women with urinary incontinence (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>);</LI>
<LI>women recruited from the urodynamic clinic with urinary incontinence (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>);</LI>
</UL>
<UL>
<LI>women with urinary incontinence and lower urinary tract symptoms who chose to be randomised (no preference group) (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>);</LI>
</UL>
<UL>
<LI>men and women with multiple sclerosis and urinary incontinence (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>);</LI>
<LI>women with mixed urinary incontinence and lower urinary tract symptoms (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>);</LI>
<LI>women with predominant stress urinary incontinence (SUI) (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>).</LI>
</UL>
<P>Subgroup analysis according to type of participant was not possible as each trial included different types of populations.</P>
<P>For the trials measuring subjective (woman-reported) urinary incontinence (UI), the definitions were as follows:</P>
<UL>
<LI>cure rate determined by asking participants &#8220;are you cured?&#8221; (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>);</LI>
<LI>pure statement of number of people with any new or continuing evidence of recurrent SUI in the supplementary appendix of the trial (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>);</LI>
<LI>questionnaire use (Urogenital Distress Inventory) to detail the number of women subjectively confident of a cure of SUI, defined as no leakage during physical activity (<LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>);</LI>
<LI>questionnaire use (Urogenital Distress Inventory) defining cure as no leakage at all on the overall UI section of the questionnaire (<LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>In seven out of eight trials (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>), participants were randomised to having urodynamic investigations or not, although in one trial urodynamic investigation could be performed later (delayed group) (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>). In the eighth trial (<LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>), all patients underwent urodynamics but in one arm of the trial the patients were randomised to immediate surgery regardless of the urodynamic results. The following types of urodynamics were used:</P>
<UL>
<LI>cystometry and cystoflowmetry (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>);</LI>
<LI>ambulatory urodynamics (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>);</LI>
<LI>non-instrumented uroflowmetry, filling cystometry and pressure-flow studies with urethral pressure profilometry and videourodynamics permitted if routinely performed as preoperative assessment at each centre (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>);</LI>
<LI>urodynamics (unspecified) (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>; <LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>);</LI>
<LI>uroflowmetry and filling and voiding cystometry (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>).</LI>
</UL>
<P>It is likely that some of these descriptions (cystometry, cystoflowmetry, pressure flow urodynamics, uroflowmetry, and filling and voiding cystometry) are similar enough to be described as 'standard urodynamics'.</P>
<P>The comparator or control groups were:</P>
<UL>
<LI>delayed urodynamics (after 12 months, if required) (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>);</LI>
<LI>treatment based on symptoms, history or clinical findings only (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; Kristjansson 1999a; <LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>);</LI>
<LI>participants all had urodynamics but treatment was based on history only by a nurse blinded to the results of the urodynamics (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>);</LI>
<LI>participants all had urodynamics but treatment was designated as immediate surgery regardless of urodynamic findings (<LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>All the outcomes considered in each trial are detailed in the table '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-10-28 13:13:54 +0000" MODIFIED_BY="[Empty name]">
<P>Of the 91 studies, 81 were excluded because they did not report clinical outcomes (that is, effect of the trial on urinary outcomes) or effect on clinical decision making, or because they were concerned with antibiotic prophylaxis cover for the urodynamic procedure.</P>
<P>Another two were possible randomised controlled trials with clinical outcomes but the conference abstracts did not provide enough detail for this to be confirmed (<LINK REF="STD-Benson-1991" TYPE="STUDY">Benson 1991</LINK>; <LINK REF="STD-Choe-2001" TYPE="STUDY">Choe 2001</LINK>). The authors have been approached for more information but this outreach has not been successful. Further details are given in the table '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>'.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-10-28 13:14:11 +0000" MODIFIED_BY="[Empty name]">
<P>One trial provided no useable data (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>) and therefore the rest of this section excludes evaluation of this trial.</P>
<P>
<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> provide a visual summary of the findings.</P>
<ALLOCATION MODIFIED="2013-10-28 13:13:58 +0000" MODIFIED_BY="[Empty name]">
<P>One of the seven trials failed to provide details of the method of sequence generation (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>) while six provided adequate information. The adequate methods of sequence generation included a sequence derived from a random numbers table (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>), a web-based trial simulator programme (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>), an automated randomisation system stratified according to surgeon (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>), a balanced randomisation schedule based upon permuted blocks and stratified according to multiple sclerosis and urological status (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>), a computer-generated random numbers sequence (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>), and a computer-generated block randomisation with variable block sizes and stratified by centre (<LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>).</P>
<P>Two trials did not describe the method of allocation concealment (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>) whereas the other five provided full and adequate information. Adequate methods of allocation concealment included phoning a third party who opened the top sealed opaque envelope from a pile (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>), sealed opaque envelopes opened in front of the patients (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>), an automated randomisation system (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>), and a computer-controlled system (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>).</P>
</ALLOCATION>
<EXCLUSIONS MODIFIED="2013-10-28 13:14:02 +0000" MODIFIED_BY="[Empty name]">
<P>There was differential dropout from the control groups in two trials (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>), which was judged likely to introduce bias. Options for analysis may have included presuming all dropouts still had the disease at the defined endpoints, presuming all were cured or using the data available for each participant up to the latest timepoint in the trials. However, in this instance, it was not judged appropriate to compensate for differential dropout by imputation of results for the women lost to follow up and therefore analysis was based upon the results for the women which were available.</P>
<P>However, in one of these trials (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>) the authors interpreted this loss as demonstrating that women who did have urodynamics were more motivated to attend and might therefore have had better compliance with treatment (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). It may be of relevance that the two randomised groups reported in this review were amongst women who had no preference about whether they had urodynamics or not; the remaining non-randomised women in the study chose to have urodynamics (N = 153) or chose to have conservative treatment without urodynamics (N = 57).</P>
<P>In two trials (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>), 12 out of 60 women (seven from the intervention group and five from the control group due to failure to complete treatment) and 11 out of 126 women (four plus 1 deceased from the intervention group and 6 from the control group) dropped out. However, we judged that this would not introduce bias as the numbers were comparable.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-12-05 13:23:37 +0000" MODIFIED_BY="[Empty name]">
<P>Two trials did not report the primary outcome of this review (number of women with incontinence) (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>). </P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-10-28 13:14:11 +0000" MODIFIED_BY="[Empty name]">
<P>One trial was only reported in an abstract, and no further data were available (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>). Another trial did not provide measures of dispersion (SDs) for an important outcome (incontinence episode frequency) (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>), although it was possible to calculate the SDs for change in incontinence episode frequency using assumptions.</P>
<P>Follow up was short (three months) in one trial (<LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>). Recruitment was stopped prematurely in one trial because of delays in recruitment (<LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>).</P>
<P>Details of medical ethics approval were not full detailed in three trials (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>), as well as the provision of informed consent not being clear in two trials (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1. Urodynamics versus clinical management without urodynamics</HEADING>
<P>All eight included trials addressed this comparison. However, one trial provided no useable data and therefore it will not be discussed further in this section (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>). This was the only trial which included men or people with neurological disease. No trials included children. The remaining seven trials included 1036 women, of whom 526 were randomised to a urodynamic intervention.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome (urinary incontinence)</HEADING>
<P>Five trials addressed this outcome (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>). There was no statistically significant evidence that the women who received treatment guided by urodynamics were better or worse off than those who did not (for example, proportion of women with incontinence after first year 150/402 (37%) versus 145/400 (36%), RR 1.02, 95% CI 0.86 to 1.21; the GRADE quality of evidence for this outcome was 'high'). It was calculated using the risk difference that in order to prevent one woman having incontinence after the first year 100 (95% CI 86 to 114) women would have to undergo urodynamic testing (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Clinical decision making</HEADING>
<P>There was evidence from two trials (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>) that women treated after urodynamic investigations were more likely to receive drugs (45% versus 21% in no-urodynamic group, RR 2.09, 95% CI 1.32 to 3.31, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). Women treated after urodynamic investigation were not, in five trials (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>;<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>), more likely to undergo surgery (401/495 (81%) versus 383/487 (79%), RR 0.99, 95% CI 0.88 to 1.12, <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>; a random-effects model was used because of significant heterogeneity). As one of the seven pre-specified GRADE outcomes, the evidence behind the number of women undergoing surgery after urodynamics was seen to be of 'moderate' quality. There was no evidence of a difference in the number treated conservatively after urodynamics but the numbers were small (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
<P>Women in the urodynamic group of another trial (<LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>) were more likely to return for further treatment (RR 0.28, 95% CI 0.10 to 0.79, <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>); the authors argued that this would result in better compliance with treatment. Finally, with regards to another of the seven GRADE outcomes, women in the urodynamic arms of three trials (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) were more likely to have their management changed (proportion with change in management 17% versus 3%, RR 5.07, 95% CI 1.87 to 13.74, <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). All three trials showed that more women had their management changed after urodynamics although there was statistical heterogeneity and its importance was unclear. However, the GRADE quality of evidence for this outcome was seen to be 'low'.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Observations of people being investigated for incontinence</HEADING>
<P>One trial reported that more women had urgency symptoms in the urodynamic group (<LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>) but this did not reach statistical significance (RR 5.42, 95% CI 0.69 to 42.28, <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>).</P>
<P>The number of women not satisfied with treatment (another pre-specified outcome, with the quality of evidence being described as 'low') was detailed in two trials (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) but was not found to be statistically significant (RR 0.90, 95% CI 0.55 to 1.49, <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quantification of people's symptoms</HEADING>
<P>The evidence from pad weights and incontinence episodes was too scant to be conclusive (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Clinicians' observations</HEADING>
<P>Although more women had clinician-observed incontinence with urodynamics (39/286 (14%) versus 29/286 (10%) without urodynamics) this did not reach statistical significance (RR 1.33, 95% CI 0.85 to 2.08, <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse effects</HEADING>
<P>One trial (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>) found no statistically significant difference in the number of women with adverse effects (RR 1.10, 95% CI 0.81 to 1.50, <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>). Two trials (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>) reported data on the number of women with voiding dysfunction between arms and found no statistically significant difference (RR 0.66, 95% CI 0.29 to 1.49, <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>). There were four deaths in the control group of one trial with none in the urodynamic group (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>), while there was one death in the urodynamic group in another trial (<LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>).</P>
<P>One of the seven pre-specified GRADE outcomes, 'incidence of urinary tract infection associated with urodynamics', was not measured in any of the included studies and therefore could not be detailed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quality of life</HEADING>
<P>The data for effect on quality of life, evaluated using a variety of health status measures, were largely inconclusive although two trials reported a statistically significant change in the Urogenital Distress Inventory (UDI) questionnaire subscale for UI at 12 months in favour of clinical assessment alone (RR 14.70, 95% CI 7.21 to 22.19, <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>).</P>
<P>Furthermore, a GRADE outcome regarding the quality of life in people following urodynamics was measured using the general health of patients as recorded by the mean difference of the King's Quality of Life (QoL) score at six months. The quality of evidence was described as 'moderate' and the results were inconclusive (MD -6.40, 95% CI -16.61 to 3.81, <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Socioeconomic measures</HEADING>
<P>To date no trials have reported any costs of investigations or treatments and as a result the last of the seven GRADE outcomes, 'health economics measures', could not be assessed.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. One type of urodynamics versus another</HEADING>
<P>No trials were identified which compared one method of urodynamics with another and also provided clinical outcome data.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-10-28 14:05:09 +0000" MODIFIED_BY="[Empty name]">
<P>There was statistically significant evidence to support the hypothesis that urodynamic testing changed clinical decision making in women treated for urinary incontinence (RR 5.07, 95% CI 1.87 to 13.74) but the GRADE quality of evidence for this outcome was low. However, no evidence was available showing a difference in the number of women with incontinence after one year between those undergoing testing and those not (number with incontinence after first year (subjective) RR 1.02, 95% CI 0.86 to 1.21) and the GRADE quality of evidence for this outcome was high. There was no evidence related to the use of urodynamics in men, children, or people with neurological diseases with UI. Despite the expected incidence of UTI after the procedure (<LINK REF="REF-Latthe-2012" TYPE="REFERENCE">Latthe 2012</LINK>), only one trial (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>) reported whether or not there were any adverse effects (RR 1.10, 95% CI 0.81 to 1.50).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-10-28 13:15:42 +0000" MODIFIED_BY="[Empty name]">
<P>Although we found 91 potential trials, only eight proved to be eligible. Of these, one did not provide useable data; this was also the only one which included men (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>). Therefore, no trial data were available about the clinical consequences of urodynamics in men, in people with a neurological cause for their incontinence, or in children, therefore no comment can be made about these population groups. The excluded studies, which generally compared different approaches to urodynamics, were excluded because they did not address clinical outcomes; even if they were randomised controlled trials. This may have been because they were not designed to assess whether to use urodynamics or not and were mainly focused on the best method to carry out the investigation.</P>
<P>The included studies also failed to provide relevant outcome data. Only five reported primary outcome data (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) and only four of these could be combined in any one meta-analysis. Furthermore, of the seven pre-specified GRADE outcomes, only five were reported and no evidence was available for two of the outcomes.</P>
<P>There is, however, one other large ongoing trial, of similar design to the two new included trials in this update of the review (<LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>), which may produce robust, reliable evidence (<LINK REF="STD-Hilton-2011" TYPE="STUDY">Hilton 2011</LINK>). However, again it only includes women.</P>
<P>In the light of the findings of this review, the question of whether clinicians will continue to perform urodynamics on their patients is an interesting one. It seems intuitive that if clinicians have more information available to counsel their patients, care and outcomes should be improved. However, this depends on whether the clinician and the patient feel that the extra information provided by the investigation translates into better outcomes and so would be worth the associated risks and costs of urodynamics.</P>
<P>An issue affecting generalisability is that urodynamics are a relatively sophisticated and expensive investigation. The relevant equipment and resources may not be of an equivalent level of sophistication or even available in countries with limited healthcare resources, and the level of technical expertise to perform and interpret the studies may not be the same in different countries.</P>
<P>There are countries which do not have access to urodynamics, and the results of this review may be particularly important for them in making decisions about which resources to source. Where resources are more limited, the policymakers, funders of healthcare services and clinicians must decide whether or not there are important health gains from the use of sophisticated investigations such as urodynamics, and therefore further research providing more definitive answers will aid in these decisions.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-10-28 13:15:52 +0000" MODIFIED_BY="[Empty name]">
<P>Most of the trials were small and all had one or more factors which increased the risk of bias (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Seven of eight trials undertook adequate random sequence generation (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>; <LINK REF="STD-Ramsay-1995" TYPE="STUDY">Ramsay 1995</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>) while six of eight provided evidence of secure allocation concealment (<LINK REF="STD-Holtedahl-2000" TYPE="STUDY">Holtedahl 2000</LINK>; <LINK REF="STD-Majumdar-2009" TYPE="STUDY">Majumdar 2009</LINK>; <LINK REF="STD-Nager-2009" TYPE="STUDY">Nager 2009</LINK>; <LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>; <LINK REF="STD-van-Leijsen-2011" TYPE="STUDY">van Leijsen 2011</LINK>; <LINK REF="STD-van-Leijsen-2012" TYPE="STUDY">van Leijsen 2012</LINK>), but one of these did not provide useable data (<LINK REF="STD-O_x0027_Connell-2003" TYPE="STUDY">O'Connell 2003</LINK>). The four deaths and 12 dropouts from the control arm of one trial were unexplained (<LINK REF="STD-Khullar-2000" TYPE="STUDY">Khullar 2000</LINK>) and may indicate high risk of bias in this trial.</P>
<SUBSECTION>
<HEADING LEVEL="3">GRADE quality of evidence</HEADING>
<P>By adopting the GRADE approach to the assessment of risk of bias, the quality of evidence of the GRADE specified outcomes was found to vary from high to low GRADE ('Summary of findings' table 1). The number with incontinence after the first year (subjective), which was the primary outcome of this systematic review, was graded as high. The body of evidence for two outcomes (number treated with surgery, quality of life measures following treatment after urodynamics) were graded as moderate. The quality of evidence of two outcomes (number not satisfied with treatment, number whose treatment was not changed after urodynamics) were deemed to have low quality of evidence. Lastly, two out of seven outcomes were not reported and therefore GRADE could not be applied (incidence of UTI associated with urodynamics, health economics measures).</P>
</SUBSECTION>
</QUALITY_OF_EVIDENCE>
<AGREEMENT MODIFIED="2013-10-28 13:27:43 +0000" MODIFIED_BY="[Empty name]">
<P>Recent systematic reviews on the subject of urodynamics have identified the lack of high quality primary research confirming the clinical utility of carrying out urodynamic investigations (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>; <LINK REF="REF-LUTS-Guideline-2010" TYPE="REFERENCE">LUTS Guideline 2010</LINK>; <LINK REF="REF-NCCWCH-2006" TYPE="REFERENCE">NCCWCH 2006</LINK>). The current review incorporates the newer evidence available but is still not conclusive regarding when and in which situations urodynamics are useful.</P>
<P>Some consensus statements and practice recommendations do not advocate initial urodynamic tests prior to conservative treatment of stress incontinence, whereas they do recommend them prior to continence surgery (<LINK REF="REF-AHCPR-1996" TYPE="REFERENCE">AHCPR 1996</LINK>; <LINK REF="REF-Homma-1999" TYPE="REFERENCE">Homma 1999</LINK>; <LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>; <LINK REF="REF-RCOG-2003" TYPE="REFERENCE">RCOG 2003</LINK>) but not before conservative treatment or if there is a clear history of SUI alone (<LINK REF="REF-NCCWCH-2006" TYPE="REFERENCE">NCCWCH 2006</LINK>). The <LINK REF="REF-NCCWCH-2006" TYPE="REFERENCE">NCCWCH 2006</LINK> group concluded that: "It has not been shown that carrying out urodynamic investigations before initial treatment improves outcome. Complex reconstructive urological procedures were developed for use for specific urodynamic abnormalities. Hence, the guideline group concluded that urodynamic investigations should be used to demonstrate the presence of specific abnormalities before undertaking these procedures. The guideline group considered that urodynamic investigations were also of value when the clinical diagnosis is unclear prior to surgery or if initial surgical treatment has failed". <I>S</I>ome clinicians find the use of urodynamics reassuring to prevent them missing specific abnormalities such as DO, even if the overall management of patients does not change. However, the findings of these abnormalities are not actually predictive of outcome and therefore the use of the investigation in these circumstances may be unwarranted.</P>
<P>The role of urodynamic studies before prolapse surgery is also controversial (<LINK REF="REF-Fowler-2006" TYPE="REFERENCE">Fowler 2006</LINK>). An ICI Committee found no evidence to suggest whether or not women with occult UI (revealed by prolapse reduction) in fact manifest the problem after surgery, nor whether urodynamics was helpful in predicting this outcome (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009 </LINK>page 448). Their role in men with regards to the diagnosis of UI (that is, storage LUTS secondary to conditions of the bladder and not voiding LUTS due to bladder outlet obstruction, as is the case in prostatic disease) is controversial but one review recommended a trial of drugs for both conditions, in the first instance with urodynamics being reserved for resistant cases (<LINK REF="REF-Chapple-2006" TYPE="REFERENCE">Chapple 2006</LINK>). The situation in children is also unclear, but the ICI recommend urodynamic testing when there are congenital abnormalities and in children with incontinence or nocturnal enuresis if invasive treatments are contemplated (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009 </LINK>).</P>
<P>Finally, there are concerns about the reproducibility, accuracy, standardisation and safety of the tests (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009 </LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="2">Future research</HEADING>
<P>Despite the recent publication of two large trials, larger definitive randomised trials are still needed to determine the place for urodynamics in both the routine and specialised clinical care of people with incontinence. This was first suggested by Black et al in their survey of clinical practice (<LINK REF="REF-Black-1997" TYPE="REFERENCE">Black 1997</LINK>) and supported by Black and others in subsequent correspondence (<LINK REF="REF-Black-1998" TYPE="REFERENCE">Black 1998</LINK>; Lose 1998b). Further support was provided by the ICI Committee on Dynamic Testing that such a trial "may provide objective documentation of the utility of soundly based tests" (<LINK REF="REF-Griffiths-2005" TYPE="REFERENCE">Griffiths 2005</LINK>, page 630). Cost effectiveness was also identified as an important consideration (<LINK REF="REF-Hosker-2009" TYPE="REFERENCE">Hosker 2009</LINK>).</P>
<P>One new trial amongst women is in progress and has completed recruitment (attaining 222 participants of a targeted 240) in January 2013 (<LINK REF="STD-Hilton-2011" TYPE="STUDY">Hilton 2011</LINK>). It is possible, when results are available, that the findings of this trial may inform practice.</P>
</SUBSECTION>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-10-28 13:16:25 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-10-28 13:16:10 +0000" MODIFIED_BY="[Empty name]">
<P>When women with incontinence are assessed using urodynamics in addition to clinical methods, they are more likely to receive different treatment and to have their management plan changed. However, the evidence was not conclusive in showing whether these differences in management resulted in differences in health outcomes, such as incontinence, quality of life or economic outcomes after treatment, compared to women who did not have urodynamic tests.</P>
<P>No data were available to evaluate the use of urodynamics in men, children, or people with neurological diseases.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-10-28 13:16:25 +0000" MODIFIED_BY="[Empty name]">
<P>There remains insufficient evidence about the value and risks of urodynamic tests. Further trials are needed in all types of patients whose incontinence could be investigated with urodynamics. In such trials, people would be randomised to treatment based on urodynamic investigations compared with treatment based on clinical history and examination. They should include all people for whom urodynamics might be indicated to ensure that those considering surgery but who decided not to proceed due to urodynamic findings are not missed, and that those for whom surgery is not an option are also evaluated. The trial(s) should if possible be designed so that the role of urodynamic testing in different populations (women, men, children, and people with neurological disease) can be assessed separately. Furthermore, they should take into account the seven specified GRADE outcomes within this review to allow a comprehensive analysis of those outcomes most important to clinical practice.</P>
<P>In order to give a definitive answer to the question of whether urodynamic studies are no better than clinical assessment in treating urinary incontinence in adults, a trial of 3222 participants would be required. Assuming the incontinence event rate is similar to that of the four trials already included in this analysis, 1611 patients per arm would reduce the confidence interval of the risk ratio to plus or minus 10% (RR would be 1.02, 95% CI 0.94 to 1.10).</P>
<P>Thus currently there is insufficient evidence to indicate that one method of management is better than another. Any other additional studies could be highly informative.
<BR/>

</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-09-25 22:56:24 +0100" MODIFIED_BY="[Empty name]">
<P>We thank the external referees and the Editors of the Incontinence Review Group who made helpful comments on the content and text of the review. Phil Toozs-Hobson provided extra information about one trial, and Sanne van Leijsen about one completed trial. We also thank Andrew Elders who calculated the number needed for further research.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-06-02 09:33:54 +0100" MODIFIED_BY="[Empty name]">
<P>None</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]">
<P>All review authors independently assessed the studies for inclusion, extracted data and wrote the text.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-10-28 13:16:35 +0000" MODIFIED_BY="[Empty name]">
<P>This review update focuses on the use of urodynamics in the diagnosis of stress and urgency incontinence only. This review therefore now excludes trials in which urodynamics were used in the diagnosis of voiding LUTS, voiding dysfunction, and BOO. These conditions will be the focus of a further Cochrane review.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-10-28 14:13:41 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-10-28 14:13:41 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-10-28 13:48:20 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Holtedahl-2000" MODIFIED="2013-10-28 13:18:59 +0000" MODIFIED_BY="[Empty name]" NAME="Holtedahl 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-10-28 13:18:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holtedahl K, Verelst M, Schiefloe A, Hunskaar S</AU>
<TI>Usefulness of urodynamic examination in female urinary incontinence--lessons from a population-based, randomized, controlled study of conservative treatment</TI>
<SO>Scandinavian Journal of Urology and Nephrology</SO>
<YR>2000</YR>
<VL>34</VL>
<NO>3</NO>
<PG>169-74</PG>
<IDENTIFIERS MODIFIED="2011-11-02 14:25:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-02 14:25:11 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT11839"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-11-02 14:26:16 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khullar-2000" MODIFIED="2013-10-28 13:19:26 +0000" MODIFIED_BY="[Empty name]" NAME="Khullar 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-10-28 13:19:26 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{9963}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:19:26 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Khullar V, Salvatore S, Cardozo L, Howland E, Digesu A, Kelleher C, et al</AU>
<TI>Randomised study of ambulatory urodynamics versus symptomatic treatment of symptomatic women without a urodynamic diagnosis</TI>
<SO>Proceedings of the International Continence Society (ICS), 30th Annual Meeting; 2000 Aug 28-31; Tampere, Finland</SO>
<YR>2000</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Majumdar-2009" MODIFIED="2013-10-28 13:19:56 +0000" MODIFIED_BY="[Empty name]" NAME="Majumdar 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-06-22 14:54:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Majumdar A, Hassan I, Robb K, Toozs-Hobson P</AU>
<TI>Urodynamics and patient preference (Abstract number 366)</TI>
<SO>Proceedings of the 35th Annual International Continence Society (ICS), 2005 Aug 28 - Sept 2; Montreal</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2011-06-22 14:54:19 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:54:19 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21078"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-11-11 10:33:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Majumdar A, Latthe P, Toozs-Hobson P</AU>
<TI>Urodynamics prior to treatment as an intervention: A pilot study</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>4</NO>
<PG>522-6</PG>
<IDENTIFIERS MODIFIED="2011-11-02 14:28:01 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-02 14:28:01 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT34191"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:19:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Majumdar A, Toozs-Hobson P</AU>
<TI>Why women prefer to have urodynamics (Abstract number 11)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>615-6</PG>
<IDENTIFIERS MODIFIED="2011-05-26 09:42:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:42:16 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26653"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:19:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Toozs-Hobson P, Majundar A, Robb K, Powles K</AU>
<TI>How does urodynamics affect subsequent patient behaviour? (Abstract number 159)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18 Suppl 1</VL>
<PG>S94-5</PG>
<IDENTIFIERS MODIFIED="2011-05-26 09:40:08 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:40:08 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26604"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nager-2009" MODIFIED="2013-10-28 13:47:03 +0000" MODIFIED_BY="[Empty name]" NAME="Nager 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-12-10 09:33:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nager CW, Brubaker L, Daneshgari F, Litman HJ, Dandreo KJ, Sirls L, et al</AU>
<TI>Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations</TI>
<SO>Contemporary Clinical Trials</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>6</NO>
<PG>531-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT34338"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-04-22 11:16:53 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22551104&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - N Engl J Med. 366(21):1987-97, 2012 May 24&lt;br&gt;JC - 0255562, now&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Multicenter Study&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;SI - ClinicalTrials.gov&lt;br&gt;SA - ClinicalTrials.gov/NCT00803959&lt;br&gt;NO - U01 DK58225 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58229 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58231 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58234 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60379 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60380 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60393 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60395 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60397 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01DK60401 (United States NIDDK NIH HHS)&lt;br&gt;LG - English&lt;br&gt;DC - 20120524&lt;/p&gt;" NOTES_MODIFIED="2013-04-22 11:16:53 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, et al</AU>
<TI>A randomized trial of urodynamic testing before stress-incontinence surgery</TI>
<SO>New England Journal of Medicine</SO>
<YR>2012</YR>
<VL>366</VL>
<NO>21</NO>
<PG>1987-97</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT44511"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:46:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Norton P, Nager C, Brubaker L, Lemack G, Lowder J, Chai T, et al</AU>
<TI>The cost of preoperative urodynamics: a secondary analysis of the ValUE trial (Abstract number 29)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>6</NO>
<PG>762</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT45977"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:47:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirls L, Richter H, Litman H, Kenton K, Lemack G, Lukacz E, et al</AU>
<TI>The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery (Abstract number 251)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>6</NO>
<PG>1051-2</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT45980"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Connell-2003" MODIFIED="2013-10-28 13:47:16 +0000" MODIFIED_BY="[Empty name]" NAME="O'Connell 2003" YEAR="2004">
<REFERENCE MODIFIED="2013-10-28 13:47:16 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{21317}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:47:16 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dowling CR, O'Connell HE, Kurczyki L, Myles K, Poole K, Sanjeevan KV</AU>
<TI>Randomised control trial of bladder pressure management versus management based on symptoms and residual volumes in patients with established multiple sclerosis (Abstract)</TI>
<SO>BJU International</SO>
<YR>2005</YR>
<VL>95 Suppl 1</VL>
<PG>5</PG>
<IDENTIFIERS MODIFIED="2011-06-22 14:15:34 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:15:34 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21317"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-11-11 14:03:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>O'Connell HE, Costello AJ, King J, Kilpatrick T, Whishaw M, Samali R, et al</AU>
<SO>Extension study: Randomised control trial bladder pressure management vs management based on symptoms and residual volumes in patients with established multiple sclerosis</SO>
<YR>2005. Available from: http://www.bladderbowel.gov.au/ncms/projects/intervention/msurinarprob.htm</YR>
<PB>National Continence Management Strategy, Department of Health and Ageing, Australian Government</PB>
<CY>Canberra, Australia</CY>
<IDENTIFIERS MODIFIED="2011-06-21 10:02:48 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-21 10:02:48 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31113"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-11-11 14:03:23 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{21000}&lt;/p&gt;" NOTES_MODIFIED="2011-11-11 14:03:23 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="BOOK">
<AU>O'Connell HE, Costello AJ, King J, Kilpatrick T, Whishaw M, Samali R, et al</AU>
<SO>Randomised control trial bladder pressure management vs management based on symptoms and residual volumes in patients with established multiple sclerosis</SO>
<YR>2003. Available from: http://www.bladderbowel.gov.au/ncms/projects/phases/bladder%20pressure.htm</YR>
<PB>National Continence Management Strategy, Department of Health and Ageing, Australian Government</PB>
<CY>Canberra, Australia</CY>
<IDENTIFIERS MODIFIED="2011-05-26 09:33:54 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:33:54 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31112"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramsay-1995" MODIFIED="2013-10-28 13:47:26 +0000" MODIFIED_BY="[Empty name]" NAME="Ramsay 1995" YEAR="1995">
<REFERENCE MODIFIED="2013-10-28 13:47:26 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{2683}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:47:26 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay I, Hassan A, Hunter M, Donaldson K</AU>
<TI>A randomised controlled trial of urodynamic investigation prior to conservative treatment of urinary incontinence in the female (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1994</YR>
<VL>13</VL>
<NO>4</NO>
<PG>455-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{6011}&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ramsay IN, Ali HM, Hunter M, Stark D, Donaldson K</AU>
<TI>A randomized controlled trial of urodynamic investigations prior to conservative treatment of urinary incontinence in the female</TI>
<SO>International Urogynecology Journal</SO>
<YR>1995</YR>
<VL>6</VL>
<PG>277-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-van-Leijsen-2011" MODIFIED="2013-10-28 13:47:53 +0000" MODIFIED_BY="[Empty name]" NAME="van Leijsen 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-04-22 11:18:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SA, Kluivers KB, Mol BW, Broekhuis SR, Milani AL, Bongers MY, et al</AU>
<TI>A randomized controlled trial on the value of preoperative urodynamic investigation in women with stress incontinence (Abstract number 165) [nb use version sent by first author as published version has wrong RRs]</TI>
<SO>International Urogynaecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>1 Suppl</NO>
<PG>S158-60</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT45788"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:47:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SA, Kluivers KB, Mol BW, Broekhuis SR, Milani AL, Bongers MY, et al</AU>
<TI>Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>7</NO>
<PG>1118-23</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT45113"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:47:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SAL, Kluivers KB, Mol BWJ, Broekhuis SR, Milani AL, Bongers MY, et al</AU>
<TI>A randomised controlled trial on the value of preoperative urodynamics in women with stress incontinence: VUSIS 1 [Abstract 165]</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2011</YR>
<VL>22 Suppl 1</VL>
<PG>S159-61</PG>
<IDENTIFIERS MODIFIED="2011-11-11 14:03:58 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-11-02 14:52:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-02 14:52:15 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="VUSIS 1"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Leijsen-2012" MODIFIED="2013-10-28 13:48:20 +0000" MODIFIED_BY="[Empty name]" NAME="van Leijsen 2012" YEAR="2009">
<REFERENCE MODIFIED="2013-10-28 13:48:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen S, Kluivers KB, Mol BW, Milani A, Roovers J, den Boon J, et al</AU>
<TI>A randomised controlled trial on the value of urodynamics prior to stress incontinence surgery (Abstract number 248)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>6</NO>
<PG>1046-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT45979"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-12-10 09:33:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SA, Kluivers KB, Mol BW, Broekhuis SR, Milani FL, van der Vaart CH, et al</AU>
<TI>Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered</TI>
<SO>BMC Women's Health</SO>
<YR>2009</YR>
<VL>9</VL>
<PG>22</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="SR-INCONT32078"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:48:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SAL, Kluivers KB, Mol BWJ, in 't Hout J, Milani AL, Roovers JPWR, et al</AU>
<TI>Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2013</YR>
<VL>121</VL>
<NO>5</NO>
<PG>999-1008</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-04-15 16:56:06 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-15 16:56:06 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00814749"/>
<IDENTIFIER TYPE="OTHER" VALUE="VUSIS 2"/>
</IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-10-28 14:13:41 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Akil-2005" MODIFIED="2013-10-28 13:49:26 +0000" MODIFIED_BY="[Empty name]" NAME="Akil 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-10-28 13:49:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akil I, Ozkol M, Ikizoglu OY, Polat M, Tuncyurek OY, Taskin O, et al</AU>
<TI>Premedication during micturating cystourethrogram to achieve sedation and anxiolysis</TI>
<SO>Pediatric Nephrology (Berlin, Germany)</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>8</NO>
<PG>1106-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bael-2008" MODIFIED="2013-10-28 13:49:12 +0000" MODIFIED_BY="[Empty name]" NAME="Bael 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-10-28 13:49:12 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bael A, Lax H, Hoebeke P, de Jong TPVM, Nijman RJM, Sixt R, et al</AU>
<TI>The relevance of urodynamic studies in urge syndrome and dysfunctional voiding: a multi-center controlled trial in children</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>180</VL>
<NO>4</NO>
<PG>1486-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-01-15 14:06:50 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bajpai-1982" NAME="Bajpai 1982" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;{10912)&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bajpai M, Sutherst J, Brown M</AU>
<TI>Comparison of cystomat and multichannel cystometry in the diagnosis of bladder instability (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 12th Annual Meeting; 1982; Leiden, Germany</SO>
<YR>1982</YR>
<PG>203-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baker-1991" MODIFIED="2013-10-28 13:49:43 +0000" MODIFIED_BY="[Empty name]" NAME="Baker 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-10-28 13:49:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baker KR, Drutz HP, Barnes MD</AU>
<TI>Effectiveness of antibiotic prophylaxis in preventing bacteriuria after multichannel urodynamic investigations: a blind, randomized study in 124 female patients</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>165</VL>
<NO>3</NO>
<PG>679-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Batista-1998" NAME="Batista 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;{16390}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Batista JE, Arano P, Granda M, Puigpelat T, Garat JM, Bauer S</AU>
<TI>Filling rate during cystometry: its effect on detrusor instability and compliance in children (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), Annual Meeting</SO>
<YR>1998</YR>
<PG>144</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baumann-2007" MODIFIED="2011-06-21 09:48:37 +0100" MODIFIED_BY="[Empty name]" NAME="Baumann 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-06-20 16:30:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baumann BM, McCans K, Stahmer SA, Leonard MB, Shults J, Holmes WC</AU>
<TI>Caregiver and health care provider satisfaction with volumetric bladder ultrasound</TI>
<SO>Academic Emergency Medicine</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>10</NO>
<PG>903-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="26374"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Benson-1991" NAME="Benson 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;{14577}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Benson JT</AU>
<TI>Anatomic vs urodynamic evaluation of women with urinary incontinence (Abstract)</TI>
<SO>Proceedings of the American Urogynecology Society, 12th Annual Meeting; 1991 Oct 23-26; Newport Beach, California, USA</SO>
<YR>1991</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bhatia-1985" NAME="Bhatia 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;{14560}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bhatia NN, Bergman A</AU>
<TI>Antibiotic prophylaxis following instrumentation of the urinary tract (Abstract)</TI>
<SO>Proceedings of the American Urogynecology Society, 6th Annual Meeting; 1985 Nov 6-9; San Diego, California</SO>
<YR>1985</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Blaivas-2001" MODIFIED="2013-10-28 13:49:55 +0000" MODIFIED_BY="[Empty name]" NAME="Blaivas 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-10-28 13:49:55 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{11969}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:49:55 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blaivas JG, Groutz A, Verhaaren M</AU>
<TI>Does the method of cystometry affect the incidence of involuntary detrusor contractions? A prospective randomized urodynamic study</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>2</NO>
<PG>141-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bo-2003" NAME="Bo 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;{17098}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bo K, Borstad E</AU>
<TI>Urodynamic assessment during pelvic floor muscle and transversus abdominis contraction (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 33rd Annual Meeting; 2003 Oct 5-9; Florence</SO>
<YR>2003</YR>
<PG>484-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Byrne-1991" NAME="Byrne 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;{9016}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Byrne P</AU>
<TI>A comparison of rectal and vaginal placement of abdominal pressure catheters during cystometry - patient preference (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 21st Annual Meeting; 1991; Hannover, Federal Republic of Germany</SO>
<YR>1991</YR>
<PG>49-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chin_x002d_Peuckert-2004" MODIFIED="2013-10-28 13:50:05 +0000" MODIFIED_BY="[Empty name]" NAME="Chin-Peuckert 2004" YEAR="">
<REFERENCE MODIFIED="2013-10-28 13:50:05 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{19217}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:50:05 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chin-Peuckert L, Rennick JE, Jednak R, Capolicchio JP, Salle JL</AU>
<TI>Should warm infusion solution be used for urodynamic studies in children? A prospective randomized study</TI>
<SO>Journal of Urology</SO>
<YR>2004</YR>
<VL>172</VL>
<NO>4 Pt 2</NO>
<PG>1657-61</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:40:19 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:40:19 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT19217"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:40:27 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choe-2001" NAME="Choe 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;{14377}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Choe JM</AU>
<TI>Sling surgery performed with and without preoperative urodynamics: a comparative outcomes analysis (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 31st Annual Meeting; 2001 Sept 18-21; Seoul, Korea</SO>
<YR>2001</YR>
<PG>Abstract 175</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chung-2010" MODIFIED="2013-01-15 14:06:32 +0000" MODIFIED_BY="[Empty name]" NAME="Chung 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-15 14:06:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chung S, Lim R, Goldman RD</AU>
<TI>Intranasal fentanyl versus placebo for pain in children during catheterization for voiding cystourethrography</TI>
<SO>Pediatric Radiology</SO>
<YR>2010 Jul</YR>
<VL>40</VL>
<NO>7</NO>
<PG>1236-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colstrup-1982" NAME="Colstrup 1982" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;{10911}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Colstrup H, Andersen JT, Walter S</AU>
<TI>Detrusor reflex instability in the male. Fact or artefact? The influence of investigative technique on the frequency of detrusor instability in CO2-cystometry (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 12th Annual Meeting; 1992; Leiden, Germany</SO>
<YR>1982</YR>
<PG>201-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Constatini-20148" MODIFIED="2013-10-28 13:50:36 +0000" MODIFIED_BY="[Empty name]" NAME="Constatini 20148" YEAR="2005">
<REFERENCE MODIFIED="2013-10-28 13:50:36 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{20148}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:50:36 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Constantini E, Mearini L, Biscotto S, Giannantoni A, Bini V, Porena M</AU>
<TI>Impact of different sized catheters on pressure-flow studies in women with lower urinary tract symptoms</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2005</YR>
<VL>24</VL>
<NO>2</NO>
<PG>106-10</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:42:09 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:42:09 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT20148"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:41:53 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Culligan-2001" MODIFIED="2013-10-28 14:13:41 +0000" MODIFIED_BY="[Empty name]" NAME="Culligan 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-10-28 14:13:41 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{12286}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 14:13:41 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Culligan PJ, Goldberg RP, Blackhurst DW, Sasso K, Koduri S, Sand PK</AU>
<TI>Comparison of microtransducer and fiberoptic catheters for urodynamic studies</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>98</VL>
<NO>2</NO>
<PG>253-7</PG>
<IDENTIFIERS MODIFIED="2013-10-28 14:13:41 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cundiff-1999" MODIFIED="2013-10-28 13:50:59 +0000" MODIFIED_BY="[Empty name]" NAME="Cundiff 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-10-28 13:50:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cundiff GW, McLennan MT, Bent AE</AU>
<TI>Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1999 May</YR>
<VL>93</VL>
<NO>5 Pt 1</NO>
<PG>749-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Darouiche-1994" MODIFIED="2011-11-11 11:44:26 +0000" MODIFIED_BY="[Empty name]" NAME="Darouiche 1994" YEAR="">
<REFERENCE MODIFIED="2011-11-11 11:44:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darouiche RO, Smith MS, Markowski J</AU>
<TI>Antibiotic prophylaxis for urodynamic testing in patients with spinal cord injury: a preliminary study</TI>
<SO>Journal of Hospital Infection</SO>
<YR>1994</YR>
<VL>28</VL>
<NO>1</NO>
<PG>57-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dolan-2005" MODIFIED="2013-04-22 11:21:46 +0100" MODIFIED_BY="[Empty name]" NAME="Dolan 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-04-22 11:21:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dolan LM, Dixon WE, Brown K, Ord T, Hilton P</AU>
<TI>Randomized comparison of vaginal and rectal measurement of intra-abdominal pressure during subtracted dual-channel cystometry</TI>
<SO>Urology</SO>
<YR>2005</YR>
<VL>65</VL>
<NO>6</NO>
<PG>1059-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dompeyre-2007" MODIFIED="2013-10-28 13:51:08 +0000" MODIFIED_BY="[Empty name]" NAME="Dompeyre 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-10-28 13:51:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dompeyre P, Fritel X, Bader G, Delmas V, Fauconnier A</AU>
<TI>Bladder sensitivity testing using a visual analogue scale: comparative cystometric study on women</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>3</NO>
<PG>350-5</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:43:23 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:43:23 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT23235"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:42:49 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eggersmann-1996" MODIFIED="2011-11-11 14:06:50 +0000" MODIFIED_BY="[Empty name]" NAME="Eggersmann 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-11-11 14:06:50 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{5141}&lt;/p&gt;" NOTES_MODIFIED="2011-11-11 14:06:50 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Eggersmann C, Wienhold D, Dahms S, Schultz-Lampel D, Thuroff JW</AU>
<TI>Influence of different lubricants to urodynamic evaluations</TI>
<SO>Proceedings of the International Continence Society, 26th Annual Meeting; 1996 Aug 27-30; Athens, Greece</SO>
<YR>1996</YR>
<PG>440-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gehrich-2012" MODIFIED="2013-01-15 14:24:47 +0000" MODIFIED_BY="[Empty name]" NAME="Gehrich 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-01-15 14:24:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gehrich AP, Hill MJ, McWilliams GD, Larsen W, McCartin T</AU>
<TI>Comparison of urodynamic volume measurements using room and body temperature saline: a double-blinded randomized crossover study design</TI>
<SO>Female Pelvic Medicine &amp; Reconstructive Surgery</SO>
<YR>2012 May</YR>
<VL>18</VL>
<NO>3</NO>
<PG>170-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-01-15 14:22:58 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gluck-2002" NAME="Gluck 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;{14544}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gluck T, Wagg A, Fry C, Malone-Lee J</AU>
<TI>The effects of biochemical changes to filling media during urodynamic testing in women with lower urinary tract symptoms (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>4</NO>
<PG>355</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodman-2003" NAME="Goodman 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;{16556}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodman TR, Kilborn T, Pearce R</AU>
<TI>Warm or cold contrast medium in the micturating cystourethrogram (MCUG): which is best?</TI>
<SO>Clinical Radiology</SO>
<YR>2003</YR>
<VL>58</VL>
<NO>7</NO>
<PG>551-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Groutz-2000" MODIFIED="2011-12-05 12:44:20 +0000" MODIFIED_BY="[Empty name]" NAME="Groutz 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-12-05 12:44:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Groutz A, Blaivas JG, Verhaaren M</AU>
<TI>Does the method of cystometry affect the incidence of involuntary detrusor contractions? A prospective randomized urodynamic study (Abstract number 1169)</TI>
<SO>Journal of Urology</SO>
<YR>2000</YR>
<VL>163</VL>
<NO>4 Suppl</NO>
<PG>263</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:44:20 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:44:20 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT29635"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:44:00 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gurbuz-2011" MODIFIED="2013-03-26 16:25:16 +0000" MODIFIED_BY="[Empty name]" NAME="Gurbuz 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-03-26 16:25:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gurbuz C, Guner B, Atis G, Canat L, Caskrulu T</AU>
<TI>The effectiveness of fosfomycin tromethamine and ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study, do patients need prophylaxis (Abstract number 894)</TI>
<SO>Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29 to Sept 2, Glasgow, Scotland</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Handa-1994" NAME="Handa 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;{14583}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Handa VL, Jensen JK, Ostergard DR</AU>
<TI>The effect of patient position on urethral mobility (Abstract)</TI>
<SO>Proceedings of the American Urogynecology Society, 15th Annual Scientific Meeting; 1994 Sept 21-24; Toronto, Ontario</SO>
<YR>1994</YR>
<PG>Abstract P10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heslington-1996" MODIFIED="2013-10-28 13:51:19 +0000" MODIFIED_BY="[Empty name]" NAME="Heslington 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-10-28 13:51:19 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{2820}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:51:19 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heslington K, Hilton P</AU>
<TI>Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers [see comments]</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<NO>5</NO>
<PG>434-41</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="96216877"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hirakauva-2010" MODIFIED="2011-11-11 11:46:59 +0000" MODIFIED_BY="[Empty name]" NAME="Hirakauva 2010" YEAR="">
<REFERENCE MODIFIED="2011-11-11 11:46:38 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hirakauva E, Kajikawa M, de Falco K, Zucchi E, De Castro R, Sartori MGF, et al</AU>
<TI>The prophylactic antibiotic therapy prevents lower urinary tract infection after the urodynamic test? (Abstract number 819)</TI>
<SO>Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23-27, Toronto, Canada</SO>
<YR>2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hosker-1999" NAME="Hosker 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;{9931}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hosker GL, Bryant AM, Wright G, Kilcoyne PM, Lord JC, Smith ARB</AU>
<TI>A comparison of normal saline and urografin 150 for cystometry in women (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 29th Annual Meeting; 1999; Denver, Colorado</SO>
<YR>1999</YR>
<PG>420-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hougardy-2009" MODIFIED="2013-10-28 13:51:35 +0000" MODIFIED_BY="[Empty name]" NAME="Hougardy 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-10-28 13:51:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hougardy V, Vandeweerd JM, Reda AA, Foidart JM</AU>
<TI>The impact of detailed explanatory leaflets on patient satisfaction with urodynamic consultation: a double-blind randomized controlled trial</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>5</NO>
<PG>374-9</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:46:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:46:29 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT32112"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:45:50 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hundley-2006" MODIFIED="2011-12-05 12:47:55 +0000" MODIFIED_BY="[Empty name]" NAME="Hundley 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-12-05 12:47:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hundley AF, Brown MB, Brubaker L, Cundiff GW, Kreder K, Lotze P, et al</AU>
<TI>A multicentered comparison of measurements obtained with microtip and external water pressure transducers</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>4</NO>
<PG>400-6</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:47:55 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:47:55 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT22307"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:47:31 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jolic-1997" NAME="Jolic 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;{5490}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jolic V, Gilja I</AU>
<TI>Vaginal vs. transabdominal ultrasonography in the evaluation of female urinary tract anatomy, stress urinary incontinence and pelvic organs static disturbances</TI>
<SO>Zentralblatt fur Gynakologie</SO>
<YR>1997</YR>
<VL>119</VL>
<NO>10</NO>
<PG>483-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kartal-2002" MODIFIED="2011-12-05 12:50:43 +0000" MODIFIED_BY="[Empty name]" NAME="Kartal 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-12-05 12:50:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klausner AP, Galea J, Vapnek JM</AU>
<TI>Effect of catheter size on urodynamic assessment of bladder outlet obstruction</TI>
<SO>Urology</SO>
<YR>2002</YR>
<VL>60</VL>
<NO>5</NO>
<PG>875-80</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:50:43 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:50:43 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT15592"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:48:36 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keidan-2005" MODIFIED="2011-12-05 12:51:37 +0000" MODIFIED_BY="[Empty name]" NAME="Keidan 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-12-05 12:51:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keidan I, Zaslansky R, Weinberg M, Ben Shlush A, Jacobson JM, Augarten A, et al</AU>
<TI>Sedation during voiding cystourethrography: comparison of the efficacy and safety of using oral midazolam and continuous flow nitrous oxide</TI>
<SO>The Journal of Urology</SO>
<YR>2005</YR>
<VL>174</VL>
<NO>4 Pt 2</NO>
<PG>1598-1600, discussion 1601</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:51:21 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:51:21 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT21987"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:51:37 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khan-2004" MODIFIED="2013-01-15 14:34:42 +0000" MODIFIED_BY="[Empty name]" NAME="Khan 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-01-15 14:34:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan MS, Chaliha C, Leskova L, Khullar V</AU>
<TI>The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration</TI>
<SO>BJOG</SO>
<YR>2004 May</YR>
<VL>111</VL>
<NO>5</NO>
<PG>468-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khullar-1996" MODIFIED="2013-10-28 13:51:44 +0000" MODIFIED_BY="[Empty name]" NAME="Khullar 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-10-28 13:51:44 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{2710}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:51:44 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khullar V, Cardozo LD, Salvatore S, Hill S</AU>
<TI>Ultrasound: a noninvasive screening test for detrusor instability</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<NO>9</NO>
<PG>904-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khullar-2002" MODIFIED="2011-06-22 15:08:29 +0100" MODIFIED_BY="[Empty name]" NAME="Khullar 2002" YEAR="">
<REFERENCE MODIFIED="2008-10-30 18:40:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{14543}&lt;/p&gt;" NOTES_MODIFIED="2008-10-30 18:40:14 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khullar V, Soligo M, Salvatore S</AU>
<TI>Does rectal distension alter bladder function? (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>4</NO>
<PG>354</PG>
<IDENTIFIERS MODIFIED="2008-10-30 18:40:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-30 18:40:14 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="14543"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-06-22 15:08:29 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klarskov-2009" MODIFIED="2013-10-28 13:52:08 +0000" MODIFIED_BY="[Empty name]" NAME="Klarskov 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-10-28 13:52:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klarskov N, Scholfield D, Soma K, Darekar A, Mills I, Lose G</AU>
<TI>Measurement of urethral closure function in women with stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2009 Jun</YR>
<VL>181</VL>
<NO>6</NO>
<PG>2628-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kristjansson-1999" MODIFIED="2013-10-28 13:52:19 +0000" MODIFIED_BY="[Empty name]" NAME="Kristjansson 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-10-28 13:52:19 +0000" MODIFIED_BY="[Empty name]" NOTES="DB - CCTR" NOTES_MODIFIED="2013-10-28 13:52:19 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kristjansson B</AU>
<TI>A randomised evaluation of routine urodynamics in patients with LUTS [abstract]</TI>
<SO>Scandinavian Journal of Urology and Nephrology Supplementum</SO>
<YR>1999</YR>
<VL>33 Suppl 200</VL>
<PG>9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="23728"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuhn-2007" MODIFIED="2011-12-05 12:52:30 +0000" MODIFIED_BY="[Empty name]" NAME="Kuhn 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-12-05 12:52:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuhn A, Nager CW, Hawkins E, Schulz J, Stanton SL</AU>
<TI>A comparative study of water perfusion catheters and microtip transducer catheters for urethral pressure measurements</TI>
<SO>International Urogynecology Journal</SO>
<YR>18</YR>
<VL>8</VL>
<PG>931-5</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:52:30 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:52:30 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT23895"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:52:09 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kulseng-1995" NAME="Kulseng 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;{10884}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kulseng-Hanssen S, Kristoffersen M, Larsen E</AU>
<TI>Physiological bladder filling with 2 and 4 hours recording versus 45 minutes recording with 300 ml saline bladder prefilling using ambulatory urodynamic equipment (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 25th Annual Meeting; 1995; Sydney, Australia</SO>
<YR>1995</YR>
<PG>151-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2002" NAME="Lee 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;{14503}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lee F, Susser J, Mundy A, Foxall P, Craggs M</AU>
<TI>Does urinary sodium affect bladder sensations in patients with an overactive bladder during urodynamics? (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 32nd Annual Meeting; 2002 Aug 28-30; Heidelberg, Germany</SO>
<YR>2002</YR>
<PG>102-3 (Abstract 181)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lucas-2009" MODIFIED="2011-12-05 12:20:01 +0000" MODIFIED_BY="[Empty name]" NAME="Lucas 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-12-05 12:19:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lucas M, Moore K, Borkowski T,Pantuck A, Heesakkers J, Radziszewski P</AU>
<TI>Accuracy of CaptiFlow portable home flow measuring device and its use as a diagnostic tool in the management of LUTS - a randomised cross over study (Abstract number 400)</TI>
<SO>Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 - Oct 3, San Francisco, CA</SO>
<YR>2009</YR>
<IDENTIFIERS MODIFIED="2011-12-05 12:19:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:19:45 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT35613"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:19:56 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malone_x002d_Lee-2009" MODIFIED="2013-10-28 13:52:31 +0000" MODIFIED_BY="[Empty name]" NAME="Malone-Lee 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-10-28 13:52:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malone-Lee JG, Al Buheissi S</AU>
<TI>Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study</TI>
<SO>BJU International</SO>
<YR>2009 Apr</YR>
<VL>103</VL>
<NO>7</NO>
<PG>931-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Massey-1987" NAME="Massey 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;{9031} RCT of 2 different techniques, no clinical outcomes&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Massey A, Howell S, Lewis P, Tribe B</AU>
<TI>Urethral profilometry by different methods (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 17th Annual Meeting; 1987 Sept; Bristol, UK</SO>
<YR>1987</YR>
<PG>122-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Medina-2002" NAME="Medina 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;{14501}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Medina C, Fynes M, Gold R, Wang K, Stanton S</AU>
<TI>Does the order of patient position for sequential bladder filling at cystometry influence observed detrusor activity? (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 32nd Annual Meeting; 2002 Aug 28-30; Heidelberg, Germany</SO>
<YR>2002</YR>
<PG>87-8 (Abstract 162)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Medina-2005" MODIFIED="2013-10-28 13:52:39 +0000" MODIFIED_BY="[Empty name]" NAME="Medina 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-10-28 13:52:39 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Medina CA, Takacs P</AU>
<TI>Shortening the process of determining postvoid residual</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2005</YR>
<VL>91</VL>
<NO>3</NO>
<PG>266-7</PG>
<IDENTIFIERS MODIFIED="2011-06-21 09:57:44 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-21 09:57:44 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21868"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Minardi-2010" MODIFIED="2011-12-05 12:53:55 +0000" MODIFIED_BY="[Empty name]" NAME="Minardi 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-12-05 12:53:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Minardi D, d'Anzeo G, Parri G, Polito M Jr, Piergallina M, El Asmar Z</AU>
<TI>The role of uroflowmetry biofeedback and biofeedback training of the pelvic floor muscles in the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a randomized controlled prospective study</TI>
<SO>Urology</SO>
<YR>2010</YR>
<VL>75</VL>
<NO>6</NO>
<PG>1299-304</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:53:55 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:53:55 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT39965"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:53:21 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mouritsen-1999" MODIFIED="2013-10-28 13:52:50 +0000" MODIFIED_BY="[Empty name]" NAME="Mouritsen 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-10-28 13:52:50 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{9839}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:52:50 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mouritsen L, Sander P, Bernstein I, Bach A</AU>
<TI>Comparison of palpation, ultrasonography and perineometry for examination of the pelvic floor</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>1999</YR>
<VL>10 Suppl 1</VL>
<PG>S16-7</PG>
<EN>10</EN>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mueller-2007" MODIFIED="2013-10-28 13:53:00 +0000" MODIFIED_BY="[Empty name]" NAME="Mueller 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-10-28 13:53:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mueller ER, Kenton K, Mahajan S, FitzGerald MP, Brubaker L</AU>
<TI>Urodynamic prolapse reduction alters urethral pressure but not filling or pressure flow parameters</TI>
<SO>Journal of Urology</SO>
<YR>2007</YR>
<VL>177</VL>
<NO>2</NO>
<PG>600-3</PG>
<IDENTIFIERS MODIFIED="2011-12-05 12:54:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 12:54:28 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONT22546"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:54:11 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neal-1987" MODIFIED="2011-06-22 13:54:00 +0100" MODIFIED_BY="[Empty name]" NAME="Neal 1987" YEAR="">
<REFERENCE MODIFIED="2011-06-22 13:54:00 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{544}&lt;/p&gt;" NOTES_MODIFIED="2011-06-22 13:54:00 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neal DE, Rao CV, Styles RA, Ng T, Ramsden PD</AU>
<TI>Effects of catheter size on urodynamic measurements in men undergoing elective prostatectomy</TI>
<SO>British Journal of Urology</SO>
<YR>1987</YR>
<VL>60</VL>
<NO>1</NO>
<PG>64-8</PG>
<IDENTIFIERS MODIFIED="2011-06-22 13:54:00 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 13:54:00 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="544"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Panayi-2008" MODIFIED="2013-01-15 14:14:46 +0000" MODIFIED_BY="[Empty name]" NAME="Panayi 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-01-15 14:14:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Panayi D, Khullar V, Spiteri M, Hendricken C, Fernando R</AU>
<TI>Randomised study to determine if rectal distension alters urodynamic findings? (Abstract number 57)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>7</NO>
<PG>636</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Payne-2001" MODIFIED="2013-10-28 13:53:11 +0000" MODIFIED_BY="[Empty name]" NAME="Payne 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-10-28 13:53:11 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{14747}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:53:11 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Payne CK, Sirinian E, Azevedo K</AU>
<TI>Effect of physiologic levels of urinary potassium on interstitial cystitis symptoms</TI>
<SO>Urology</SO>
<YR>2001</YR>
<VL>57 Suppl 6A</VL>
<PG>124</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peschers-2001" NAME="Peschers 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;{12193}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peschers UMK</AU>
<TI>Antibiotic treatment to prevent urinary tract infections after urodynamic evaluation</TI>
<SO>International Urogynecology Journal</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>4</NO>
<PG>254-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peters_x002d_Gee-2003" MODIFIED="2013-10-26 12:23:19 +0100" MODIFIED_BY="[Empty name]" NAME="Peters-Gee 2003" YEAR="">
<REFERENCE MODIFIED="2013-10-26 12:23:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{17196}&lt;/p&gt;" NOTES_MODIFIED="2013-10-26 12:23:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peters-Gee J, McKinney T, Rezapour M, Mastropietro M, Lucente V, Slack M, et al</AU>
<TI>Multicenter study of gynecare MoniTorr urethral resistance pressure versus standard urodynamic MEA</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2003</YR>
<VL>101</VL>
<NO>4 Suppl</NO>
<PG>114S</PG>
<IDENTIFIERS MODIFIED="2011-06-22 13:54:44 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 13:54:44 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="17196"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philip-2007" MODIFIED="2013-10-28 13:53:32 +0000" MODIFIED_BY="[Empty name]" NAME="Philip 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-06-22 13:59:08 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{19085}&lt;/p&gt;" NOTES_MODIFIED="2011-06-22 13:59:08 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Philip J, Irwin P</AU>
<TI>A double-blind, randomised controlled trial of cystometry using normal saline versus 3M potassium chloride infusion (Abstract)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International UroGynecological Association; 2004 Aug 23-27; Paris</SO>
<YR>2004</YR>
<PG>Abstract number 739</PG>
<IDENTIFIERS MODIFIED="2011-06-22 13:59:08 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 13:59:08 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="19085"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:53:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Philip J, Willmott S, Irwin P</AU>
<TI>Interstitial cystitis versus detrusor overactivity: a comparative, randomized, controlled study of cystometry using saline and 0.3 M potassium chloride</TI>
<SO>Journal of Urology</SO>
<YR>2006</YR>
<VL>175</VL>
<NO>2</NO>
<PG>566-570, discussion 570-1</PG>
<IDENTIFIERS MODIFIED="2011-05-26 09:38:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:38:24 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21625"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:53:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philip J, Willmott S, Owen D, Samsudin C, Irwin PP</AU>
<TI>A double-blind, randomized controlled trial of cystometry using saline versus 0.3 M potassium chloride infusion in women with overactive bladder syndrome</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>1</NO>
<PG>110-4</PG>
<IDENTIFIERS MODIFIED="2011-05-26 09:37:53 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:37:53 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="22576"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Radley-2001" MODIFIED="2013-10-28 13:53:42 +0000" MODIFIED_BY="[Empty name]" NAME="Radley 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-10-28 13:53:42 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{12174}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:53:42 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Radley SC, Rosario DJ, Chapple CR, Farkas AG</AU>
<TI>Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity</TI>
<SO>Journal of Urology</SO>
<YR>2001</YR>
<VL>166</VL>
<NO>6</NO>
<PG>2253-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11696746"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{9961}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Radley SC, Rosario DJ, Chapple CR</AU>
<TI>Inter-observer agreement in interpreting ambulatory urodynamics in women</TI>
<SO>Proceedings of the International Continence Society (ICS), 30th Annual Meeting; 2000 Aug; Tampere, Finland</SO>
<YR>2000</YR>
<PG>Abstract 265</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{9967}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rosario DJ, Chapple CR, Radley SC</AU>
<TI>Inter-observer agreement in interpreting ambulatory urodynamics in women</TI>
<SO>Proceedings of the International Continence Society (ICS), 30th Annual Meeting; 2002 Aug; Tampere, Finland</SO>
<YR>2000</YR>
<PG>Abstract 359</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Realfonso-2005" MODIFIED="2011-06-22 14:00:31 +0100" MODIFIED_BY="[Empty name]" NAME="Realfonso 2005" YEAR="">
<REFERENCE MODIFIED="2011-06-22 14:00:31 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{21088}&lt;/p&gt;" NOTES_MODIFIED="2011-06-22 14:00:31 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Realfonso T, Di Mauro U, Campitelli A, Angrisani R, Sanseverino R</AU>
<TI>Influence of the bladder filling speed over the voiding phase in the pressure flow study in the woman (Abstract number 680)</TI>
<SO>Proceedings of the 35th Annual International Continence Society (ICS); 2005 Aug 28-Sept 2; Montreal</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2011-06-22 14:00:31 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:00:31 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21088"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rehme-2009" MODIFIED="2011-12-05 12:54:55 +0000" MODIFIED_BY="[Empty name]" NAME="Rehme 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-11-11 14:17:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rehme C, Niedworok C, Rubben H, Stohrer M</AU>
<TI>A technically reduced urodynamic measuring method compared with a conventional urodynamic study (Abstract number 876)</TI>
<SO>Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 - Oct 3, San Francisco, CA</SO>
<YR>2009</YR>
<IDENTIFIERS MODIFIED="2011-11-11 14:17:10 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-11 14:17:10 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="35362"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-05 12:54:55 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robinson-2002" MODIFIED="2013-10-28 13:53:51 +0000" MODIFIED_BY="[Empty name]" NAME="Robinson 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-10-28 13:53:51 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{13097}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:53:51 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson D, Anders K, Cardozo L, Bidmead J, Toozs-Hobson P, Khullar V</AU>
<TI>Can ultrasound replace ambulatory urodynamics when investigating women with irritative urinary symptoms?</TI>
<SO>BJOG: an International Journal of Obstetrics and Gynaecology</SO>
<YR>2002</YR>
<VL>109</VL>
<NO>2</NO>
<PG>145-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="21884932"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rovner-2005" MODIFIED="2013-01-15 14:51:11 +0000" MODIFIED_BY="[Empty name]" NAME="Rovner 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-01-15 14:51:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rovner E, Payne C, Yalla S, Nitti V</AU>
<TI>Response to fesoterodine in overactive bladder (OAB) patients is independent of the urodynamic finding of detrusor overactivity (Abstract number 147)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting</SO>
<YR>2005 Aug 28 - Sep 2, Montreal, Canada, 2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sand-1985" NAME="Sand 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;{14561}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sand PK, Bowen LW, Ostergard DR</AU>
<TI>The effect of a filling catheter during urodynamics (Abstract)</TI>
<SO>Proceedings of the American Urogynecology Society, 6th Annual Meeting; 1985 Nov 6-9; San Diego, California</SO>
<YR>1985</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{14589}&lt;/p&gt;" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Sand PK, Bowen LW, Ostergard DR</AU>
<TI>The effect of a filling catheter during urodynamics (Abstract)</TI>
<SO>Proceedings of the International Urogynecology Association, 9th Annual Meeting; 1985 Sept 9-11; Budapest, Hungary</SO>
<YR>1985</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scaldazza-2005" MODIFIED="2011-06-22 14:02:11 +0100" MODIFIED_BY="[Empty name]" NAME="Scaldazza 2005" YEAR="">
<REFERENCE MODIFIED="2011-06-22 14:02:11 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{20808}&lt;/p&gt;" NOTES_MODIFIED="2011-06-22 14:02:11 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scaldazza CV, Morosetti C</AU>
<TI>Effect of different sized transurethral catheters on pressure-flow studies in women with lower urinary tract symptoms</TI>
<SO>Urologia Internationalis</SO>
<YR>2005</YR>
<VL>75</VL>
<NO>1</NO>
<PG>21-5</PG>
<IDENTIFIERS MODIFIED="2011-06-22 14:02:11 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:02:11 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20808"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmidt-2001" NAME="Schmidt 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;{14374}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Schmidt F, Jorgensen TM, Djurhuus JC</AU>
<TI>Ambulatory urodynamics and home flowmetry, are there differences in the recorded data (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 31st Annual Meeting; 2001 Sept 18-21; Seoul, Korea</SO>
<YR>2001</YR>
<PG>Abstract 13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shukla-2006" MODIFIED="2011-06-21 10:05:33 +0100" MODIFIED_BY="[Empty name]" NAME="Shukla 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-06-21 10:05:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shukla A, Johnson D, Bibby J</AU>
<TI>Impact of patient position on filling phase of urodynamics in women</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>3</NO>
<PG>231-3</PG>
<IDENTIFIERS MODIFIED="2011-06-21 10:05:33 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-21 10:05:33 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21915"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siracusano-2004" MODIFIED="2011-11-11 12:08:28 +0000" MODIFIED_BY="[Empty name]" NAME="Siracusano 2004" YEAR="">
<REFERENCE MODIFIED="2011-11-11 12:08:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siracusano S, Knez R, Tiberio A, Alfano V, Giannantoni A, Pappagallo G</AU>
<TI>The usefulness of antibiotic prophylaxis in invasive urodynamics in postmenopausal female subjects</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>7</NO>
<PG>939-42</PG>
<IDENTIFIERS MODIFIED="2011-06-22 14:06:09 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:06:09 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27793"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-11-11 12:08:02 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{19087}&lt;/p&gt;" NOTES_MODIFIED="2011-11-11 12:08:02 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Siracusano S, Tiberio A, Cucchi A, Simonazzi M, Facchini M, Alfano V et al</AU>
<TI>Usefulness of antibiotic prophylaxis in invasive urodynamics in fertile and in post menopausal female subjects (Abstract)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International UroGynecological Association; 2004 Aug 23-27; Paris</SO>
<YR>2004</YR>
<PG>Abstract number 753</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirls-2013" MODIFIED="2013-10-28 13:54:25 +0000" MODIFIED_BY="[Empty name]" NAME="Sirls 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-10-28 13:54:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirls L, Richter H, Litman H, Kenton K, Lemack G, Lukacz E, et al</AU>
<TI>The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery (Abstract number 251)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31(6)</VL>
<PG>1051-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:54:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirls LT, Richter HE, Litman HJ, Kenton K, Lemack GE, Lukacz ES, et al</AU>
<TI>The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery</TI>
<SO>Journal of Urology</SO>
<YR>2013 Jan</YR>
<VL>189</VL>
<NO>1</NO>
<PG>204-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Slack-2004" MODIFIED="2013-10-28 13:54:33 +0000" MODIFIED_BY="[Empty name]" NAME="Slack 2004" YEAR="">
<REFERENCE MODIFIED="2011-11-11 12:11:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Culligan PJ, Lewis-Priestley J, Blackwell L, Tate SB</AU>
<TI>Can urethral retroresistance pressures predict midurethral sling outcomes?</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>2010</YR>
<VL>55</VL>
<NO>3-4</NO>
<PG>103-7</PG>
<IDENTIFIERS MODIFIED="2011-06-21 10:05:53 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-21 10:05:53 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="39947"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:54:33 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{17437}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:54:33 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Slack M, Culligan P, Tracey M, Hunsicker K, Patel B, Sumeray M</AU>
<TI>Relationship of urethral retro-resistance pressure to urodynamic measurements and incontinence severity</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>2</NO>
<PG>109-14</PG>
<IDENTIFIERS MODIFIED="2011-06-22 14:08:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:08:16 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="17437"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Slack-2004a" MODIFIED="2011-05-22 15:52:31 +0100" MODIFIED_BY="[Empty name]" NAME="Slack 2004a" YEAR="2004">
<REFERENCE MODIFIED="2011-05-22 15:52:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Slack M, Hunsicker K, Patel B, Godwin A, Owens C</AU>
<TI>Comparison of multichannel cystometrogram (PVES, PABD, PDET) to single channel cystometrogram (PVES) (Abstract number 72)</TI>
<SO>Progres en Urologie</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>3 Suppl 3</NO>
<PG>23</PG>
<IDENTIFIERS MODIFIED="2011-05-22 15:52:31 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-22 15:52:31 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31089"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soligo-2002" MODIFIED="2013-10-26 12:30:19 +0100" MODIFIED_BY="[Empty name]" NAME="Soligo 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-10-26 12:30:19 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{14502}&lt;/p&gt;" NOTES_MODIFIED="2013-10-26 12:30:19 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Soligo M, Salvatore S, Arcari V, Citterio S, Malberti S, Lalia M, et al</AU>
<TI>Cough stress test and urodynamics: do they correlate? (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 32nd Annual Meeting; 2002 Aug 28-30; Heidelberg, Germany</SO>
<YR>2002</YR>
<PG>90-1 (Abstract 166)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sullivan-1999" NAME="Sullivan 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;{9915}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sullivan J, Lewis P, Howell S, Shepherd A, Abrams P</AU>
<TI>Does contrast medium affect the results of urodynamics? (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 29th Annual Meeting; 1999 Aug; Denver, Colorado</SO>
<YR>1999</YR>
<PG>98-9 (Abstract 331)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sullivan-2001" MODIFIED="2013-10-28 13:54:43 +0000" MODIFIED_BY="[Empty name]" NAME="Sullivan 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-10-28 13:54:43 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{13096}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:54:43 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sullivan J, Bulmer P, Lewis P, Howell S, Shepherd A, Swithinbank L, et al</AU>
<TI>Small changes in filling medium temperature and filling rate affect urodynamic results</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>4</NO>
<PG>567-8 (Abstract 121)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sutherst-1984" NAME="Sutherst 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;{649}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sutherst JR, Brown MC</AU>
<TI>Comparison of single and multichannel cystometry in diagnosing bladder instability</TI>
<SO>British Medical Journal</SO>
<YR>1984</YR>
<VL>288</VL>
<NO>6432</NO>
<PG>1720-2</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="84232969"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swift-1997" MODIFIED="2013-10-28 13:54:51 +0000" MODIFIED_BY="[Empty name]" NAME="Swift 1997" YEAR="1997">
<REFERENCE MODIFIED="2013-10-28 13:54:51 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{5634}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:54:51 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swift SE</AU>
<TI>The reliability of performing a screening cystometrogram using a fetal monitoring device for the detection of detrusor instability</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1997</YR>
<VL>89</VL>
<NO>5 Pt 1</NO>
<PG>708-12</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="97309115"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swithinbank-1995" NAME="Swithinbank 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;{10898}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Swithinbank LV, Lewis PA, Abrams P</AU>
<TI>Low detrusor compliance in neurologically normal women - the need for a working definition (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 25th Annual Meeting; 1995 Oct; Sydney, Australia</SO>
<YR>1995</YR>
<PG>426-7 (Abstract 326)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Truzzi-1999" NAME="Truzzi 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;{16391}&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Truzzi JC, Bruschini H, Srougi M</AU>
<TI>Interferences of fluid osmolality in vesical parameters during urodynamic examination (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 29th Annual Meeting; 1999 Aug 22-26; Denver, Colorado</SO>
<YR>1999</YR>
<PG>92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Visco-2004" MODIFIED="2013-10-28 13:54:58 +0000" MODIFIED_BY="[Empty name]" NAME="Visco 2004" YEAR="">
<REFERENCE MODIFIED="2013-10-28 13:54:58 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{19019}&lt;/p&gt;" NOTES_MODIFIED="2013-10-28 13:54:58 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Visco A</AU>
<TI>Comparison of measurements obtained with microtip and external water pressure transducers (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>5/6</NO>
<PG>588-9</PG>
<IDENTIFIERS MODIFIED="2011-06-22 14:12:25 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:12:25 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="19019"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Visco-2008" MODIFIED="2013-10-28 13:55:09 +0000" MODIFIED_BY="[Empty name]" NAME="Visco 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-10-28 13:55:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Visco AG, Brubaker L, Nygaard I, Richter HE, Cundiff G, Fine P, et al</AU>
<TI>The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial.</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>5</NO>
<PG>607-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Voorham_x002d_Van-2007" MODIFIED="2011-11-11 12:14:02 +0000" MODIFIED_BY="[Empty name]" NAME="Voorham-Van 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-11-11 12:14:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Voorham-Van Der Zalm PJ, Pelger RCM, Ouwerkerk TJ, Elzevier HW, Lycklama a Nijeholt GAB</AU>
<TI>Impact of intra vaginal electrostimulation on urodynamic parameters in the overactive bladder syndrome (Abstract number ?90164)</TI>
<SO>Proceedings of the Annual Meeting of the American Urological Association (AUA), 2007 May 19-24, Anaheim CA</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2011-05-26 09:46:25 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:46:25 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23768"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wadie-2009" MODIFIED="2013-10-28 13:55:22 +0000" MODIFIED_BY="[Empty name]" NAME="Wadie 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-10-28 13:55:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wadie BS, El Hefnawy AS</AU>
<TI>Urethral pressure meaurement in stress incontinence: does it help?</TI>
<SO>International Urology and Nephrology</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>3</NO>
<PG>491-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yip-2006" MODIFIED="2013-10-28 13:56:08 +0000" MODIFIED_BY="[Empty name]" NAME="Yip 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-10-28 13:55:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yip S, Cheon C, Wong T, Pang M, Lee L, Yuen C, et al</AU>
<TI>A randomised double-blind placebo-controlled trial of prophylactic antibiotics in preventing female urinary tract infection after urodynamic study (Abstract number 99)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2006</YR>
<VL>25</VL>
<NO>6</NO>
<PG>627-8</PG>
<IDENTIFIERS MODIFIED="2011-05-26 09:46:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:46:39 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26628"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-10-28 13:56:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yip SK, Cheon C, Wong T, Pang MW, Lee L, Yuen C, et al</AU>
<TI>Preventing female urinary tract infection caused by urodynamic study: a randomised double-blind placebo-controlled trial of prophylactic Augmentin (Abstract number 47)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2006</YR>
<VL>17 Suppl 2</VL>
<PG>S85-6</PG>
<IDENTIFIERS MODIFIED="2011-06-22 14:28:51 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-22 14:28:51 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="34184"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zehnder-2008" MODIFIED="2013-10-28 13:56:18 +0000" MODIFIED_BY="[Empty name]" NAME="Zehnder 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-10-28 13:56:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zehnder P, Roth B, Burkhard FC, Kessler TM</AU>
<TI>Air charged and microtip catheters cannot be used interchangeably for urethral pressure measurement: a prospective, single-blind, randomized trial</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>180</VL>
<NO>3</NO>
<PG>1013-7</PG>
<IDENTIFIERS MODIFIED="2011-05-26 09:47:15 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-26 09:47:15 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27508"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zerin-1993" NAME="Zerin 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;{35}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zerin JM</AU>
<TI>Impact of contrast medium temperature on bladder capacity and cystographic diagnosis of vesicoureteral reflux in children</TI>
<SO>Radiology</SO>
<YR>1993</YR>
<VL>187</VL>
<NO>1</NO>
<PG>161-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-10-28 13:57:18 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Romero-Maroto-2010" MODIFIED="2013-10-28 13:57:18 +0000" MODIFIED_BY="[Empty name]" NAME="Romero Maroto 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-10-28 13:57:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Romero Maroto J, Ortiz Gorraiz MA, Gomez Perez L, Lopez Lopez A, Sanchez A, Pacheco Bru JJ</AU>
<TI>Does pressure flow study improve the outcome of surgery in women with SUI?</TI>
<SO>European Eurology Supplements</SO>
<YR>2010</YR>
<VL>9</VL>
<NO>2</NO>
<PG>228</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2012-12-10 09:33:37 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Hilton-2011" MODIFIED="2011-12-05 13:28:26 +0000" MODIFIED_BY="[Empty name]" NAME="Hilton 2011" YEAR="2011">
<REFERENCE MODIFIED="2011-09-07 11:33:40 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21733166&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Trials. 12:169, 2011&lt;br&gt;JC - 101263253&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;NO - 09/22/136 (United Kingdom Department of Health)&lt;br&gt;LG - English&lt;br&gt;DC - 20110809&lt;/p&gt;" NOTES_MODIFIED="2011-09-07 11:33:40 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murdoch M, McColl E, Howel D, Deverill M, Buckley BS, Lucas M, et al</AU>
<TI>INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): study protocol for a mixed methods study to assess the feasibility of a future randomised controlled trial of the clinical utility of invasive urodynamic testing</TI>
<SO>Trials [Electronic Resource]</SO>
<YR>2011</YR>
<VL>12</VL>
<PG>169</PG>
<IDENTIFIERS MODIFIED="2011-09-07 11:33:40 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-09-07 11:33:40 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="SR-INCONTid41694"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-10-28 14:12:15 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-10-28 14:12:15 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abrams-2002" MODIFIED="2013-10-28 13:57:29 +0000" MODIFIED_BY="[Empty name]" NAME="Abrams 2002" TYPE="JOURNAL_ARTICLE">
<AU>Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al</AU>
<TI>The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>2</NO>
<PG>167-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Abrams-2009" MODIFIED="2013-09-25 22:16:26 +0100" MODIFIED_BY="[Empty name]" NAME="Abrams 2009" TYPE="BOOK">
<AU>Abrams P, Cardozo L, Khoury S, Wein A</AU>
<SO>Incontinence, 4th International Consultation on Incontinence</SO>
<YR>2009</YR>
<EN>4</EN>
<PB>Editions 21</PB>
<CY>Paris</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-AHCPR-1996" MODIFIED="2011-11-11 14:26:57 +0000" MODIFIED_BY="[Empty name]" NAME="AHCPR 1996" TYPE="BOOK_SECTION">
<AU>Fantl JA, Newman DK, Colling J, DeLancey JOL, Keeys C, Loughery R, et al</AU>
<TI>Chapter 2: Identifying and evaluating urinary incontinence</TI>
<SO>Urinary Incontinence in Adults: Acute and Chronic Management</SO>
<YR>1996</YR>
<EN>2</EN>
<ED>Agency for Health Care Policy and Research</ED>
<PB>US Government Printing Office</PB>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Alhasso-2005" MODIFIED="2011-11-11 10:12:54 +0000" MODIFIED_BY="[Empty name]" NAME="Alhasso 2005" TYPE="COCHRANE_REVIEW">
<AU>Alhasso A, Glazener CMA, Pickard R, N'Dow J</AU>
<TI>Adrenegic drugs for urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-11-11 10:04:42 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-11 10:04:42 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001842.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Alhasso-2006" MODIFIED="2011-11-11 10:12:49 +0000" MODIFIED_BY="[Empty name]" NAME="Alhasso 2006" TYPE="COCHRANE_REVIEW">
<AU>Alhasso AA, McKinlay J, Patrick K, Stewart L</AU>
<TI>Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2011-11-10 15:53:08 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-10 15:53:08 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003193.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Black-1997" MODIFIED="2011-11-11 10:12:43 +0000" MODIFIED_BY="[Empty name]" NAME="Black 1997" TYPE="JOURNAL_ARTICLE">
<AU>Black N, Griffiths J, Pope C, Bowling A, Abel P</AU>
<TI>Impact of surgery for stress incontinence on morbidity: cohort study</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>1493-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="98082059"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Black-1998" MODIFIED="2011-11-11 10:12:39 +0000" MODIFIED_BY="[Empty name]" NAME="Black 1998" TYPE="JOURNAL_ARTICLE">
<AU>Black N</AU>
<TI>Impact of surgery for stress incontinence on morbidity. Author's reply [letter]</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<NO>7151</NO>
<PG>144</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Campbell-2007" MODIFIED="2011-11-11 10:12:35 +0000" MODIFIED_BY="[Empty name]" NAME="Campbell 2007" TYPE="COCHRANE_REVIEW">
<AU>Campbell R, Cook J, Dublin N</AU>
<TI>Anticholinergic drugs versus other medications for overactive bladder syndrome in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2011-11-11 10:04:20 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-11 10:04:20 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003190.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cardozo-1980" MODIFIED="2013-10-28 13:57:42 +0000" MODIFIED_BY="[Empty name]" NAME="Cardozo 1980" TYPE="JOURNAL_ARTICLE">
<AU>Cardozo LD, Stanton SL</AU>
<TI>Genuine stress incontinence and detrusor instability--a review of 200 patients</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1980</YR>
<VL>87</VL>
<NO>3</NO>
<PG>184-90</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="80220963"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chapple-2006" MODIFIED="2013-10-28 13:57:53 +0000" MODIFIED_BY="[Empty name]" NAME="Chapple 2006" TYPE="JOURNAL_ARTICLE">
<AU>Chapple CR, Roehrborn CG</AU>
<TI>A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: Focus on the bladder</TI>
<SO>European Urology</SO>
<YR>April 2006</YR>
<VL>49</VL>
<NO>4</NO>
<PG>651-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2011-11-15 14:38:26 +0000" MODIFIED_BY="[Empty name]" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duggan-2003" MODIFIED="2011-11-11 10:12:24 +0000" MODIFIED_BY="[Empty name]" NAME="Duggan 2003" TYPE="JOURNAL_ARTICLE">
<AU>Duggan PM, Wilson PD, Norton P, Brown AD, Drutz HP, Herbison P</AU>
<TI>Utilization of preoperative urodynamic investigations by gynecologists who frequently operate for female urinary incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>4</NO>
<PG>282-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fowler-2006" NAME="Fowler 2006" TYPE="JOURNAL_ARTICLE">
<AU>Fowler G, Richmond D</AU>
<TI>Urodynamics: a mandatory preoperative investigation?</TI>
<SO>The Obstetrician and Gynaecologist</SO>
<YR>2006</YR>
<VL>8</VL>
<PG>86-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gorton-1999" MODIFIED="2013-10-28 13:58:03 +0000" MODIFIED_BY="[Empty name]" NAME="Gorton 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gorton E, Stanton S</AU>
<TI>Women's attitudes to urodynamics: a questionnaire survey</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1999</YR>
<VL>106</VL>
<NO>8</NO>
<PG>851-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="99381640"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gorton-2000" MODIFIED="2013-10-28 13:58:10 +0000" MODIFIED_BY="[Empty name]" NAME="Gorton 2000" TYPE="JOURNAL_ARTICLE">
<AU>Gorton E, Stanton S</AU>
<TI>Ambulatory urodynamics: do they help clinical management?</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>2000</YR>
<VL>107</VL>
<NO>3</NO>
<PG>316-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="20201607"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Griffiths-2005" MODIFIED="2013-10-26 12:39:45 +0100" MODIFIED_BY="[Empty name]" NAME="Griffiths 2005" TYPE="BOOK_SECTION">
<AU>Griffiths D, Kondo A, Bauer S, Diamant N, Liao L, Lose G, et al</AU>
<TI>Dynamic testing</TI>
<SO>Incontinence: 3rd International Consultation on Incontinence</SO>
<YR>2005</YR>
<EN>3nd</EN>
<PB>Health Publication Ltd</PB>
<CY>Paris, France</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haylen-2010" MODIFIED="2013-10-28 13:58:22 +0000" MODIFIED_BY="[Empty name]" NAME="Haylen 2010" TYPE="JOURNAL_ARTICLE">
<AU>Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al</AU>
<TI>An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<PG>4-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-10-26 12:41:01 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Homma-1999" MODIFIED="2013-10-26 12:41:36 +0100" MODIFIED_BY="[Empty name]" NAME="Homma 1999" TYPE="BOOK_SECTION">
<AU>Homma Y, Batista JE, Bauer SB, Griffiths DJ, Hilton P, Kramer G, et al</AU>
<TI>Urodynamics</TI>
<SO>Incontinence. First International Consultation on Incontinence. Recommendations of the International Scientific Committee: the evaluation and treatment of urinary incontinence</SO>
<YR>1999</YR>
<PG>Chapter 9</PG>
<ED>Abrams P, Wein A, Schussler B, Kawabi K, Bump R, Melchior H, et al</ED>
<PB>Health Publication Ltd</PB>
<CY>Plymouth,UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hosker-2009" MODIFIED="2013-10-28 13:58:37 +0000" MODIFIED_BY="[Empty name]" NAME="Hosker 2009" TYPE="BOOK_SECTION">
<AU>Hosker G, Rosier P, Gajewski J, Sand P</AU>
<TI>Dynamic Testing</TI>
<SO>Incontience: 4th International Consultation on Incontinence</SO>
<YR>2009</YR>
<PG>413-522</PG>
<ED>Abrams P, Cardozo L, Khoury S, Wein A</ED>
<PB>Health Publication Ltd</PB>
<CY>Paris</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunskaar-2002" NAME="Hunskaar 2002" TYPE="BOOK_SECTION">
<AU>Hunskaar S, Burgio K, Diokno AC, Herzog AR, Hjalmas K, Lapitan M</AU>
<TI>Epidemiology and natural history of urinary incontinence</TI>
<SO>Incontinence: 2nd International Consultation on Incontinence</SO>
<YR>2002</YR>
<PG>165-202</PG>
<PB>Health Publication Ltd</PB>
<CY>Plymouth, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jarvis-1980" MODIFIED="2013-10-28 13:58:50 +0000" MODIFIED_BY="[Empty name]" NAME="Jarvis 1980" TYPE="JOURNAL_ARTICLE">
<AU>Jarvis GJ, Hall S, Stamp S, Millar DR, Johnson A</AU>
<TI>An assessment of urodynamic examination in incontinent women</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1980</YR>
<VL>87</VL>
<NO>10</NO>
<PG>893-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="81039795"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Latthe-2012" MODIFIED="2013-10-28 14:05:37 +0000" MODIFIED_BY="[Empty name]" NAME="Latthe 2012" TYPE="COCHRANE_REVIEW">
<AU>Foon R, Toozs-Hobson P, Latthe P</AU>
<TI>Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2013-10-28 14:05:03 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-28 14:05:03 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD008224.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lose-1996" MODIFIED="2013-10-28 14:06:15 +0000" MODIFIED_BY="[Empty name]" NAME="Lose 1996" TYPE="JOURNAL_ARTICLE">
<AU>Lose G, Thyssen H</AU>
<TI>Reproducibility of cystometry and pressure-flow parameters in female patients</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1996</YR>
<VL>15</VL>
<PG>302-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lose-1998a" MODIFIED="2013-10-28 14:11:44 +0000" MODIFIED_BY="[Empty name]" NAME="Lose 1998a" TYPE="JOURNAL_ARTICLE">
<AU>Lose G, Fantl JA, Victor A, Walter S, Wells TL, Wyman J et al</AU>
<TI>Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>3</NO>
<PG>255-62</PG>
<IDENTIFIERS MODIFIED="2013-10-28 14:11:44 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-LUTS-Guideline-2010" MODIFIED="2011-12-05 13:21:21 +0000" MODIFIED_BY="[Empty name]" NAME="LUTS Guideline 2010" TYPE="OTHER">
<AU>National Clinical Guideline Centre, National Institute for Health &amp; Clinical Excellence (NICE)</AU>
<TI>The management of lower urinary tract symptoms in men</TI>
<SO>http://www.nice.org.uk/nicemedia/live/12984/48554/48554.pdf</SO>
<YR>2010 (last accessed 5 December 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Madhuvrata-2012" MODIFIED="2011-12-05 11:31:57 +0000" MODIFIED_BY="[Empty name]" NAME="Madhuvrata 2012" TYPE="COCHRANE_REVIEW">
<AU>Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJC</AU>
<TI>Which anticholinergic drug for overactive bladder symptoms in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-12-05 11:31:23 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-05 11:31:23 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005429.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mariappan-2005" MODIFIED="2011-11-11 10:11:36 +0000" MODIFIED_BY="[Empty name]" NAME="Mariappan 2005" TYPE="COCHRANE_REVIEW">
<AU>Mariappan P, Alhasso AA, Grant A, N'Dow JMO</AU>
<TI>Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-11-11 10:08:41 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-11 10:08:41 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004742.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nabi-2006" MODIFIED="2011-11-11 10:11:19 +0000" MODIFIED_BY="[Empty name]" NAME="Nabi 2006" TYPE="COCHRANE_REVIEW">
<AU>Nabi G, Cody JD, Ellis G, Hay-Smith J, Herbison GP</AU>
<TI>Anticholinergic drugs versus placebo for overactive bladder syndrome in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2011-11-11 10:10:02 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-11-11 10:10:02 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003781.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-NCCWCH-2006" MODIFIED="2011-11-11 14:37:03 +0000" MODIFIED_BY="[Empty name]" NAME="NCCWCH 2006" TYPE="BOOK_SECTION">
<AU>National Collaborating Centre for Women's &amp; Children's Health</AU>
<TI>Urinary Incontinence - the management of urinary incontinence in women</TI>
<SO>Commissioned by the National Institute for Health &amp; Clinical Excellence</SO>
<YR>2006</YR>
<PB>RCOG Press</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RCOG-2003" NAME="RCOG 2003" TYPE="BOOK">
<AU>RCOG</AU>
<SO>Guideline No. 35. Surgical management of urodynamic stress incontinence</SO>
<YR>2006</YR>
<PB>Royal College of Obstetricians and Gynaecologists, UK</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sevestre-2003" MODIFIED="2011-11-11 10:11:26 +0000" MODIFIED_BY="[Empty name]" NAME="Sevestre 2003" TYPE="JOURNAL_ARTICLE">
<AU>Sevestre S, Ciofu C, Deval B, Traxer O, Amarenco G, Haab F</AU>
<TI>Results of the tension-free vaginal tape technique in the elderly</TI>
<SO>European Urology</SO>
<YR>2003</YR>
<VL>44</VL>
<NO>1</NO>
<PG>128-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sorensen-1988" MODIFIED="2013-10-28 14:12:15 +0000" MODIFIED_BY="[Empty name]" NAME="Sorensen 1988" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen S, Gregersen H, Sorensen SM</AU>
<TI>Long term reproducibility of urodynamic investigations in healthy fertile females</TI>
<SO>Scandinavian Journal of Urology and Nephrology Supplementum</SO>
<YR>1988</YR>
<VL>114</VL>
<PG>35-41</PG>
<IDENTIFIERS MODIFIED="2013-10-28 14:12:07 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Ward-2002" MODIFIED="2013-09-25 22:15:26 +0100" MODIFIED_BY="[Empty name]" NAME="Ward 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ward K, Hilton P</AU>
<TI>Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence</TI>
<SO>BMJ</SO>
<YR>13 July 2002</YR>
<VL>325</VL>
<NO>7355</NO>
<PG>67</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2013-04-22 11:23:04 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-10-28 13:24:42 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-10-28 13:17:26 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-10-28 13:16:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Holtedahl-2000">
<CHAR_METHODS MODIFIED="2011-06-22 11:25:02 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. </P>
<P>Setting: women recruited from the community in North-Norwegian municipalities, and treated by GPs and gynaecologists at Norwegian hospitals (Tromso, Bodo), between 1994-95 </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-28 13:16:36 +0000" MODIFIED_BY="[Empty name]">
<P>Women invited from random sample of community-dwelling women to attend GP to have gynaecological examination (N = 507, of whom 240 had some UI). A subset with incontinence were randomised to early (6 months) or delayed (12 months) urodynamic studies (87/155 who leaked &gt;1x/month)</P>
<P>Inclusion: women with UI that is a social or hygienic problem; UI at least twice per month; objective UI diagnosed by GP (visible leakage; or &gt; 2 g urine on 48-hour pad test; or record of 'wet' on 48-hour frequency/volume chart)</P>
<P>Exclusion: cardiac pacemaker, dementia, inability to comply with treatment, conditions requiring early gynaecological referral</P>
<P>Age range: 50 to 74 years</P>
<P>Comparability at baseline: age: A, 60; B, 61 years: parity: A, 3.2; B, 3: BMI: A, 26.8; B, 26.4</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-28 13:16:40 +0000" MODIFIED_BY="[Empty name]">
<P>A (45) EARLY URODYNAMICS: no treatment by GP for 6 months, then urodynamic investigation and treatment by gynaecologist at 6 and 12 months (diagnosis or treatment could be changed at 6 or 12 months)</P>
<P>B (42) DELAYED URODYNAMICS: conservative treatment by GP for 12 months, then urodynamic investigation by gynaecologist at 12 months if still required (diagnosis or treatment could be changed at 12 months)</P>
<P>Urodynamics: measurement of residual urine; bladder filling; urethral pressure profile; stress test with pad weighing; cystometry, cystoflowmetry; cystoscopy (first examination only); and gynaecological examination</P>
<P>Conservative treatment: all women had oestriol and pelvic floor exercises, and advice about pads or pants; women with urgency also had bladder training and maximal electrical stimulation; women with stress had vaginal long-term electrical stimulation; women with mixed UI had all treatments</P>
<P>Surgical treatment: women with persistent UI after 12 months had the option of surgery (but every woman had the option of urodynamics by then either at 6 or 12 months)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-28 13:16:53 +0000" MODIFIED_BY="[Empty name]">
<P>Data at 6 months not relevant to randomisation to urodynamics or not, as group A were not treated (but their incontinence outcomes did not improve, while those in group B did)</P>
<P>Not cured within 12 months: A, 41/44; B, 37/41</P>
<P>Not improved within 12 months: A, 19/44; B, 17/41</P>
<P>Change in severity index at 12 months (mean, (95% CI) SD): A, 1.4 (0.7 to 2.2) 2.3; B, 1.6 (0.8 to 2.4) 2.5</P>
<P>Change in impact index at 12 months (mean, (95% CI) SD): A, 0.6 (0.4 to 0.9) 0.99; B, 0.7 (0.4 to 1) 0.95</P>
<P>Wet episodes at 12 months (mean/24 hours): A, 0.9; B, 0.4 (no SDs)</P>
<P>Pad test weight (mean g): A, 10; B, 10 (no SDs)</P>
<P>Number having urodynamics at 12 months: A, 37/45; B, 12/42</P>
<P>Number whose treatment was changed after urodynamics: A (at 6 months), 11/45 plus (at 12 months) 4/45; B (at 12 months): 1/42</P>
<P>Number having surgery after 12 months: A, 4/45 (3 cured); B, 1/42 (assumed 1 cured)</P>
<P>Number failed after 12 months (including results of surgery): A, 38/44; B, 36/41</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-06-22 11:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>While some women had different diagnoses resulting in different treatments after urodynamics, there were no apparent differences in UI outcomes. However, only 12/42 women in the delayed-urodynamics group (B) elected to have urodynamics at 12 months because they were still bothered by their incontinence. The meaning of this finding is unclear. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:16:55 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khullar-2000">
<CHAR_METHODS MODIFIED="2009-11-16 17:05:39 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, method of allocation unknown: 'randomised'</P>
<P>Follow up for 3 years</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-28 13:16:54 +0000" MODIFIED_BY="[Empty name]">
<P>105<BR/>80 women followed up by case records<BR/>64 women followed up at 3 years<BR/>Inclusion: women with urinary symptoms and no previous urodynamic diagnosis, recruited form urodynamic clinic<BR/>Groups comparable at baseline: age (year, SD) A: 50 (16); B: 56 (17)<BR/>Hospital urogynaecology unit, London, England<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-28 13:16:54 +0000" MODIFIED_BY="[Empty name]">
<P>A (42): Ambulatory urodynamics (4-hour ambulatory urodynamic test with a set fluid intake and provocative manoeuvres with a full bladder)<BR/>B (38): Symptomatic treatment (12 women lost from this group at 3 years and a further 4 died)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-28 13:16:55 +0000" MODIFIED_BY="[Empty name]">
<P>Number treated with drugs: A: 30/42; B: 14/38<BR/>Number treated surgically: A: 16/42; B: 6/38<BR/>Stress Incontinence Score (n, mean, (SD)): A: 42, 0.7 (0.9); B: 22, 1.2 (1.7)<BR/>Death: A: 0/42; B: 4/38</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-10-21 13:42:42 +0100" MODIFIED_BY="[Empty name]">
<P>No mention of power calculation or blinding</P>
<P>Analysis excluding dropouts</P>
<P>Authors contacted for more information</P>
<P>Abstract only</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:16:55 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Majumdar-2009">
<CHAR_METHODS MODIFIED="2011-06-22 15:00:16 +0100" MODIFIED_BY="[Empty name]">
<P>RCT: 'randomised' to treatment or investigation using web-based generation of random sequence, and sealed opaque envelopes for allocation</P>
<P>Women who did not wish to be randomised were included as extra cohorts in a patient preference design and given treatment of choice (urodynamics or not)</P>
<P>Setting: tertiary referral centre</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-28 13:16:55 +0000" MODIFIED_BY="[Empty name]">
<P>309 women with UI and lower urinary tract symptoms, of whom 99 agreed to be randomised: the rest chose whether or not to have urodynamics before treatment, 153 chose to have urodynamics, 57 chose not according to their own preference</P>
<P>Inclusion: age &gt;18 years; urinary incontinence; lower urinary tract symptoms (frequency, urgency, nocturia, voiding difficulties)</P>
<P>Exclusion: planned surgery for prolapse stage 2 or more; neurological problems; cognitive problems; previous tertiary treatment for UI; recurrent dysuria or UTI</P>
<P>Incontinence Episode Frequency at baseline: A 5.2, B 5.5 (NS)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-06-21 17:24:40 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised women only:</P>
<P>A (52): urodynamic assessment before conservative treatment</P>
<P>B (47): conservative treatment without urodynamic assessment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-10-21 13:48:00 +0100" MODIFIED_BY="[Empty name]">
<P>Failure to attend next appointment: A 4/52, B 13/47</P>
<P>Incontinence Episode Frequency after treatment (mean, N): A 4.34, 42; B: 5.51, 33 </P>
<P>Change in Incontinence Episode Frequency from before to after treatment (mean change (SD*) N): A -0.29 (1.03) 42, B: -0.7 (1.11) 33</P>
<P>Quality of life (incontinence impact on King's QoL questionnaire) mean (SD) N: A 82.1 (24.6), 42; B 76.3 (24.2) 33</P>
<P>Also 8 other King's Health questionnaire outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-10-21 13:48:04 +0100" MODIFIED_BY="[Empty name]">
<P>*SDs for change in incontinence episode frequency calculated from 95% CI for change from baseline</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:17:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nager-2009">
<CHAR_METHODS MODIFIED="2013-10-28 13:16:59 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised non-inferiority trial</P>
<P>Setting: 11 centres of reproductive medicine, urology and obstetrics and gynaecology, USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-28 13:17:01 +0000" MODIFIED_BY="[Empty name]">
<P>683 participants were enrolled and 630 were randomized (315 per arm)</P>
<P>Inclusion: Women presenting with UI, aged over 21, history of symptoms of SUI of at least 3 months, MESA score for SUI greater than for UUI on same scale, post-voiding residual bladder volume less than 150 ml, negative urinalysis or culture, clinical assessment of urethral mobility, desire for surgery for SUI and a positive provocative stress test</P>
<P>Exclusion: Aged &lt; 21 years, previous surgery for incontinence, history of pelvic irradiation, pelvic surgery within previous 3 months, anterior or apical POP of 1cm or more distal to the hymen, within 1 year post partum, pregnant or not completed family, cancer, radiotherapy, urological surgery, recent gynaecological surgery, any mesh surgery, previous botox treatment, previous urodynamics in last 12 months or knowledge about early urodynamics.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]">
<P>A: (n = 315) basic office evaluation (history and examination without urodynamic studies)</P>
<P>B: (n=315) As above plus urodynamic studies (non-instrumented flowmetry, filing cystometry with Valsalva leak point pressures, pressure flow study).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-28 13:17:05 +0000" MODIFIED_BY="[Empty name]">
<P>Maximum number of people with outcome data per arm: A: 272 and B: 266</P>
<P>Persistent SUI at 12 months after treatment following assessment with and without UDS (number/total number): A 81/274, B 85/273</P>
<P>Success defined as 70% decrease in UDI score or &#8220;better/much better&#8221; on PGI: A 203/264, B 200/259</P>
<P>Number of people having surgery: A 298/315, B 288/315</P>
<P>Number of women satisfied with treatment (PGI-I score classed as 'very much better' or 'much better'): A 248/270, B 238/262</P>
<P>Objective assessment of incontinence cure or improvement at post-intervention urodynamics testing (positive provocative stress test at 12 months): A 36/225, B 26/222</P>
<P>Adverse events: total number of adverse events: A 80/315, B 79/315; Number of women with adverse events: A 67/315, B 61/315</P>
<P>General health status measures:</P>
<P>Change in SF-12 from baseline to 12 months (mean (SD) N): A 5.0 (10.8) 267, B 7.3 (12.0) 261</P>
<P>Condition specific health status measures:</P>
<P>Urgency symptoms or urgency incontinence (change in MESA score from baseline to 12 months for UUI, mean (SD) N): A -19.7 (21.4) 272, B -22.2 (22.4) 266</P>
<P>Change in Incontinence Impact Questionnaire score from baseline to 12 months (mean (SD) N): A -35.9 (23.2) 272, B -37.3 (23.7) 266</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-28 13:17:07 +0000" MODIFIED_BY="[Empty name]">
<P>ClinicalTrials.gov identifier: NCT00803959</P>
<P>Powere calculations were used to estimate participant numbers. A sample of 300 women per group was required assuming a 10% dropout rate.</P>
<P>Reported per protocol and also intention-to-treat (ITT) analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:17:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Connell-2003">
<CHAR_METHODS>
<P>RCT, using balanced randomisation schedule based on permuted blocks, stratified on MS and urological status<BR/>Setting: Neurourology and Continence Outpatient Clinic, Royal Melbourne Hospital, Australia<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>19 (4 male, 15 female)<BR/>Inclusion: Multiple sclerosis, informed consent, bladder problems or urgency or difficulty starting to urinate or urinary incontinence<BR/>Exclusion: Asymptomatic, recent urodynamic investigation, unable to attend clinic, unwilling to be catheterised, prostate problems, pregnancy, urinary diversion<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-28 13:17:14 +0000" MODIFIED_BY="[Empty name]">
<P>A (9): Treatment based on history and urodynamic investigation<BR/>B (10): Treatment based on history only (participants did have urodynamics, but the nurse who provided treatment was blinded to the results)</P>
<P>Fluoroscopic urodynamic testing included assessment of bladder sensation, detrusor reflex function, detrusor compliance, presence of obstruction and location, activity of the external urethral sphincter by direct measurement and indirect measurement using bladder leak point pressures</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Incontinence outcomes measured using UGDI-6, IIQ-7, AVA-SS, Urol QoL<BR/>No outcome data presented according to the randomised groups</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-10-21 12:00:33 +0100" MODIFIED_BY="[Empty name]">
<P>Information from Grant Report only, no response from author when requesting more data<BR/>Power calculation suggested 25 participants needed per arm<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:17:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramsay-1995">
<CHAR_METHODS MODIFIED="2009-11-16 17:14:34 +0000" MODIFIED_BY="[Empty name]">
<P>RCT, computer-generated random numbers but method of allocation unknown</P>
<P>Follow up for 3 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-10-21 13:26:38 +0100" MODIFIED_BY="[Empty name]">
<P>60, of whom 12 withdrawn due to not completing treatment (A,7; B,5)<BR/>Inclusion: women with urinary frequency, urgency, nocturia, urge incontinence or stress incontinence<BR/>Exclusion: previous incontinence treatment, hematuria, recurrent dysuria, voiding difficulty or UTI<BR/>Groups stated to be comparable at baseline but data not given<BR/>Hospital outpatient clinic, Glasgow, Scotland<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-28 13:17:15 +0000" MODIFIED_BY="[Empty name]">
<P>A (27): Urodynamics (uroflowmetry, filling and voiding cystometry, perineal pad test) and treatment tailored according to diagnosis (pelvic floor muscle training for stress urinary incontinence, bladder training for urgency urinary incontinence, clean intermittent self-catheterisation for voiding dysfunction)<BR/>B (33): Conservative treatment as inpatient (5 day stay, dietary advice, monitoring fluid intake, psychological support, psychotherapy if necessary, pelvic floor muscle training by physiotherapists for stress urinary incontinence, bladder training for urgency urinary incontinence)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-10-21 13:59:44 +0100" MODIFIED_BY="[Empty name]">
<P>Subjective questionnaire, urinary diary, pad test<BR/>Subjective failure rate (patient report): A: 8/20; B: 8/28<BR/>Subjective failure rate (diary record): A: 10/20; B: 12/28<BR/>Incontinence episodes/week (mean (SD) N): A: 3.6 (3.1) 20; B: 3.0 (2.8) 28<BR/>Pad test, weight urine lost: A: 6.0 (19.3); B: 3.9 (11.1)<BR/>Objective failure rate (wet pad test): A: 7/20; B: 7/28<BR/>Visual analogue scale: A: 20, 4.1 (3.0); B: 28, 3.4 (2.4)<BR/>Urinary frequency per day (mean (SD) N): A: 6.9 (1.3) 20, B: 6 (1.4) 28</P>
<P>Nocturia voids per night (mean (SD) N): A: 0.9 (1.2) 20, B: 0.8 (0.9) 28</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Pad test = short test, bladder filled with 200 ml fluid</P>
<P>No mention of power calculation or blinding</P>
<P>Analysis excluding dropouts</P>
<P>Method of urodynamics described</P>
<P>Authors contacted for more information</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:17:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Leijsen-2011">
<CHAR_METHODS MODIFIED="2011-10-21 10:59:34 +0100" MODIFIED_BY="[Empty name]">
<P>RCT VUSiS 1</P>
<P>Computer generated, stratified by centre</P>
<P>Setting: University and other hospitals in Holland</P>
<P>Follow up: 6 weeks, 6 12 and 24 months: mean 22 months (SD 7) VUSIS 1</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-17 11:34:26 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria:<B> </B>stress urinary incontinence or mixed urinary incontinence with predominant symptoms of stress urinary incontinence, failed conservative management, patients eligible for and opting for surgical management, incontinence suggestive of stress urinary incontinence must have been demonstrated on physical examination and/or micturition diary.</P>
<P>Exclusion criteria: previous incontinence surgery, pelvic organ prolapse over 1cm beyond the level of the hymen, postvoid residual urine volume of more than 150ml on ultrasound or catheterization.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-29 16:45:52 +0100" MODIFIED_BY="[Empty name]">
<P>A (31): Urodynamics before treatment</P>
<P>B (28): no urodynamics, treatment based on symptoms only</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-28 13:17:16 +0000" MODIFIED_BY="[Empty name]">
<P>Clinical examination, voiding diary, self-completed questionnaires (UDI, IIQ and PGI-I)</P>
<P>Number treated surgically: A, 26/31; B, 27/28</P>
<P>Number with management changed to drugs due to urodynamics: A, 3/31; B, 0/28</P>
<P>Subjective incontinence (22 months, SD 7): A, 13/29, B, 7/28</P>
<P>Subjective stress incontinence (from UDI) A: 10/29, B 6/28</P>
<P>Incontinence on voiding diary (objective): A, 8/31; B, 3/27</P>
<P>Incontinence on stress test (objective): A, 2/27; B 2/26</P>
<P>Voiding dysfunction: A, 3/31, B: 7/28</P>
<P>De novo urgency or OAB: A, 6/31; B, 1/28</P>
<P>Quality of life (Urogenital Distress Inventory, mean improvement (SD) N) at 1 year: A, -34 (22) 19; B, -48 (22) 21</P>
<P>Quality of life (UDI, mean improvement (SD) N) at 2 years: A, -33 (23) 29; B, -41 (23) 28</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-29 16:48:22 +0100" MODIFIED_BY="[Empty name]">
<P>Trial stopped prematurely because of a hesitating inclusion rate</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-10-28 13:17:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Leijsen-2012">
<CHAR_METHODS MODIFIED="2013-10-28 13:17:19 +0000" MODIFIED_BY="[Empty name]">
<P>VUSIS 2 - Multicentre RCT embedded within a cohort study</P>
<P>Participants with discordant urodynamic and clinical assessment findings entered into RCT</P>
<P>Web-based block randomisation based upon a computer-generated random number list</P>
<P>Setting: 6 academic and 24 non-academic hospitals in the Netherlands</P>
<P>Follow up: 6 weeks, 6 and 12 months after randomisation (outcomes measured at 12 months)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion: Women with SUI demonstrated on clinical assessment or micturition diary, eligible for surgery for SUI, failed conservative therapy for SUI - particularly PFMT, discordant urodynamic findings, able to comply with intervention and study procedures</P>
<P>Exclusion: Previous incontinence surgery, mixed urinary incontinence with predominant urgency, pelvic organ prolapse with leading edge of prolapse 1cm beyond the level of the hymen on valsalva, post void residual volume of bladded &gt;150 ml on USS or catheterisation, other prolapse surgery or hysterectomy planned, radiotherapy, family not finished</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]">
<P>Women whose urodynamic findings are discordant with clinical assessment findings will be randomised to:</P>
<P>A (64): immediate surgery (midurethral sling) versus</P>
<P>B (62): individual treatment based on urodynamic diagnosis (medical, physiotherapy, pessary, surgery)</P>
<P>Dropout rates: A, 6; B, 4 + 1 deceased</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]">
<P> Outcome data available for A: 58 and B: 57</P>
<P>Number of women with no<B> </B>UI at 12 months (UDI questionnaire): A 17/58, B 18/55</P>
<P>Number of women with no<B> </B>SUI at 12 months (UDI questionnaire): A 15/58, B 14/56</P>
<P>Number of people treated conservatively: A 3/64, B 5/62<BR/>
</P>
<P>Number of people having surgery: A 61/64, B 57/62</P>
<P>Number of people whose treatment was changed after urodynamics: A 3/64, B 5/62</P>
<P>Need for repeat or alternative treatment (surgery but reason unclear): A 1/62, B 0/64</P>
<P>Voiding dysfunction (subjective) (UDI questionnaire measuring for obstructive symptoms, mean (SD) N): A 11 (22) 58, B 14 (22) 57</P>
<P>Urgency symptoms or urgency incontinence post-intervention (UDI questionnaire measuring for overactive bladder symptoms, mean (SD) N): A 11(17) 58, B 9(13) 57</P>
<P>Satisfaction with treatment (PGI-I score classed as &#8216;Improvement&#8217;): A 50/55, B 52/57</P>
<P>Objective assessment of incontinence cure (no leakage of 48-hour micturition diary): A 45/53, B 41/50</P>
<P>Objective assessment of incontinence cure (negative stress test) A 37/38, B 33/34</P>
<P>Deaths: A 0/64, B 1/62</P>
<P>Condition-specific health measures (UDI questionnaire demonstrating mean improvement of UI, mean (SD) N): A 44 (24) 58, B 29 (25) 57</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-04-17 11:38:15 +0100" MODIFIED_BY="[Empty name]">
<P>Gynaecologists unwilling to randomise women to having urodynamics or not, hence more complicated design used.</P>
<P>One protocolviolation occurred in immediate surgery group where one participant was postponed and the patient received treatment for DOA in the abscence of urodynamic SUI.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>OAB = overactive bladder</P>
<P>RCT = randomised controlled trial</P>
<P>RR = risk ratio<BR/>UTI = urinary tract infection</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-10-28 13:24:42 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-11-05 09:10:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Akil-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 09:10:59 +0000" MODIFIED_BY="[Empty name]">
<P>RCT but of sedation during micturating cystogram in children (midazolam, chloral hydrate or control) and no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:48:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bael-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:48:18 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Participants randomised to treatment regimen (placebo, oxybutynin, bladder training). Compares clinical patterns and urodynamic patterns in urgency syndrome and dysfunctional voiding
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bajpai-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of Cystomat versus standard multichannel cystometry, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:48:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baker-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:48:36 +0100" MODIFIED_BY="[Empty name]">
<P>RCT but of placebo versus prophylactic antibiotic in preventing bacteriuria after urodynamic investigation
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Batista-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Cystometry comparing saline filling at two different filling rates in children, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-06-20 16:32:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baumann-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-06-20 16:32:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Compariosn of urine collection success in children with and without bladder ultrasonography</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Benson-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Possible RCT. Comparison of women randomised to a dynamic ultrasound adjunctive study or urodynamics. However, reference incomplete and author contacted for more information</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bhatia-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of antibiotic (cefadroxil) versus placebo before lower urinary tract instrumentation, including urethrocystometry as prophylaxis for UTI. No clinical outcomes related to incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:49:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Blaivas-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:49:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Two different methods of patient instruction compared, but no clinical outcomes reported
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:49:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bo-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:49:22 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Urodynamics used to demonstrate differential effects on urethral pressure when contracting different muscle groups (pelvic floor muscles or abdominal transversus abdominis) but no effect on incontinence reported
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Byrne-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of rectal versus vaginal placement of pressure catheter, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:49:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chin_x002d_Peuckert-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:49:35 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of different filing solutions but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Choe-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Possible RCT. Comparison of preoperative multichannel urodynamics or preoperative urethroscopy before suburethral mycromesh sling surgery for stress urinary incontinence. However, method of allocation to groups unclear, author contacted for more information</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:49:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chung-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:49:55 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of fentanyl versus placebo in pain reduction in paediatric patients undergoing catheteri
sation
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Colstrup-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of cystometry with balloon inflated versus not inflated, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:50:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Constatini-20148">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:50:11 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of different catheter sizes, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-05 12:27:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Culligan-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-05 12:27:35 +0000" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of microtransducer and fibreoptic catheters for urodynamic studies, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:50:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cundiff-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:50:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Assessing effectiveness of antibiotic prophylaxis for combined urodynamics and cystoscopy. No clinical outcomes related to incontinence
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:50:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Darouiche-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:50:33 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of antibiotic (ciprofloxacin versus placebo) before urodynamics</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:50:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dolan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:50:40 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of different ways of measuring intra-abdominal pressure but no clinical outcomes
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 09:10:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dompeyre-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 09:10:37 +0000" MODIFIED_BY="[Empty name]">
<P>RCT but in normal women. Two types of cystometry compared (standard and VAS-based) and no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:51:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eggersmann-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:51:01 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of two different lubricants to aid urodynamic study in healthy male volunteers. Subjects not incontinent and no clinical outcomes reported
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:51:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gehrich-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:51:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of room and body temperature saline used during cystometry. No clinical outcomes
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gluck-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of two different filling solutions used during urodynamics (hyperosmolar solution, an extracellular alkalosis solution, two solutions designed to influence intracellular and extracellular pH, and a high-potassium solution, each versus normal saline in random order. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Goodman-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of warm or cold contrast medium in micturating cystourethrogram in children, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:51:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Groutz-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:51:33 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Crossover of order of having two types of cystometry (ICS method, trying to inhibit micturition versus avoiding inhibition) but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:51:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gurbuz-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:51:47 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of antibiotic prophylaxis prior to urodynamic studies
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Handa-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of supine and standing Q-tip tests in random order to diagnose urethral hypermobility. No clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Heslington-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of conventional versus ambulatory cystometry, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:52:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hirakauva-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:52:06 +0100" MODIFIED_BY="[Empty name]">
<P>?RCT. Antiobiotics to prevent infection after urodynamics
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hosker-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison (in incontinent women) of urodynamics using normal saline versus Urografin 150, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-06-20 16:42:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hougardy-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-06-20 16:42:57 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Compariosn of explanatory leaflet or not for women having urodynamics</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 09:12:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hundley-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 09:12:16 +0000" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of two different microtip catheters or one of each type, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jolic-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT. Comparison of modified transabdominal ultrasonographic method of diagnosing pelvic organ static disturbance (cystocele) and/or stress urinary incontinence with transvaginal endosonography applied to the vaginal introitus. Not in randomised order. Some women were not incontinent, and so did not have urodynamics. No clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:52:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kartal-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:52:38 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of ciprofloxacin versus nothing</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 09:13:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Keidan-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 09:13:47 +0000" MODIFIED_BY="[Empty name]">
<P>RCT but of sedation during micturating cystogram in children (midazolam versus 50% nitrous oxide) and no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:52:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khan-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:52:54 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of two methods of administration of a standard urinary symptom questionnaire
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Khullar-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT. Comparison of transvaginal ultrasound scan to measure vaginal wall thickness with videocystourethrography (urodynamics). Some women also had ambulatory urodynamics. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:53:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khullar-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:53:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of urodynamics with rectum empty or full, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:53:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Klarskov-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:53:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT with crossover design assessing usefulness of urethral pressure reflectometry in detecting pressure increases in the urethra. Patients randomised according to treatment to increase urethral closure pressure
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:53:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kristjansson-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:53:19 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of treatment based on urodynamic findings versus treatment decision directly in men with presumed bladder outflow obstruction (voiding dysfunction)
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:53:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuhn-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:53:28 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Comparison of tow different techniques, water perfused catheter and microtip transducer catheter</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kulseng-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of two different methods of ambulatory urodynamics, 2 and 4 hour recording versus 45 minute recording, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lee-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of two saline filling solutions (20 mM and 200 mM) in double-blind random order. Some differences in bladder sensation found, but no relation to clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-28 13:24:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lucas-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-28 13:24:42 +0000" MODIFIED_BY="[Empty name]">
<P>RCT. Crossover trial about the accuracy of CaptiFlow portable home flow measuring device and its use as a diagnostic tool in the management of LUTS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:54:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malone_x002d_Lee-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:54:49 +0100" MODIFIED_BY="[Empty name]">
<P>RCT assessing whether urodynamically assessed patients with detrusor overactivity respond differently to treatments. Patients randomised according to placebo or tolterodine
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Massey-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Trial 1: Comparison of two methods of obtaining the static profile, Brown and Wickham versus Gaeltec. Trial 2: Comparison of two methods of obtaining a microtransducer cough stress profile, using the rectal line as reference for subtraction versus vesical pressure measured using an epidural catheter. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Medina-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of order of position (sit-stand or stand-sit) on urodynamic findings, but no clinical outcomes related to incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:55:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Medina-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:55:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of physiological or retrograde fill for urodynamics performed after pelvic surgery. No clinical outcomes and 10 participants from one group excluded due to incorrect or incomplete recording of data
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-06-20 16:05:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Minardi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-06-20 16:05:13 +0100" MODIFIED_BY="[Empty name]">
<P>RCT but of PFMT and biofeedback for storage and emptying symptoms, and avoiding UTI, using uroflowmetry biofeedback </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mouritsen-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of 4 different methods of measuring pelvic floor function. Outcome was quality of the pelvic floor muscle contractions. No urodynamics, no incontinence, no clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-06-20 17:08:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mueller-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-06-20 17:08:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Crossover comparison of urodynamics + quantitative urethral electromyography with prolapse reduced and not reduced, but not related to urinary incontinence or LUTS outcomes </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:55:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Neal-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:55:38 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of different catheter sizes used for urodynamics, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:55:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Panayi-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:55:49 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Women randmised to have rectal balloon inflated or not during first or second filling phase of filling cystometry. No clinical outcomes
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Payne-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of effect of two filling solutions (normal saline and normal saline + 115 mEq/litre potassium chloride added) on bladder capacity in patients with interstitial cystitis. No clinical outcomes but 2 of 6 patients identified the potassium chloride solution as 'worse' when it was first, and 9 of 10 when it was second</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Peschers-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of cotrimoxazole (antibiotic) administration with matching placebo after urodynamics. No clinical outcomes related to incontinence reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:56:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peters_x002d_Gee-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:56:11 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Crossover comparison of 2 different urodynamics systems, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:56:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Philip-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:56:30 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of different filling solutions (0.9% saline versus 0.3M 
potassium chloride). No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Radley-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT, double blind crossover. Comparison of ambulatory urodynamic monitoring versus videocystometrography performed in random order and assessed double-blind in order to assess inter-observer agreement. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:56:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Realfonso-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:56:55 +0100" MODIFIED_BY="[Empty name]">
<P>?RCT (unclear). Comparison of 2 different filling speeds, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-29 11:01:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rehme-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-29 11:01:54 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of 2 methods or urodynamics, but no clinical outcomes </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Robinson-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT. Comparison of ambulatory urodynamics versus ultrasound assessment of bladder wall thickness</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:57:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rovner-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:57:09 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Patients randomised to fesoterodine or placebo for treatment of overactive bladder syndrome
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-05 12:28:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sand-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-05 12:28:15 +0000" MODIFIED_BY="[Empty name]">
<P>Prospective crossover study, randomisation not mentioned. Comparison of presence or absence of a filling catheter (6F paediatric feeding tube) upon urethral closure pressure. No clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:57:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scaldazza-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:57:24 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of 2 different catheter sizes, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmidt-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of ambulatory urodynamics with higher or lower fluid intake. Participants not incontinent, and no clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:57:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shukla-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:57:54 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparoson of different positions (sitting versus standing) while having urodynamic investigation. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:58:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Siracusano-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:58:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of antibiotic prophylaxis or not (norfloxacin vs placebo) to prevent post-intervention UTI, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:58:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sirls-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:58:11 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT. Secondary analysis with extra data of Nager 2009 trial but only gives new data on intervention arm of trial and therefore not useable for comparisons
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:58:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Slack-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:58:21 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Crossover comparison of urodynamics versus urethral retro-resistance pressure measurement, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:58:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Slack-2004a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:58:29 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of multichannel versus single channel cystometrogram. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Soligo-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison in random order of cough stress test and complete urodynamic test for diagnosis of stress urinary incontinence. No effect on decision making described, and no clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sullivan-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT, crossover. Comparison (in incontinent men) of urodynamics using normal saline versus Urografin 150, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:59:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sullivan-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:59:02 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, two trials:<BR/>Trial I: crossover. Comparison (in incontinent but neurologically normal people) of urodynamics using room temperature or body temperature saline filling solution
<BR/>Trial II: crossover. Comparison (in incontinent but neurologically normal people) of urodynamics using 50 ml saline on first examination, followed by randomisation to 50 ml or 100 ml
<BR/>Both temperature and filling rate affected results of urodynamic test, but no clinical outcomes were provided</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sutherst-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT, single blind crossover. Comparison of single channel cystometry versus standard multichannel cystometry, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Swift-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of multichannel electronic cystometer versus intrauterine pressure channel of a fetal monitor, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Swithinbank-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT, single blind crossover. Comparison of two different filling speeds (50 ml/m versus 100 ml/m) to measure bladder compliance, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-10 16:55:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Truzzi-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-10 16:55:44 +0100" MODIFIED_BY="[Empty name]">
<P>RCT ('by chance'). Comparison of hypotonic (100 mOsm/litre) and hypertonic (1000 mOsm/litre) sodium chloride filling solutions. No clinical outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:59:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Visco-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:59:36 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of 2 different transducers, but no clinical incontinence outcomes or effect on clinical decisions
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:59:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Visco-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:59:47 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of surgical treatments of prolapse. All patients received urodyamic investigation
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-05 11:55:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Voorham_x002d_Van-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-05 11:55:54 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear whether RCT. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 12:59:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wadie-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 12:59:56 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of surgical treatments of stress urinary incontinence. All patients received urodynamic investigation
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 13:00:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yip-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 13:00:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of antibiotic (Augmentin) versus placebo as prophylaxis to prevent UTI after urodynamics</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-10-26 13:00:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zehnder-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-10-26 13:00:17 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Comparison of microtip or air charged catheters for urodynamics, crossover design. No clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zerin-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Comparison of room temperature or warmed cystographic contrast material in children, but no clinical outcomes reported</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT = randomised controlled trial<BR/>UTI = urinary tract infection</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-10-28 13:17:31 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2013-10-28 13:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Romero-Maroto-2010">
<CHAR_METHODS MODIFIED="2013-10-07 19:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-10-28 13:17:26 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion: patients with stress or mixed urinary incontinence agreeing to be randomised in the trial</P>
<P>Exclusion: patients younger than 18 years of age; previous radiotherapy; any anti-incontinence procedure previously</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-10-28 13:17:28 +0000" MODIFIED_BY="[Empty name]">
<P>A (44): basic office evaluation only prior to stress urinary incontinence surgery</P>
<P>B (42): basic office evaluation as well as urodynamic studies prior to stress urinary incontinence surgery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-28 13:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>Urinary incontinence grade on cough stress test: Dry (A 36/44, B 38/42); Improved (A 7/44, B 3/42); Failure (A 1/44, B 1/42)</P>
<P>ICIQ-SF 'How often leak': Never (A 24/44, B 24/42); Once/week (A 10/44, B 6/42); 2-3 times/week (A 2/44, 3/42); Once a day (A 2/44, B 6/42); Several/day (A 5/44, 3/42); All the time (A 0/44, B 0/42)</P>
<P>ICIQ-SF 'UI type': SUI (A 3/44, B 5/42); MUI (A 16/44, B 10/42); UUI (A 4/44, B 3/42)</P>
<P>I-QOL Points: (A 84.9 ± 20.1, B 88 ± 17.6)</P>
<P>Qmax ml/s: (A 21.7 ± 7.9, B 22.7 ± 8.3)</P>
<P>Urgency (clinical history): 'de novo' (A 3/44, B 1/44); Disappears (A 11/44, B 16/42); Persists (A 17/44, B 17/42)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-10-07 19:20:59 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear as to whether randomisation to urodynamic studies could affect the decision making of the clinician with regards to the treatment the patients would receive or not.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-10-28 13:17:32 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2013-10-28 13:17:32 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hilton-2011">
<CHAR_STUDY_NAME MODIFIED="2011-10-21 12:24:26 +0100" MODIFIED_BY="[Empty name]">
<P>INVESTIGATE-1</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2011-10-21 12:30:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT (pilot) </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-16 15:53:11 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion: women with a clinical diagnosis of SUI or stress predominant MUI; failed conservative treatment (e.g. PFMT); requiring surgery for UI</P>
<P>Exclusion: symptomatic pelvic organ prolapse; previous incontinence or prolapse surgery; neurological disease causing UI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-10-21 12:32:38 +0100" MODIFIED_BY="[Empty name]">
<P>A: Urodynamics </P>
<P>B: Basic clinical assessment with non-invasive tests before continence surgery</P>
<P>Urodynamics includes multi-channel cystometry; videourodynamics; long-term ambulatory bladder pressure monitoring</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-10-28 13:17:32 +0000" MODIFIED_BY="[Empty name]">
<P>Non-invasive and invasive investigations; operative and inpatient procedures including postoperative complications; non-surgical treatments; and resource utilisation</P>
<P>ICIQ-FLUTS; three day bladder diary and ICIQ-UI<BR/>Short Form; the prevalence of symptomatic &#8216;de novo&#8217;<BR/>functional abnormalities including voiding dysfunction<BR/>and detrusor overactivity (subscales of ICIQ-FLUTS,<BR/>with cystometry in symptomatic patients), the impact of<BR/>urinary symptoms on quality of life (ICIQ-LUTSqol and<BR/>Urogenital Distress Inventory (UDI)) and utility values<BR/>from the EQ-5D questionnaire and SF-6D (utility score<BR/>generated from SF-12 questionnaire)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2011-10-21 12:37:47 +0100" MODIFIED_BY="[Empty name]">
<P>June 2011</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2011-10-21 12:38:24 +0100" MODIFIED_BY="[Empty name]">
<P>paul.hilton@ncl.ac.uk </P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2011-10-21 12:39:27 +0100" MODIFIED_BY="[Empty name]">
<P>Current Controlled Trials ISRCTN71327395 assigned 7th June 2010.</P>
<P>Feasibility study to determine practicality of definitive trial INVESTIGATE-2</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:20 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-22 09:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Sequence derived from random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-16 11:08:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Web-based Trial Simulator programme</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Used "randomly assigned ... use of an automated randomization system stratified according to surgeon"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-29 14:45:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>Balanced randomisation schedule based on permuted blocks, stratified on MS and urological status</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-20 11:02:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Computer-generated random number</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 10:47:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Computer generated using block randomisation with variable block sizes, stratified by centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Computer-generated using block randomisation with variable block sizes, stratified by centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:09 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>GP telephoned third party who opened top sealed, opaque envelope to reveal allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-29 15:13:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>'Randomised'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Sealed opaque envelopes opened infront of patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>"automated randomization system" was used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-29 14:45:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>Computer-controlled</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-29 15:04:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>'Randomly allocated'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 10:47:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Computer-generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Generated by computer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-07-29 12:06:16 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-03-26 13:51:59 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2013-10-28 13:17:10 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-06-22 09:52:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Gynaecologists were blinded to GP diagnosis when reviewing the patient with urodynamics, but method of measurement of cure outcomes not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-06-21 11:52:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>No data (postal questionnaires and case note review)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-06-21 11:54:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Outcomes analysed blinded to randomised groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-10-28 13:17:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Outcome assessor at baseline for urodynamics group may or may not have remembered which diagnosis they came to before and after the intervention. Moreover, at 3 and 12 months, it is unclear whether the outcome assessor was the same as baseline or not and if so they may remember the initial diagnosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-02-19 10:48:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>No data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-21 10:50:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Outcomes (questionnaires, diaries, pad test, VAS) were participant-reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-24 10:45:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Gynaecologist or urologist was not blinded to allocation when performing stress test. Nurses were not blinded when recording data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Subjective outcome assessors extracting data from questionnaires were blinded. Not possible in clinicians performing stress test.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-21 13:36:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Data reported for all women</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-21 13:39:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>4 women died and 12 were lost to follow up from control group, none from intervention group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-28 13:16:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Higher dropout from control group (4 versus 13)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-28 13:17:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Well documented data of small dropouts, numbers were equally balanced and reasons were well documented. Found to be statistically insignificant (P = 0.12)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-21 13:51:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>No useable data reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-21 14:01:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Dropouts similar in each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-21 11:19:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Missing data identified (3%), data entered as reported, excluding missing information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Missing data accounted for (11 participants): 6 subjects lost to follow up in arm A and 4 lost in arm B, 1 patient deceased in arm B</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 14:36:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Range of outcomes reported, including primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 13:41:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>No primary outcome data (number of women with incontinence)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 13:50:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>No primary outcome (number of women with incontinence)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Reported all pre-specified outcomes from the study protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 13:51:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>No useable data reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 13:53:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Range of outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 10:53:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Objective and subjective cure and global improvement/impairment reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Objective and subjective cure data reported and compared</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Financial support</NAME>
<DESCRIPTION>
<P>Details disclosed of funding for trial</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Comprehensive details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>No details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Financial support details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>No details given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Full details provided and no commercial partner involved</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Full details given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:17 +0000" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Sample size calculation</NAME>
<DESCRIPTION>
<P>Calculation made to determine number of participants to find statistcally significant effect if present</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:16:57 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Not calculated. Authors give reason for this being the lack of background data in the scientific literature</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Calculated needing 300 women per arm for statistical significance. Recruitment achieved these numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>Both sample size and power calculation carried out. Required number of 17 patients per arm was not met, however still deemed 'low risk' as sample size was calculated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>No details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Sample of 130 in each group required to reach a power of 70%. Only 31 patients in arm A were recruited and 28 in arm B. Low risk however as appropriate calculations were performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>51 women per arm required for 80% power. Recruitment numbers met this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:17 +0000" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Medical ethics approval</NAME>
<DESCRIPTION>
<P>Details of ethical approval for trial given</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Protocol approved at each site</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>Received from the local hospital ethics committee</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Ethical approval sought and gained from local institutional review board</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Approval obtained from local institutional review board</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:18 +0000" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Informed consent</NAME>
<DESCRIPTION>
<P>Was it detailed that participants were sought for informed consent</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>Written and informed consent given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>Not Specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>Provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>Written and informed consent gained from participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>Written and informed consent gained from participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Written, informed consent provided by all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>Written and informed consent provided by all participants before enrolment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 14:36:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Holtedahl-2000">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-22 09:14:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khullar-2000">
<DESCRIPTION>
<P>Abstract only, no further information provided by authors when contacted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 13:48:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Majumdar-2009">
<DESCRIPTION>
<P>SDs not available for incontinence episode frequency</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nager-2009">
<DESCRIPTION>
<P>No other sources of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 13:51:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Connell-2003">
<DESCRIPTION>
<P>No useable data reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 14:21:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ramsay-1995">
<DESCRIPTION>
<P>Short follow up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-21 10:51:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Leijsen-2011">
<DESCRIPTION>
<P>Underpowered due to lack of recruitment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-10-28 13:17:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2012">
<DESCRIPTION>
<P>None identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-10-28 13:18:44 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2013-10-28 13:18:44 +0000" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2013-10-28 13:17:50 +0000" MODIFIED_BY="Grade Profiler">Urodynamics compared to clinical management for management of urinary incontinence in children and adults</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>Urodynamics compared to clinical management for management of urinary incontinence in children and adults</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with management of urinary incontinence in children and adults<BR/>
<B>Settings:</B>
<BR/>
<B>Intervention:</B> urodynamics<BR/>
<B>Comparison: </B>clinical management</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>CLINICAL MANAGEMENT</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>URODYNAMICS</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number with incontinence after first year (subjective)</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.02 </B>
<BR/>(0.86 to 1.21)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>802<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>362 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>370 per 1000</B>
<BR/>(312 to 439)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>302 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>308 per 1000</B>
<BR/>(260 to 365)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number treated with surgery</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.99 </B>
<BR/>(0.88 to 1.12)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>982<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1,2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>786 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>779 per 1000</B>
<BR/>(692 to 881)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>914 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>905 per 1000</B>
<BR/>(804 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number not satisfied with treatment</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 0.9 </B>
<BR/>(0.55 to 1.49)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>644<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>91 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>82 per 1000</B>
<BR/>(50 to 136)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>91 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>82 per 1000</B>
<BR/>(50 to 136)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Number whose treatment was changed after urodynamics</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 5.07 </B>
<BR/>(1.87 to 13.74)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>272<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,3,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>30 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>151 per 1000</B>
<BR/>(56 to 410)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>30 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>152 per 1000</B>
<BR/>(56 to 412)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Incidence of urinary tract infection associated with urodynamics</B> - not reported</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life measures following treatment after urodynamics</B>
<BR/>Health status measures - General health King's QoL scores at 6 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life measures following treatment after urodynamics in the intervention groups was<BR/>
<B>6.4 lower</B>
<BR/>(16.61 lower to 3.81 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>75<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1,6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Health economics measure</B> - not reported</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% CI) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Not applicable as there are fewer than 10 trials<BR/>
<SUP>2</SUP> 4/5 trials included in the meta-analysis had low risk of bias and it was unclear in the fifth trial<BR/>
<SUP>3</SUP> Results are inconsistent<BR/>
<SUP>4</SUP> Crosses line of no effect and the CI is very wide (0.55 to 1.49)<BR/>
<SUP>5</SUP> No explanation was provided<BR/>
<SUP>6</SUP> Not applicable<BR/>
<SUP>7</SUP> Imprecise result</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Urodynamics versus clinical management</NAME>
<DICH_OUTCOME CHI2="1.004336765995826" CI_END="1.2897556370884684" CI_START="0.9161602436869879" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0870247645622604" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="45" I2="0.4318039668224215" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.11050743470473012" LOG_CI_START="-0.038028558141664184" LOG_EFFECT_SIZE="0.03623943828153298" METHOD="MH" MODIFIED="2013-02-08 09:41:28 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3162636693997469" P_Q="1.0" P_Z="0.3388832388014398" Q="0.0" RANDOM="NO" SCALE="3.299381906001905" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="69" WEIGHT="100.0" Z="0.9563741755874486">
<NAME>Number with incontinence within first year (subjective)</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1741639334065055" CI_START="0.9080251753599914" EFFECT_SIZE="1.0325552825552826" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="37" LOG_CI_END="0.06972873609691636" LOG_CI_START="-0.04190211032433924" LOG_EFFECT_SIZE="0.013913312886288587" MODIFIED="2011-06-22 10:15:59 +0100" MODIFIED_BY="[Empty name]" ORDER="22" O_E="0.0" SE="0.06557251176944727" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="44" TOTAL_2="41" VAR="0.004299754299754301" WEIGHT="85.17614230903384"/>
<DICH_DATA CI_END="3.0984074462823625" CI_START="0.6325830395068648" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.49113852770235333" LOG_CI_START="-0.19888245634587734" LOG_EFFECT_SIZE="0.146128035678238" ORDER="4798" O_E="0.0" SE="0.4053217416888888" STUDY_ID="STD-Ramsay-1995" TOTAL_1="20" TOTAL_2="28" VAR="0.1642857142857143" WEIGHT="14.823857690966168"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.7112669689368545" CI_END="1.206552509440132" CI_START="0.8592983573319918" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0182281617578144" ESTIMABLE="YES" EVENTS_1="150" EVENTS_2="145" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.081546227250905" LOG_CI_START="-0.06585601842087509" LOG_EFFECT_SIZE="0.00784510441501495" METHOD="MH" MODIFIED="2013-03-26 12:52:51 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4383160553448885" P_Q="1.0" P_Z="0.8347386057665119" Q="0.0" RANDOM="NO" SCALE="4.43" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="402" TOTAL_2="400" WEIGHT="100.0" Z="0.2086280577111886">
<NAME>Number with incontinence after first year (subjective)</NAME>
<GROUP_LABEL_1>Favours UDS</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1585291726462228" CI_START="0.8350598017314715" EFFECT_SIZE="0.9835858585858586" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="36" LOG_CI_END="0.06390697412924139" LOG_CI_START="-0.0782824219630995" LOG_EFFECT_SIZE="-0.007187723916929054" MODIFIED="2011-06-22 10:29:25 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.08352275511350324" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="44" TOTAL_2="41" VAR="0.006976050621750232" WEIGHT="25.510770695659264"/>
<DICH_DATA CI_END="1.2240498535058302" CI_START="0.736473710209354" EFFECT_SIZE="0.9494632889652211" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="85" LOG_CI_END="0.08779910625853991" LOG_CI_START="-0.13284275148908972" LOG_EFFECT_SIZE="-0.022521822615274904" MODIFIED="2013-02-19 14:22:33 +0000" MODIFIED_BY="[Empty name]" ORDER="51" O_E="0.0" SE="0.1296061194357682" STUDY_ID="STD-Nager-2009" TOTAL_1="274" TOTAL_2="273" VAR="0.016797746195198606" WEIGHT="58.28670296158784"/>
<DICH_DATA CI_END="3.8266251380439367" CI_START="0.8402233979632292" EFFECT_SIZE="1.793103448275862" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" LOG_CI_END="0.5828159201673205" LOG_CI_START="-0.07560522869563431" LOG_EFFECT_SIZE="0.2536053457358431" MODIFIED="2011-07-29 16:57:57 +0100" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.3867598420793508" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="29" TOTAL_2="28" VAR="0.1495831754452444" WEIGHT="4.875380430994158"/>
<DICH_DATA CI_END="1.9367286535709127" CI_START="0.6437377795658471" EFFECT_SIZE="1.116577540106952" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="17" LOG_CI_END="0.2870687779148938" LOG_CI_START="-0.19129100232744253" LOG_EFFECT_SIZE="0.04788888779372562" MODIFIED="2013-02-08 09:40:27 +0000" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.28099090283344985" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="55" TOTAL_2="58" VAR="0.07895588747515725" WEIGHT="11.327145911758738"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="19" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-02-08 09:41:28 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.31" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="44" TOTAL_2="41" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence or not improved within first year (subjective)</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7121503741319133" CI_START="0.6334754876946227" EFFECT_SIZE="1.0414438502673797" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.2335419050769768" LOG_CI_START="-0.19827018546077055" LOG_EFFECT_SIZE="0.01763585980810312" MODIFIED="2011-06-22 10:16:48 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.2536485594861942" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="44" TOTAL_2="41" VAR="0.06433759172942138" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0689427095747347" CI_END="1.3806945776236663" CI_START="0.7706175249342642" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0314976675196648" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="69" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.14009761925743988" LOG_CI_START="-0.11316111873892272" LOG_EFFECT_SIZE="0.013468250259258545" METHOD="MH" MODIFIED="2013-02-19 15:12:28 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7928824638119607" P_Q="1.0" P_Z="0.8348690279114843" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="326" TOTAL_2="323" WEIGHT="100.0" Z="0.20846100436067186">
<NAME>Number with incontinence or not improved after first year (subjective)</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3887208485933245" CI_START="0.7408535489241486" EFFECT_SIZE="1.014316897791474" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="59" LOG_CI_END="0.14261495552916698" LOG_CI_START="-0.1302676343690798" LOG_EFFECT_SIZE="0.006173660580043601" MODIFIED="2013-02-19 14:25:08 +0000" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.16029258409683542" STUDY_ID="STD-Nager-2009" TOTAL_1="264" TOTAL_2="259" VAR="0.025693712516441054" WEIGHT="85.82058354862352"/>
<DICH_DATA CI_END="2.4817691269049247" CI_START="0.519517954853373" EFFECT_SIZE="1.135483870967742" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.3947613776563198" LOG_CI_START="-0.2843994383686031" LOG_EFFECT_SIZE="0.055180969643858345" MODIFIED="2013-01-22 15:58:47 +0000" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.3989424252332991" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="62" TOTAL_2="64" VAR="0.15915505865102642" WEIGHT="14.17941645137649"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0012315043066435652" CI_END="5.756329619129995" CI_START="0.5277818827278625" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7430107526881722" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.7601456545610631" LOG_CI_START="-0.2775455219719033" LOG_EFFECT_SIZE="0.24130006629457987" METHOD="MH" MODIFIED="2013-04-04 13:37:21 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.972005748942541" P_Q="1.0" P_Z="0.36202013450964654" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="92" WEIGHT="100.0" Z="0.9115225224996971">
<NAME>Number treated conservatively</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>UDS</GRAPH_LABEL_2>
<DICH_DATA CI_END="18.85544248701275" CI_START="0.17306766637846546" EFFECT_SIZE="1.8064516129032258" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2754367285959523" LOG_CI_START="-0.7617840622520969" LOG_EFFECT_SIZE="0.2568263331719277" MODIFIED="2013-02-11 09:51:25 +0000" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="1.1966735769496981" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="31" TOTAL_2="28" VAR="1.4320276497695852" WEIGHT="26.250000000000004"/>
<DICH_DATA CI_END="6.894094531898393" CI_START="0.429335533649828" EFFECT_SIZE="1.7204301075268817" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8384772341633654" LOG_CI_START="-0.367203165959386" LOG_EFFECT_SIZE="0.23563703410198966" MODIFIED="2013-02-08 10:51:35 +0000" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.7082226352463389" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="62" TOTAL_2="64" VAR="0.5015793010752688" WEIGHT="73.75"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6590260709542883" CI_END="3.313709946260831" CI_START="1.3188925264946736" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="2.0905566921503174" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.5203144913339737" LOG_CI_START="0.12020940733409274" LOG_EFFECT_SIZE="0.32026194933403324" METHOD="MH" MODIFIED="2013-04-04 13:38:03 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.41690428287812964" P_Q="1.0" P_Z="0.0017028769838195676" Q="0.0" RANDOM="NO" SCALE="232.33" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="73" TOTAL_2="66" WEIGHT="99.99999999999999" Z="3.1376851303068345">
<NAME>Number treated with drugs</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>UDS</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.065429883433188" CI_START="1.2262066404720042" EFFECT_SIZE="1.9387755102040816" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="14" LOG_CI_END="0.4864913868190468" LOG_CI_START="0.0885636637016214" LOG_EFFECT_SIZE="0.2875275252603341" ORDER="4796" O_E="0.0" SE="0.23374471433317318" STUDY_ID="STD-Khullar-2000" TOTAL_1="42" TOTAL_2="38" VAR="0.05463659147869673" WEIGHT="96.55432324755033"/>
<DICH_DATA CI_END="117.65286794762505" CI_START="0.3420500049383825" EFFECT_SIZE="6.34375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.070602518155874" LOG_CI_START="-0.4659103989692598" LOG_EFFECT_SIZE="0.802346059593307" MODIFIED="2011-10-21 11:32:11 +0100" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="1.4899602434607429" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="31" TOTAL_2="28" VAR="2.219981527093596" WEIGHT="3.445676752449661"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.38884651113031" CI_END="1.1161579140437765" CI_START="0.8798134449028202" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.990964550027094" ESTIMABLE="YES" EVENTS_1="401" EVENTS_2="383" I2="67.71289404218267" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.04772564294041635" LOG_CI_START="-0.055609405620704495" LOG_EFFECT_SIZE="-0.003941881340144057" METHOD="MH" MODIFIED="2013-08-21 11:46:26 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.014682278513348912" P_Q="1.0" P_Z="0.8811339033984831" Q="0.0" RANDOM="YES" SCALE="37.27379998783161" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.008585246571037649" TOTALS="YES" TOTAL_1="495" TOTAL_2="487" WEIGHT="100.00000000000003" Z="0.14953194614203136">
<NAME>Number treated with surgery</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>UDS</GRAPH_LABEL_2>
<DICH_DATA CI_END="32.06873347701284" CI_START="0.4346220217199567" EFFECT_SIZE="3.7333333333333334" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5060818082350789" LOG_CI_START="-0.3618882723340406" LOG_EFFECT_SIZE="0.5720967679505192" MODIFIED="2011-06-22 10:15:15 +0100" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="1.0972548719273267" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="45" TOTAL_2="42" VAR="1.2039682539682541" WEIGHT="0.3038572409576892"/>
<DICH_DATA CI_END="5.529353013298537" CI_START="1.0527657786792044" EFFECT_SIZE="2.4126984126984126" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.7426743177075027" LOG_CI_START="0.022331759274878956" LOG_EFFECT_SIZE="0.3825030384911908" ORDER="4797" O_E="0.0" SE="0.4231327845764951" STUDY_ID="STD-Khullar-2000" TOTAL_1="42" TOTAL_2="38" VAR="0.17904135338345864" WEIGHT="1.9637043003327508"/>
<DICH_DATA CI_END="1.080059788105273" CI_START="0.9912877869832686" EFFECT_SIZE="1.0347222222222223" ESTIMABLE="YES" EVENTS_1="298" EVENTS_2="288" LOG_CI_END="0.03344779708464352" LOG_CI_START="-0.0038002444505946917" LOG_EFFECT_SIZE="0.014823776317024424" MODIFIED="2013-02-19 14:29:23 +0000" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.021879683978578174" STUDY_ID="STD-Nager-2009" TOTAL_1="315" TOTAL_2="315" VAR="4.7872057100245037E-4" WEIGHT="40.649216332499705"/>
<DICH_DATA CI_END="1.030981581564015" CI_START="0.733771662829378" EFFECT_SIZE="0.8697729988052568" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="27" LOG_CI_END="0.013250906702949906" LOG_CI_START="-0.13443906406339554" LOG_EFFECT_SIZE="-0.060594078680222825" MODIFIED="2011-07-29 16:57:15 +0100" MODIFIED_BY="[Empty name]" ORDER="29" O_E="0.0" SE="0.08675381990529728" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="31" TOTAL_2="28" VAR="0.007526225268160755" WEIGHT="22.868373843477993"/>
<DICH_DATA CI_END="1.0570757296268636" CI_START="0.8801577324199379" EFFECT_SIZE="0.9645690111052353" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="61" LOG_CI_END="0.024106101575109874" LOG_CI_START="-0.05543949128039454" LOG_EFFECT_SIZE="-0.01566669485264235" MODIFIED="2013-02-08 09:44:16 +0000" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.04672547500035836" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="62" TOTAL_2="64" VAR="0.0021832700140091144" WEIGHT="34.214848282731886"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.3637742756239053" CI_END="13.742224378116504" CI_START="1.8732736509340124" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="5.0737507657302885" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="4" I2="40.5429783296311" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="1.1380570352674948" LOG_CI_START="0.27260122447061497" LOG_EFFECT_SIZE="0.7053291298690548" METHOD="MH" MODIFIED="2013-04-09 10:29:00 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.18602282251256075" P_Q="1.0" P_Z="0.0013999435884978597" Q="0.0" RANDOM="NO" SCALE="305.43" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="138" TOTAL_2="134" WEIGHT="100.00000000000001" Z="3.1946626842043875">
<NAME>Number whose treatment was changed after urodynamics</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Clinical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>UDS</GRAPH_LABEL_2>
<DICH_DATA CI_END="101.40677548901837" CI_START="1.9328097067954337" EFFECT_SIZE="14.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="1" LOG_CI_END="2.0060669733324974" LOG_CI_START="0.2861890980239787" LOG_EFFECT_SIZE="1.146128035678238" MODIFIED="2013-03-28 09:25:11 +0000" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="1.010264777489011" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="45" TOTAL_2="42" VAR="1.0206349206349208" WEIGHT="22.930141530824127"/>
<DICH_DATA CI_END="117.65286794762505" CI_START="0.3420500049383825" EFFECT_SIZE="6.34375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.070602518155874" LOG_CI_START="-0.4659103989692598" LOG_EFFECT_SIZE="0.802346059593307" MODIFIED="2013-03-28 09:25:12 +0000" MODIFIED_BY="[Empty name]" ORDER="33" O_E="0.0" SE="1.4899602434607429" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="31" TOTAL_2="28" VAR="2.219981527093596" WEIGHT="11.627962481204802"/>
<DICH_DATA CI_END="6.894094531898393" CI_START="0.429335533649828" EFFECT_SIZE="1.7204301075268817" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8384772341633654" LOG_CI_START="-0.367203165959386" LOG_EFFECT_SIZE="0.23563703410198966" MODIFIED="2013-03-28 09:25:12 +0000" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.7082226352463389" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="62" TOTAL_2="64" VAR="0.5015793010752688" WEIGHT="65.44189598797108"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-04-09 10:29:00 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="277.35" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="52" TOTAL_2="47" WEIGHT="0.0" Z="0.0">
<NAME>Number not returning for further treatment</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7938814751059218" CI_START="0.09742415298043389" EFFECT_SIZE="0.2781065088757396" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.10024433201850808" LOG_CI_START="-1.0113333613374043" LOG_EFFECT_SIZE="-0.5557888466779561" MODIFIED="2011-10-28 15:48:04 +0100" MODIFIED_BY="[Empty name]" ORDER="10" O_E="0.0" SE="0.5351782057853505" STUDY_ID="STD-Majumdar-2009" TOTAL_1="52" TOTAL_2="47" VAR="0.2864157119476269" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.014916845162643981" CI_END="1.4893501068769233" CI_START="0.5469319883037833" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9025370990904739" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.17299680091665867" LOG_CI_START="-0.2620666753864671" LOG_EFFECT_SIZE="-0.044534937234904204" METHOD="MH" MODIFIED="2013-04-09 10:28:59 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.9027924729978262" P_Q="1.0" P_Z="0.6882284140023422" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="327" TOTAL_2="317" WEIGHT="100.0" Z="0.4012604035432655">
<NAME>Number not satisfied with treatment</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5463348823346392" CI_START="0.511675213796515" EFFECT_SIZE="0.8895061728395062" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="24" LOG_CI_END="0.18930355284267295" LOG_CI_START="-0.2910056202999562" LOG_EFFECT_SIZE="-0.050851033728641644" MODIFIED="2013-02-11 09:36:40 +0000" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.28213598587273236" STUDY_ID="STD-Nager-2009" TOTAL_1="270" TOTAL_2="262" VAR="0.07960071452437864" WEIGHT="82.71900430828147"/>
<DICH_DATA CI_END="3.1494283887570287" CI_START="0.2956268866988009" EFFECT_SIZE="0.9649122807017544" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4982317378736229" LOG_CI_START="-0.529256070230118" LOG_EFFECT_SIZE="-0.015512166178247553" MODIFIED="2013-02-08 10:18:03 +0000" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.6035514246268159" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="57" TOTAL_2="55" VAR="0.36427432216905903" WEIGHT="17.280995691718527"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-04-09 11:36:37 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="89.22" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Number with urgency symptoms or urgency incontinence after treatment</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="42.28295214113616" CI_START="0.6945921554818106" EFFECT_SIZE="5.419354838709677" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6261653015740585" LOG_CI_START="-0.1582701257908779" LOG_EFFECT_SIZE="0.7339475878915901" MODIFIED="2011-10-21 11:25:01 +0100" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="1.0481862031319873" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="31" TOTAL_2="28" VAR="1.098694316436252" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Volume/weight of urine lost on pad test</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<CONT_DATA CI_END="11.504735007784681" CI_START="-7.304735007784682" EFFECT_SIZE="2.1" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="3.9" ORDER="4799" SD_1="19.3" SD_2="11.1" SE="4.798422359782134" STUDY_ID="STD-Ramsay-1995" TOTAL_1="20" TOTAL_2="28" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.32318000461680324" CI_START="-0.1631800046168032" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.5190710599856784" Q="0.0" RANDOM="NO" SCALE="1.1113630549099953" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="28" UNITS="" WEIGHT="100.0" Z="0.6447780071814754">
<NAME>Number of incontinence episodes in 24 hours</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.32318000461680324" CI_START="-0.1631800046168032" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.43" ORDER="4800" SD_1="0.44" SD_2="0.4" SE="0.12407371081049247" STUDY_ID="STD-Ramsay-1995" TOTAL_1="20" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence within first year (objective)</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.3635426451257926" CI_START="0.5827189385692173" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.5267969383144665" LOG_CI_START="-0.2345408669579906" LOG_EFFECT_SIZE="0.146128035678238" ORDER="4801" O_E="0.0" SE="0.4472135954999579" STUDY_ID="STD-Ramsay-1995" TOTAL_1="20" TOTAL_2="28" VAR="0.2" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.1409153826662124" CI_END="2.0830453012643306" CI_START="0.8490943085494397" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3299255278977828" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.3186987149190316" LOG_CI_START="-0.07104407017070291" LOG_EFFECT_SIZE="0.12382732237416438" METHOD="MH" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.9319671826254893" P_Q="1.0" P_Z="0.2129767460951012" Q="0.0" RANDOM="NO" SCALE="18.5" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="286" TOTAL_2="286" WEIGHT="100.00000000000001" Z="1.2454218599557365">
<NAME>Number with incontinence after first year (objective)</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1839271964789164" CI_START="0.8545964052144466" EFFECT_SIZE="1.366153846153846" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="26" LOG_CI_END="0.33923815660848883" LOG_CI_START="-0.06823893833699803" LOG_EFFECT_SIZE="0.1354996091357454" MODIFIED="2013-02-11 09:37:43 +0000" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.2393540626151294" STUDY_ID="STD-Nager-2009" TOTAL_1="225" TOTAL_2="222" VAR="0.05729036729036729" WEIGHT="89.77187866826075"/>
<DICH_DATA CI_END="6.339402912186508" CI_START="0.14627523772874956" EFFECT_SIZE="0.9629629629629629" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8020483550183094" LOG_CI_START="-0.8348291873946482" LOG_EFFECT_SIZE="-0.01639041618816937" MODIFIED="2011-10-21 17:19:52 +0100" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.9615099710878845" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="27" TOTAL_2="26" VAR="0.9245014245014246" WEIGHT="6.988916649877368"/>
<DICH_DATA CI_END="17.18683964160233" CI_START="0.07267973485208065" EFFECT_SIZE="1.1176470588235294" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2351960248896725" LOG_CI_START="-1.1385866657405623" LOG_EFFECT_SIZE="0.048304679574555046" MODIFIED="2013-02-08 10:19:49 +0000" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="1.3943717028900269" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="34" TOTAL_2="38" VAR="1.9442724458204335" WEIGHT="3.239204681861887"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="67" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.2958288697812916" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="315" TOTAL_2="315" WEIGHT="0.0" Z="0.0">
<NAME>Number with adverse events / complications</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4970969328028683" CI_START="0.805823660204783" EFFECT_SIZE="1.098360655737705" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="61" LOG_CI_END="0.1752499205959103" LOG_CI_START="-0.0937599852157914" LOG_EFFECT_SIZE="0.04074496769005944" MODIFIED="2013-02-19 14:41:24 +0000" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.15801775029430343" STUDY_ID="STD-Nager-2009" TOTAL_1="315" TOTAL_2="315" VAR="0.02496960940807283" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.22576008385195" CI_END="1.4932706469627943" CI_START="0.293866474449625" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6624365482233502" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" I2="18.417966682558234" I2_Q="100.0" ID="CMP-001.17" LOG_CI_END="0.1741385283077876" LOG_CI_START="-0.5318499572823739" LOG_EFFECT_SIZE="-0.1788557144872932" METHOD="MH" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.26823326382866675" P_Q="0.0" P_Z="0.3206720372539327" Q="1.7918020469972366E-32" RANDOM="NO" SCALE="29.456105575339517" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="346" TOTAL_2="343" WEIGHT="100.0" Z="0.9930778361951196">
<NAME>Number with voiding dysfunction after treatment</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.0671749105430144" CI_START="0.3260329225316203" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.4867385430244386" LOG_CI_START="-0.48673854302443853" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-02-06 11:25:54 +0000" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.5718252591344029" STUDY_ID="STD-Nager-2009" TOTAL_1="315" TOTAL_2="315" VAR="0.326984126984127" WEIGHT="44.923857868020306"/>
<DICH_DATA CI_END="1.3541563655651117" CI_START="0.11065480796858986" EFFECT_SIZE="0.3870967741935484" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.1316688155907795" LOG_CI_START="-0.9560297111640752" LOG_EFFECT_SIZE="-0.41218044778664786" MODIFIED="2011-10-21 11:24:29 +0100" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.6389194988103443" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="31" TOTAL_2="28" VAR="0.40821812596006146" WEIGHT="55.076142131979694"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.4764998264445337" CI_END="1.8804801088166756" CI_START="0.07823815691762243" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3835691565207853" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="59.62042923153836" I2_Q="100.0" ID="CMP-001.18" LOG_CI_END="0.2742687439393035" LOG_CI_START="-1.1065813889200244" LOG_EFFECT_SIZE="-0.41615632249036055" METHOD="MH" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.1155594206095627" P_Q="0.0" P_Z="0.23745352338131964" Q="1.8734933826353674E-32" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="102" WEIGHT="100.0" Z="1.1813757113971124">
<NAME>Deaths</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8122253641771893" CI_START="0.005603960680533836" EFFECT_SIZE="0.10077519379844961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.25821220456187643" LOG_CI_START="-2.251504920546701" LOG_EFFECT_SIZE="-0.9966463579924122" ORDER="4804" O_E="0.0" SE="1.4742202625889078" STUDY_ID="STD-Khullar-2000" TOTAL_1="42" TOTAL_2="38" VAR="2.1733253826277084" WEIGHT="90.55610398157289"/>
<DICH_DATA CI_END="74.56410178659046" CI_START="0.12848674679450237" EFFECT_SIZE="3.0952380952380953" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.872529790631925" LOG_CI_START="-0.8911416668140524" LOG_EFFECT_SIZE="0.49069406190893633" MODIFIED="2013-02-08 10:29:13 +0000" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="1.623394294498116" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="62" TOTAL_2="64" VAR="2.6354090354090354" WEIGHT="9.443896018427115"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="32.99926379486955" CI_END="0.1613695586056949" CI_START="-0.49147974323212384" CI_STUDY="95" CI_TOTAL="95" DF="21" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.16505509231321447" ESTIMABLE="YES" I2="36.36221665264876" I2_Q="39.36611791128146" ID="CMP-001.19" MODIFIED="2013-10-28 13:30:44 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.04622530621970977" P_Q="0.033870094460782374" P_Z="0.3216628452950908" Q="32.98485815362492" RANDOM="NO" SCALE="18.23406931874937" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1600" TOTAL_2="1478" UNITS="" WEIGHT="2100.0" Z="0.9910465875912017">
<NAME>Health status measures</NAME>
<GROUP_LABEL_1>Urodynamics</GROUP_LABEL_1>
<GROUP_LABEL_2>Clinical management</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours UDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clinical</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.8127215401357333" CI_START="-16.61272154013573" DF="0" EFFECT_SIZE="-6.399999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.01" MODIFIED="2011-07-29 10:19:20 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.21935336804725925" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="1.2282494388748049">
<NAME>General health King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="3.8127215401357315" CI_START="-16.61272154013573" EFFECT_SIZE="-6.399999999999999" ESTIMABLE="YES" MEAN_1="25.0" MEAN_2="31.4" MODIFIED="2011-07-29 10:19:20 +0100" MODIFIED_BY="[Empty name]" ORDER="13" SD_1="24.5" SD_2="20.6" SE="5.210667961601526" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="16.914091191477247" CI_START="-5.314091191477251" DF="0" EFFECT_SIZE="5.799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.02" MODIFIED="2011-07-29 10:43:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3063897252085396" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="1.022826870365218">
<NAME>Incontinence impact from King's QoL questionnaire</NAME>
<CONT_DATA CI_END="16.914091191477247" CI_START="-5.314091191477251" EFFECT_SIZE="5.799999999999997" ESTIMABLE="YES" MEAN_1="82.1" MEAN_2="76.3" MODIFIED="2011-07-29 10:14:57 +0100" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="24.6" SD_2="24.2" SE="5.670558887379452" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="11.58290110760646" CI_START="-16.38290110760647" DF="0" EFFECT_SIZE="-2.4000000000000057" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.03" MODIFIED="2011-07-29 10:43:16 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.7365657111222494" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="0.33640469361091957">
<NAME>Role limitations King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="11.582901107606462" CI_START="-16.38290110760647" EFFECT_SIZE="-2.4000000000000057" ESTIMABLE="YES" MEAN_1="57.3" MEAN_2="59.7" MODIFIED="2011-07-29 10:19:42 +0100" MODIFIED_BY="[Empty name]" ORDER="14" SD_1="31.5" SD_2="30.0" SE="7.134264311947468" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="11.365219599232473" CI_START="-16.96521959923247" DF="0" EFFECT_SIZE="-2.799999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.04" MODIFIED="2011-07-29 10:43:17 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.698444789649729" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="0.38742069039363874">
<NAME>Physical limitations King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="11.365219599232471" CI_START="-16.965219599232466" EFFECT_SIZE="-2.799999999999997" ESTIMABLE="YES" MEAN_1="53.1" MEAN_2="55.9" MODIFIED="2011-07-29 10:20:04 +0100" MODIFIED_BY="[Empty name]" ORDER="16" SD_1="31.9" SD_2="30.4" SE="7.227285659821258" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.462831293921546E-32" CI_END="6.5929953992971315" CI_START="-22.19299539929713" DF="0" EFFECT_SIZE="-7.799999999999998" ESTIMABLE="YES" I2="100.0" ID="CMP-001.19.05" MODIFIED="2011-07-29 10:43:17 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.28816133396380816" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="1.062163827284971">
<NAME>Severity measures King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="6.592995399297132" CI_START="-22.192995399297125" EFFECT_SIZE="-7.799999999999997" ESTIMABLE="YES" MEAN_1="56.2" MEAN_2="64.0" MODIFIED="2011-07-29 10:20:18 +0100" MODIFIED_BY="[Empty name]" ORDER="20" SD_1="26.9" SD_2="34.8" SE="7.343499938176028" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="8.0337954393725" CI_START="-20.233795439372496" DF="0" EFFECT_SIZE="-6.099999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.06" MODIFIED="2011-07-29 10:43:18 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.3976084326579231" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="0.8459001941112805">
<NAME>Social limitations King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="8.0337954393725" CI_START="-20.233795439372496" EFFECT_SIZE="-6.099999999999998" ESTIMABLE="YES" MEAN_1="29.8" MEAN_2="35.9" MODIFIED="2011-07-29 10:20:37 +0100" MODIFIED_BY="[Empty name]" ORDER="17" SD_1="31.0" SD_2="31.0" SE="7.21125263058815" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="15.633944506399533" CI_START="-16.83394450639953" DF="0" EFFECT_SIZE="-0.5999999999999979" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.07" MODIFIED="2011-07-29 10:43:20 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Z="0.942252172087912" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="0.07243947336769875">
<NAME>Personal relationships King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="15.633944506399533" CI_START="-16.83394450639953" EFFECT_SIZE="-0.5999999999999979" ESTIMABLE="YES" MEAN_1="28.6" MEAN_2="29.2" MODIFIED="2011-07-29 10:20:55 +0100" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="34.3" SD_2="36.6" SE="8.2827769461331" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.399878625345786E-33" CI_END="9.621937474649108" CI_START="-16.62193747464911" DF="0" EFFECT_SIZE="-3.4999999999999996" ESTIMABLE="YES" I2="100.0" ID="CMP-001.19.08" MODIFIED="2011-07-29 10:43:21 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.6011280256009238" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="99.99999999999999" Z="0.5227790453310042">
<NAME>Emotions King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="9.621937474649108" CI_START="-16.62193747464911" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="49.3" MEAN_2="52.8" MODIFIED="2011-07-29 10:21:12 +0100" MODIFIED_BY="[Empty name]" ORDER="19" SD_1="30.1" SD_2="27.7" SE="6.694989080489885" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.882822390304939E-36" CI_END="12.209286219237233" CI_START="-12.409286219237222" DF="0" EFFECT_SIZE="-0.0999999999999943" ESTIMABLE="YES" I2="100.0" ID="CMP-001.19.09" MODIFIED="2011-07-29 14:04:09 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.987296103947678" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="0.01592264530722234">
<NAME>Sleep energy King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="12.209286219237233" CI_START="-12.409286219237222" EFFECT_SIZE="-0.09999999999999432" ESTIMABLE="YES" MEAN_1="52.2" MEAN_2="52.3" MODIFIED="2011-07-29 14:02:13 +0100" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="28.1" SD_2="26.1" SE="6.280363474192029" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.462831293921546E-32" CI_END="6.5929953992971315" CI_START="-22.19299539929713" DF="0" EFFECT_SIZE="-7.799999999999998" ESTIMABLE="YES" I2="100.0" ID="CMP-001.19.10" MODIFIED="2011-07-29 14:04:17 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.28816133396380816" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0" Z="1.062163827284971">
<NAME>Severity measures King's QoL scores at 6 months</NAME>
<CONT_DATA CI_END="6.592995399297132" CI_START="-22.192995399297125" EFFECT_SIZE="-7.799999999999997" ESTIMABLE="YES" MEAN_1="56.2" MEAN_2="64.0" MODIFIED="2011-07-29 14:03:32 +0100" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="26.9" SD_2="34.8" SE="7.343499938176028" STUDY_ID="STD-Majumdar-2009" TOTAL_1="42" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.26073206642272573" CI_START="-1.2607320664227257" DF="0" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.11" MODIFIED="2011-10-21 11:25:59 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Z="0.19767317521394617" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="22" WEIGHT="100.0" Z="1.288209128449527">
<NAME>Stress Incontinence Score (King's QoL)</NAME>
<CONT_DATA CI_END="0.26073206642272573" CI_START="-1.2607320664227257" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="1.2" MODIFIED="2011-07-29 10:14:34 +0100" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="0.9" SD_2="1.7" SE="0.3881357374029743" STUDY_ID="STD-Khullar-2000" TOTAL_1="42" TOTAL_2="22" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.2871041007798736" CI_START="-0.8871041007798739" DF="0" EFFECT_SIZE="0.6999999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.12" MODIFIED="2011-07-29 14:04:15 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Z="0.38733982836032543" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="28" WEIGHT="100.0" Z="0.8644516692407728">
<NAME>Visual Analogue Scale</NAME>
<CONT_DATA CI_END="2.2871041007798736" CI_START="-0.8871041007798739" EFFECT_SIZE="0.6999999999999997" ESTIMABLE="YES" MEAN_1="4.1" MEAN_2="3.4" MODIFIED="2011-07-29 10:14:44 +0100" MODIFIED_BY="[Empty name]" ORDER="28" SD_1="3.0" SD_2="2.4" SE="0.8097618697581936" STUDY_ID="STD-Ramsay-1995" TOTAL_1="20" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8843320520634759" CI_START="-1.2843320520634762" DF="0" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.13" MODIFIED="2011-07-29 14:04:14 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Z="0.717721046062352" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="41" WEIGHT="100.0" Z="0.36150623433297185">
<NAME>Change in severity index</NAME>
<CONT_DATA CI_END="0.8843320520634759" CI_START="-1.2843320520634762" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.6" MODIFIED="2011-07-29 10:44:25 +0100" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="2.6" SD_2="2.5" SE="0.5532408047375099" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="44" TOTAL_2="41" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.31246507287893044" CI_START="-0.5124650728789304" DF="0" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.14" MODIFIED="2011-07-29 14:04:13 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="1.0" P_Z="0.634656531256544" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="41" WEIGHT="100.0" Z="0.47518301873656">
<NAME>Change in incontinence impact index</NAME>
<CONT_DATA CI_END="0.31246507287893044" CI_START="-0.5124650728789304" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.7" MODIFIED="2011-07-29 10:48:22 +0100" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="0.99" SD_2="0.95" SE="0.2104452306942384" STUDY_ID="STD-Holtedahl-2000" TOTAL_1="44" TOTAL_2="41" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.014405641244629475" CI_END="22.189494895644728" CI_START="7.208466079272702" DF="1" EFFECT_SIZE="14.698980487458714" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.15" MODIFIED="2013-02-19 14:48:30 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.9044645326415957" P_Z="1.1999940771733139E-4" STUDIES="2" TAU2="0.0" TOTAL_1="76" TOTAL_2="79" WEIGHT="100.0" Z="3.8461273545367782">
<NAME>Change in UI (UDI subscale score for UI) at 12 months</NAME>
<CONT_DATA CI_END="27.6525670989956" CI_START="0.3474329010043995" EFFECT_SIZE="14.0" ESTIMABLE="YES" MEAN_1="-34.0" MEAN_2="-48.0" MODIFIED="2013-02-08 10:38:32 +0000" MODIFIED_BY="[Empty name]" ORDER="36" SD_1="22.0" SD_2="22.0" SE="6.965723455474339" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="19" TOTAL_2="21" WEIGHT="30.10195125412866"/>
<CONT_DATA CI_END="23.959403942855225" CI_START="6.040596057144777" EFFECT_SIZE="15.0" ESTIMABLE="YES" MEAN_1="-29.0" MEAN_2="-44.0" MODIFIED="2013-02-08 10:40:32 +0000" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="25.0" SD_2="24.0" SE="4.571208457668538" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="57" TOTAL_2="58" WEIGHT="69.89804874587134"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="19.94360247885428" CI_START="-3.943602478854279" DF="0" EFFECT_SIZE="8.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.16" MODIFIED="2013-02-19 14:48:59 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Z="0.189246101723252" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="28" WEIGHT="100.0" Z="1.3128126044115085">
<NAME>Change in UI (UDI subscale score for UI) at 24 months</NAME>
<CONT_DATA CI_END="19.94360247885428" CI_START="-3.943602478854279" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="-33.0" MEAN_2="-41.0" MODIFIED="2013-02-08 10:38:46 +0000" MODIFIED_BY="[Empty name]" ORDER="37" SD_1="23.0" SD_2="23.0" SE="6.093786708870107" STUDY_ID="STD-van-Leijsen-2011" TOTAL_1="29" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1713861627114018E-32" CI_END="11.042077748126237" CI_START="-5.042077748126237" DF="0" EFFECT_SIZE="3.0000000000000004" ESTIMABLE="YES" I2="100.0" ID="CMP-001.19.17" MODIFIED="2013-02-08 10:07:08 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Z="0.46469310072868" STUDIES="1" TAU2="0.0" TOTAL_1="57" TOTAL_2="58" WEIGHT="100.0" Z="0.7311408988790427">
<NAME>Voiding dysfunction (UDI subscale score)</NAME>
<CONT_DATA CI_END="11.042077748126237" CI_START="-5.042077748126237" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="14.0" MEAN_2="11.0" MODIFIED="2013-02-08 10:06:00 +0000" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="22.0" SD_2="22.0" SE="4.103176288728323" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="57" TOTAL_2="58" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.525454776588445" CI_START="-7.525454776588445" DF="0" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.18" MODIFIED="2013-02-11 09:35:38 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="1.0" P_Z="0.47805716654722197" STUDIES="1" TAU2="0.0" TOTAL_1="57" TOTAL_2="58" WEIGHT="100.0" Z="0.7094308301443326">
<NAME>Overactive bladder symptoms (UDI subscale score)</NAME>
<CONT_DATA CI_END="3.525454776588445" CI_START="-7.525454776588445" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="11.0" MODIFIED="2013-02-08 10:07:30 +0000" MODIFIED_BY="[Empty name]" ORDER="46" SD_1="13.0" SD_2="17.0" SE="2.819161382644032" STUDY_ID="STD-van-Leijsen-2012" TOTAL_1="57" TOTAL_2="58" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.20323888740986" CI_START="-1.20323888740986" DF="0" EFFECT_SIZE="2.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.19" MODIFIED="2013-02-19 14:33:26 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Z="0.18578824472864972" STUDIES="1" TAU2="0.0" TOTAL_1="272" TOTAL_2="266" WEIGHT="100.0" Z="1.3231417443818372">
<NAME>Urgency score (change in MESA score from baseline for UUI)</NAME>
<CONT_DATA CI_END="6.20323888740986" CI_START="-1.20323888740986" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="-19.7" MEAN_2="-22.2" MODIFIED="2013-02-19 14:33:26 +0000" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="21.4" SD_2="22.4" SE="1.8894423145631938" STUDY_ID="STD-Nager-2009" TOTAL_1="272" TOTAL_2="266" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.3639950921212645" CI_START="-2.5639950921212673" DF="0" EFFECT_SIZE="1.3999999999999986" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.20" MODIFIED="2013-02-19 15:42:22 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Z="0.48880031075107544" STUDIES="1" TAU2="0.0" TOTAL_1="272" TOTAL_2="266" WEIGHT="100.0" Z="0.6922182077898825">
<NAME>Change in IIQ score from baseline to 12 months</NAME>
<CONT_DATA CI_END="5.3639950921212645" CI_START="-2.5639950921212673" EFFECT_SIZE="1.3999999999999986" ESTIMABLE="YES" MEAN_1="-35.9" MEAN_2="-37.3" MODIFIED="2013-02-19 14:47:48 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="23.2" SD_2="23.7" SE="2.022483639183553" STUDY_ID="STD-Nager-2009" TOTAL_1="272" TOTAL_2="266" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.35126144674925786" CI_START="-4.248738553250742" DF="0" EFFECT_SIZE="-2.3" ESTIMABLE="YES" I2="0.0" ID="CMP-001.19.21" MODIFIED="2013-02-19 15:42:22 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="1.0" P_Z="0.020708962658403416" STUDIES="1" TAU2="0.0" TOTAL_1="267" TOTAL_2="261" WEIGHT="100.0" Z="2.3132488228974326">
<NAME>Change in SF-12 score from baseline to 12 months</NAME>
<CONT_DATA CI_END="-0.35126144674925763" CI_START="-4.2487385532507425" EFFECT_SIZE="-2.3" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="7.3" MODIFIED="2013-02-19 14:44:26 +0000" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="10.8" SD_2="12.0" SE="0.9942726338964099" STUDY_ID="STD-Nager-2009" TOTAL_1="267" TOTAL_2="261" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-10-28 13:20:46 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>One type of urodynamics versus another</NAME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-10-28 13:17:24 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-03-27 13:32:27 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAOgCAYAAAAXr/B1AABhGElEQVR42u2dD4RWy//HfyRJklhJ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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-10-28 13:17:24 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjAAAAFLCAMAAAD/IkbCAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-10-28 13:17:24 +0000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAaMAAAIXCAIAAAC+RKZdAAAkmElEQVR42u2dsU7kyPaHLSEhgg4I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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;11 reports of 7 studies were included in the quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;14 reports of 8 studies included in qualitative synthesis (plus 1 report of 1 ongoing study, please see the &lt;a link_type=&quot;SECTION&quot; href=&quot;CHARACTERISTICS_OF_ONGOING_STUDIES&quot; protected=&quot;true&quot;&gt;Characteristics of ongoing studies&lt;/a&gt; table)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;108 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;229 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;229 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;228 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;1 additional record identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;121 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;93 reports of 84 studies in full-text articles excluded, with reasons (Please see &lt;a link_type=&quot;SECTION&quot; href=&quot;CHARACTERISTICS_OF_EXCLUDED_STUDIES&quot; protected=&quot;true&quot;&gt;Characteristics of excluded studies&lt;/a&gt; table)&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>